FINAL PROGRAMME Chairman: Massimo SANTINI Co-Chairmen: Renato P. RICCI, Claudio PANdozI www.pacing2014.com

Transcription

ROME, ITALY - DECEMBER 2-5, 2014 - ERGIFE PALACE HOTEL
FINAL PROGRAMME
Chairman: Massimo SANTINI
Co-Chairmen: Renato P. Ricci, Claudio Pandozi
www.pacing2014.com
ROME, ITALY - DECEMBER 2 - 5, 2014
Chairman: Massimo SANTINI
Co-Chairmen: Renato P. Ricci, Claudio Pandozi
UNDER THE AUSPICES OF
2014
4
2014
Pag.
Acknowledgements
6
Faculty
8
Timetable
15
Scientific Programme
Tuesday, December 2
26
Wednesday, December 3
68
Thursday, December 4
111
Friday, December 5
154
171
181
Scientific and General Information
Scientific Information
192
General Information
195
Congress venue and Exhibition floorplan
201
ExhibitION Guide
203
Secretariats
Index of Chairmen and Authors
223
224
5
CONTENTS
Poster SessionS
2014
ACKNOWLEDGEMENTS
The Organizers express their gratitude to the following Companies, which have generously
contributed to the best success of the XVI International Symposium on Progress in Clinical
Pacing.
Principal Sponsor
Major Sponsors
6
ACKNOWLEDGEMENTS
2014
Sponsors
7
FACULTY
2014
H. Abdeddayem (Tunis, Tunisia)
A. Abdel-Aziz (Cairo, Egypt)
H. Abe (Kitakyushu, Japan)
B. Abi-Saleh (Beirut, Lebanon)
K. Adalet (Istanbul, Turkey)
P. Adragao (Carnaxide, Portugal)
P.M.G. Agricola (Crema-CR, Italy)
T. Agricola (Pescara, Italy)
L. Aguinaga (Buenos Aires, Argentina)
A. Aiello (Rome, Italy)
C. Akdeniz (Istanbul, Turkey)
A. Al Fagih (Riyadh, Saudi Arabia)
Y. Al Hebaishi (Riyadh, Saudi Arabia)
A.M. Al Musaad (Riyadh, Saudi Arabia)
J.P. Albenque (Toulouse, France)
E. Aliot (Vandoeuvre-lès-Nancy, France)
S. Alkaabi (Abu Dhabi, United Arab Emirates)
A.S. Al-Khadra (Riyadh, Saudi Arabia)
J. Almendral Garrote (Madrid, Spain)
G. Al-Mohani (Rome, Italy)
N. Al-Rawahi (Muscat, Oman)
E.U. Alt (Houston-TX, USA)
G. Altamura (Rome, Italy)
V. Altamura (Rome, Italy)
M. Alvarez (Granada, Spain)
C. Amellone (Ciriè-TO, Italy)
F. Ammirati (Rome, Italy)
K. Ando (Kitakyushu, Japan)
F. Andreotti (Rome, Italy)
D. Andresen (Berlin, Germany)
G. Andrikopoulos (Athens, Greece)
G. Ansalone (Rome, Italy)
F. Anselme (Rouen, France)
K. Aonuma (Tsukuba, Japan)
S. Aquilani (Rome, Italy)
O. Aquilina (Msida, Malta)
A. Ardashev (Moscow, Russian Federation)
G. Arena (Massa, Italy)
A. Arenal-Maiz (Madrid, Spain)
N. Asaad (Doha, Qatar)
N. Aspromonte (Rome, Italy)
A. Auriti (Rome, Italy)
H. Baccar (Sfax, Tunisia)
Y. Badaineh (Amman, Jordan)
H.K. Bali (Chandigarh, India)
D. Bänsch (Rostock, Germany)
G. Barbato (Bologna, Italy)
N. Basterra Sola (Pamplona, Spain)
W.R. Bauer (Wuerzburg, Germany)
8
F. Bello Morgado (Lisbon, Portugal)
F. Bellocci (Rome, Italy)
G. Bencsik (Szeged, Hungary)
D.G. Benditt (Minneapolis-MN, USA)
H. Benkemoun (Saint Cyprien, France)
S. Benussi (Milan, Italy)
O. Berenfeld (Ann Arbor-MI, USA)
A. Berkowitsch (Bad Nauheim, Germany)
M. Bernabei (Lancaster-PA, USA)
M. Bertaglia (Mirano-VE, Italy)
S. Berti (Massa, Italy)
F. Bianchi (Turin, Italy)
S. Bianchi (Rome, Italy)
L. Bianconi (Rome, Italy)
A. Biffi (Rome, Italy)
M. Biffi (Bologna, Italy)
L. Binner (Ulm, Germany)
G. Bisignani (Castrovillari-CS, Italy)
J.J. Blanc (Brest, France)
P.E. Bloch-Thomsen (Aalborg, Denmark)
C. Blomstrom Lundqvist (Uppsala, Sweden)
M. Bocchiardo (Pietra Ligure-SV, Italy)
L.V. Boersma (Nieuwegein, The Netherlands)
F. Bokhari (Jeddah, Saudi Arabia)
M.G. Bongiorni (Pisa, Italy)
H. Bonnemeier (Kiel, Germany)
A. Bonso (Feltre-BL, Italy)
L. Bontempi (Brescia, Italy)
J. Borbola (Budapest, Hungary)
M. Borggrefe (Mannheim, Germany)
G. Boriani (Bologna, Italy)
A. Borrelli (Rome, Italy)
F. Borrello (Catanzaro, Italy)
E. Boschetti (Terni, Italy)
G.L. Botto (Como, Italy)
N. Bottoni (Reggio Emilia, Italy)
J. Brachmann (Coburg, Germany)
F.A. Bracke (Eindhoven, The Netherlands)
A. Braghiroli (Veruno-NO, Italy)
A. Brandes (Odense, Denmark)
F. Briand (Besançon, France)
M. Brieda (Pordenone, Italy)
M. Brignole (Lavagna-GE, Italy)
A. Buiatti (Munich, Germany)
A. Bulava (České Budějovice, Czech Republic)
N. Cabanelas (Coimbra, Portugal)
G. Calcagnini (Rome, Italy)
L. Calò (Rome, Italy)
V. Calvi (Catania, Italy)
A. Campana (Salerno, Italy)
G. Campisi (Ragusa, Italy)
I. Can (Ankara, Turkey)
R. Cappato (Milan, Italy)
A. Capucci (Ancona, Italy)
F. Caravati (Varese, Italy)
C. Carbucicchio (Milan, Italy)
M.D. Carlson (Sylmar-CA, USA)
G. Carreras (Terni, Italy)
E. Casali (Modena, Italy)
A. Casini (Milan, Italy)
S. Castelletti (London, UK)
A. Castro (Rome, Italy)
D. Catanzariti (Rovereto-TN, Italy)
E. Celentano (Bari, Italy)
F. Censi (Rome, Italy)
N. Chadha (Faridabad, India)
S. Chandra (New Delhi, India)
M. Chauvin (Strasbourg, France)
K. Chen (Beijing, Republic of China)
G.B. Chierchia (Brussels, Belgium)
R. Choudhury (Sharjah, United Arab Emirates)
M. Chudzik (Lodz, Poland)
K.R.J. Chun (Frankfurt, Germany)
C. Cianfrocca (Rome, Italy)
R. Ciudin (Bucharest, Romania)
J. Clementy (Bordeaux, France)
C.R. Cole (Colorado Springs-CO, USA)
F. Colivicchi (Rome, Italy)
N. Combes (Toulose, France)
G. Corbucci (Milan, Italy)
J. Cosedis Nielsen (Skejby, Denmark)
F. Crea (Rome, Italy)
E. Crystal (Toronto-ON, Canada)
A. Curcio (Catanzaro, Italy)
A. Curnis (Brescia, Italy)
M. Czajkowski (Lublin, Poland)
C. D’Agostino (Bari, Italy)
K. Dagriri (Riyadh, Saudi Arabia)
P. Danna (Milan, Italy)
J.C. Daubert (Rennes, France)
D.W. Davies (London, UK)
C. De Asmundis (Brussels, Belgium)
C. De Chillou (Nancy, France)
P. De Filippo (Bergamo, Italy)
G. De Martino (Bari, Italy)
R. De Ponti (Varese, Italy)
E. De Ruvo (Rome, Italy)
F. De Seta (Rome, Italy)
A. De Simone (Maddaloni-CE, Italy)
P. Defaye (Grenoble, France)
J.C. Deharo (Marseille, France)
F. Del Carpio (La Crosse-WI, USA)
M. Del Greco (Rovereto-TN, Italy)
P. Della Bella (Milan, Italy)
A. Dello Russo (Milan, Italy)
P.P. Delnoy (Zwolle, The Netherlands)
T. Deneke (Bad Neustadt, Germany)
L. Di Biase (Austin-TX, USA)
S.A. Di Fusco (Rome, Italy)
G. Di Pasquale (Bologna, Italy)
T. Dickfeld (Baltimore-MD, USA)
P. Diotallevi (Alessandria, Italy)
M. Disertori (Trento, Italy)
P. Donateo (Lavagna-GE, Italy)
A. D’Onofrio (Naples, Italy)
A. D’Urso (Rome, Italy)
F. Drago (Rome, Italy)
V. Ducceschi (Vallo Lucania-SA, Italy)
F. Duru (Zurich, Switzerland)
M. Duytschaever (Gent, Belgium)
S.K. Dwivedi (Lucknow, India)
N. El Sherif (New York-NY, USA)
B. Elencwajg (Buenos Aires, Argentina)
C. Ermis (Antalya, Turkey)
N.A.M. Estes III (Boston-MA, USA)
S. Faerestrand (Bergen, Norway)
A.S. Fak (Istanbul, Turkey)
G.M. Fassini (Milan, Italy)
M. Faustino (Pescara, Italy)
S. Favale (Bari, Italy)
F. Fedele (Rome, Italy)
S. Fichtner (Munich, Germany)
S. Ficili (Rome, Italy)
J.D. Fisher (New York-NY, USA)
S. Foresti (Milan, Italy)
G.B. Forleo (Rome, Italy)
N. Fragakis (Thessaloniki, Greece)
P. Francia (Rome, Italy)
M. Frigerio (Milan, Italy)
P. Fumero Lessmann (Caracas, Venezuela)
F. Gadler (Stockholm, Sweden)
F. Gaita (Turin, Italy)
M. Galeazzi (Rome, Italy)
M. Gallagher (London, UK)
A. Ganguly (Durgapur, India)
T. Gaspar (Leipzig, Germany)
M. Gasparini (Milan, Italy)
9
FACULTY
2014
FACULTY
2014
J.C. Geller (Bad Berka, Germany)
G.F. Gensini (Florence, Italy)
F. Giada (Mestre-VE, Italy)
L. Gianfranchi (Ferrara, Italy)
G. Giannola (Cefalù-PA, Italy)
A. Giardina (Cagliari, Italy)
U. Giordano (Palermo, Italy)
K. Girotra (Fontainbleu, France)
C. Giustetto (Turin, Italy)
P.G. Golzio (Turin, Italy)
A. Gopi (Calicut, India)
B. Gorenek (Eskisehir, Turkey)
A. Grace (Cambridge, UK)
L. Gramegna (Trento, Italy)
D. Gras (Nantes, France)
M. Grimaldi (Acquaviva delle Fonti-BA, Italy)
E.G. Gronda (Milan, Italy)
S. Grossi (Turin, Italy)
A. Guaricci (Foggia, Italy)
F. Guarracini (Milan, Italy)
J.M. Guerra Ramos (Barcelona, Spain)
M. Gulizia (Catania, Italy)
R. Gupta (New Delhi, India)
M. Gwechenberger (Vienna, Austria)
A. Hamaad (Walsall, UK)
R. Hatala (Bratislava, Slovakia)
M. Hayashi (Tokyo, Japan)
A. Hersi (Riyadh, Saudi Arabia)
G. Hindricks (Leipzig, Germany)
K. Hirao (Tokyo, Japan)
E. Hoffmann (Munich, Germany)
M.M. Hossain (Dhaka, Bangladesh)
W. Hua (Beijing, Republic of China)
D. Huang (Chengdu, Republic of China)
S. Iacopino (Bari, Italy)
D. Igidbashian (Gorizia, Italy)
S. Ikeguchi (Moriyama City, Japan)
K. Imai (Hiroshima, Japan)
G. Inama (Cremona, Italy)
T. Ishikawa (Yokohama, Japan)
C.W. Israel (Frankfurt, Germany)
E. Ivanitskiy (Krasnoyarsk, Russian Federation)
J.W.E. Jarman (London, UK)
C. Jazra (Beirut, Lebanon)
D.K. Jhamb (New Delhi, India)
L.J.L.M. Jordaens (Rotterdam, The Netherlands)
W. Jung (Villingen-Schwenningen, Germany)
R.A. Kaba (Chertsey, UK)
N. Kadri (Amman, Jordan)
10
A. Kapoor (Lucknow, India)
T. Karagoz (Ankara, Turkey)
C. Karmelic Serrano (Santiago, Chile)
J. Kautzner (Prague, Czech Republic)
R. Keegan (Bahia Blanca, Argentina)
C. Kennergren (Goteborg, Sweden)
U. Khanolkar (Goa, India)
M. Khoury (Beirut, Lebanon)
T. Klingenheben (Bonn, Germany)
A. Kloppe (Bochum, Germany)
S. Klugmann (Milan, Italy)
R.E. Knops (Amsterdam, The Netherlands)
Y. Kobayashi (Tokyo, Japan)
J. Kobe (Munster, Germany)
B. Köktürk (Köln, Germany)
A. Kol (Rome, Italy)
C. Kolb (Munich, Germany)
S. Koulouris (Bayreuth, Germany)
J. Koyama (Kumamoto City, Japan)
M. Kuniss (Bad Nauheim, Germany)
A. Kutarski (Lublin, Poland)
V. Kuznetsov (Tyumen, Russian Federation)
M. La Meir (Maastricht, The Netherlands)
M.T. La Rovere (Montescano-PV, Italy)
F. Lamberti (Rome, Italy)
M. Landolina (Pavia, Italy)
C. Lavalle (Rome, Italy)
F. Laurenzi (Rome, Italy)
M. Lawrance Jesuraj (Coimbatore, India)
J.Y. Le Heuzey (Paris, France)
B. Lemke (Luedenscheid, Germany)
M. Lettino (Milan, Italy)
S. Levy (Marseille, France)
T. Lewalter (Munich, Germany)
F. Leyva (Birmingham, UK)
H. Li (Beijing, Republic of China)
D. Liao (Shanghai, Republic of China)
D. Lin (Philadelphia-PA, USA)
X. Liu (Beijing, Republic of China)
T.C.A. Lobban (Stratford Upon Avon, UK)
E.T. Locati (Milan, Italy)
M. Lovrić Benčić (Zagreb, Croatia)
A. Lubiński (Lodz, Poland)
R. Luise (L’Aquila, Italy)
M. Lunati (Milan, Italy)
A. Lupo (Mirano-VE, Italy)
M. Luzi (Ancona, Italy)
G. Luzzi (Bari, Italy)
P. Mabo (Rennes, France)
G. Maccabelli (Milan, Italy)
A. Maciag (Warsaw, Poland)
L. Macle (Montreal, Canada)
M. Magdi (Sharjah, United Arab Emirates)
G. Magenta (Milan, Italy)
A.P. Maggioni (Florence, Italy)
G. Maglia (Catanzaro, Italy)
G. Magliano (Rome, Italy)
B. Malecka (Krakow, Poland)
T. Manaka (Tokyo, Japan)
P.C. Mandal (Kolkatta, India)
H. Mansour (Beirut, Lebanon)
M. Mantica (Milan, Italy)
R. Mantovan (Cesena-FC, Italy)
B. Mariconti (Cesate-MI, Italy)
M. Marini (Trento, Italy)
M.F. Márquez Murillo (Mexico City, Mexico)
C. Marquié (Lille, France)
N.F. Marrouche (Salt Lake City-UT, USA)
D.T. Martin (Burlington-MA, USA)
M. Martinek (Innsbruck, Austria)
G. Mascioli (Bergamo, Italy)
K. Matsumoto (Saitama, Japan)
S. Matsuo (Tokyo, Japan)
P. Mazzone (Milan, Italy)
A. Meijer (Eindhoven, The Netherlands)
M. Meine (Utrecht, The Netherlands)
F. Melandri (Sassuolo-MO, Italy)
J. Melichercik (Lahr, Germany)
E. Menardi (Cuneo, Italy)
J. Michaelsen (Lingen, Germany)
A. Michelucci (Florence, Italy)
E. Mikhaylov (Saint Petersburg, Russian Federation)
G. Milasinovic (Belgrade, Serbia)
A. Mishra (Shillong, India)
P. Mitkowski (Poznan, Poland)
D. Mocini (Rome, Italy)
L.G. Molina (Mexico City, Mexico)
G. Molon (Negrar-VR, Italy)
M. Moltrasio (Milan, Italy)
L. Mont (Barcelona, Spain)
A.S. Montenero (Sesto S. Giovanni-MI, Italy)
R. Moosdorf (Marburg, Germany)
G. Morani (Verona, Italy)
J.M. Morgan (Southampton, UK)
C. Moro Serrano (Madrid, Spain)
F.M. Moscoso Costa (Lisbon, Portugal)
C. Muto (Naples, Italy)
F. Naccarella (Bologna, Italy)
T. Nakai (Tokyo, Japan)
H. Nakajima (Tokyo, Japan)
Y. Nakano (Hiroshima, Japan)
Y. Nakazato (Tokyo, Japan)
K.K.N. Namboodiri (Thiruvananthapuram, India)
S. Nardi (Castel Volturno-CE, Italy)
R. Nayak (Thodupuzha, India)
N. Neminushiy (Moscow, Russian Federation)
G. Neri (Montebelluna-TV, Italy)
T. Neumann (Bad Nauheim, Germany)
P. Neužil (Prague, Czech Republic)
V. Nissardi (Cagliari, Italy)
T. Nitta (Tokyo, Japan)
A. Nogami (Tsukuba, Japan)
P. Notarstefano (Arezzo, Italy)
E. Occhetta (Novara, Italy)
D. O’Donnell (Melbourne, Australia)
M. O’Neill (London, UK)
K. Okishige (Yokohama, Japan)
K. Okumura (Hirosaki, Japan)
M. Oliveira (Lisbon, Portugal)
S. Orazi (Rieti, Italy)
O. Oseroff (Buenos Aires, Argentina)
A. Oto (Ankara, Turkey)
L. Ottaviano (Milan, Italy)
B. Ozin (Ankara, Turkey)
D.L. Packer (Rochester-MN, USA)
L. Padeletti (Florence, Italy)
E.C. Palma (New York-NY, USA)
P. Palmisano (Tricase-LE, Italy)
L. Pandolfo (Rome, Italy)
A. Pandozi (Rome, Italy)
C. Pandozi (Rome, Italy)
L.P. Papavasileiou (Athens, Greece)
A. Pappalardo (Rome, Italy)
S. Paraskevaidis (Thessaloniki, Greece)
Q. Parisi (Campobasso, Italy)
V. Pasceri (Rome, Italy)
J.L. Pasquié (Montpellier, France)
G. Pastore (Rovigo, Italy)
K. Patel (Birmingham, UK)
M. Patete Ayala (Caracas, Venezuela)
D. Pecora (Brescia, Italy)
R.F.E. Pedretti (Tradate-VA, Italy)
G. Pelargonio (Rome, Italy)
G.B. Perego (Milan, Italy)
T. Pezawas (Vienna, Austria)
B. Pezzulich (Turin, Italy)
M. Piacenti (Pisa, Italy)
11
FACULTY
2014
FACULTY
2014
E. Picano (Pisa, Italy)
G. Piccirillo (Rome, Italy)
P. Pieragnoli (Florence, Italy)
C. Pignalberi (Rome, Italy)
R. Piotrowicz (Warsaw, Poland)
E.C.L. Pisanò (Lecce, Italy)
E. Pokushalov (Novosibirsk, Russian Federation)
A. Polewczyk (Kielce, Poland)
D. Porcelli (Rome, Italy)
S. Porcellini (Paderno Dugnano-MI, Italy)
D. Potenza (S. Giovanni Rotondo-FG, Italy)
C. Pratola (Ferrara, Italy)
C. Pristipino (Rome, Italy)
A. Proclemer (Udine, Italy)
F. Quartieri (Reggio Emilia, Italy)
A. Quesada (Valencia, Spain)
V. Radeljič (Zagreb, Croatia)
K. Rajappan (Oxford, UK)
A. Rapacciuolo (Naples, Italy)
L. Rapallini (Mounds View-MN, USA)
A. Raviele (Mestre-VE, Italy)
M. Rebecchi (Rome, Italy)
A.S. Revishvili (Moscow, Russian Federation)
R.P. Ricci (Rome, Italy)
D. Ricciardi (Rome, Italy)
M. Rillo (Taranto, Italy)
C.A. Rinaldi (London, UK)
P. Ritter (Bordeaux, France)
G. Rodriguez Diez (Mexico City, Mexico)
H. Rodriguez Reyes (Aguascalientes, Mexico)
A. Roguin (Haifa, Israel)
V. Romano (Rome, Italy)
A. Romanov (Novosibirsk, Russian Federation)
F. Romeo (Rome, Italy)
A. Rónaszéki (Nice, France)
R. Rordorf (Pavia, Italy)
M. Roser (Berlin, Germany)
P. Rossi (Rome, Italy)
A. Rossillo (Mestre-VE, Italy)
G. Rovaris (Monza-MI, Italy)
E. Rowland (London, UK)
G. Russo (Como, Italy)
M. Russo (Rome, Italy)
V. Russo (Taranto, Italy)
H. Sabbour (Abu Dhabi, United Arab Emirates)
F. Sacher (Bordeaux, France)
S. Sack (Munich, Germany)
A. Sagone (Milan, Italy)
T. Samsel (Minneapolis-MN, USA)
12
T. Sanna (Rome, Italy)
M. Santamaria (Campobasso, Italy)
L. Santini (Rome, Italy)
M. Santini (Rome, Italy)
M. Santomauro (Naples, Italy)
O.V. Sapelnikov (Moscow, Russian Federation)
R. Sapra (Faridabad, India)
B. Sarubbi (Naples, Italy)
B. Sassone (Bentivoglio-BO, Italy)
I. Savelieva (London, UK)
S. Saxena (Chandigarh, India)
M. Scaglione (Asti, Italy)
C. Scavée (Brussels, Belgium)
M.J. Schalij (Leiden, The Netherlands)
R. Schilling (London, UK)
A. Schirdewan (Berlin, Germany)
H. Schmidinger (Vienna, Austria)
B. Schmidt (Frankfurt, Germany)
C. Schmidt (Minneapolis-MN, USA)
M.A.E. Schneider (Sindelfingen, Germany)
J.O. Schwab (Bonn, Germany)
P.J. Schwartz (Milan, Italy)
E. Sciaraffia (Uppsala, Sweden)
A.M. Sciegata (Buenos Aires, Argentina)
P. Scipione (Ancona, Italy)
A. Scopinaro (Alessandria, Italy)
L. Segreti (Pisa, Italy)
K. Seidl (Ingolstadt, Germany)
G. Senatore (Ciriè-TO, Italy)
J. Senges (Heidelberg, Germany)
M. Senni (Bergamo, Italy)
P. Serpytis (Vilnius, Lithuania)
S. Setti (Genoa, Italy)
G. Sgarito (Palermo, Italy)
M. Sgueglia (Rome, Italy)
A. Shafquat (Riyadh, Saudi Arabia)
G. Sharma (New Delhi, India)
S. Sharma (Jammu, India)
M. Shenasa (San Jose-CA, USA)
W. Shimizu (Tokyo, Japan)
E. Shlyakhto (Saint Petersburg, Russian Federation)
M. Shoda (Tokyo, Japan)
M. Siebert (Berlin, Germany)
M. Silvano (Mestre-VE, Italy)
M.S. Silvetti (Rome, Italy)
E.N. Simantirakis (Heraklion, Greece)
K. Soejima (Tokyo, Japan)
A.P.M. Sohrabuzzaman (Dhaka, Bangladesh)
E. Soldati (Pisa, Italy)
2014
F. Solimene (Mercogliano-AV, Italy)
P. Sommer (Leipzig, Germany)
T. Sommer (Neuwied, Germany)
D. Spaziani (Magenta-MI, Italy)
G. Speciale (Rome, Italy)
J. Sperzel (Bad Nauheim, Germany)
S. Spitzer (Dresden, Germany)
G. Stabile (Naples, Italy)
C.T. Starck (Zurich, Switzerland)
T. Steen (Oslo, Norway)
C. Stefanadis (Athens, Greece)
P. Stefano (Florence, Italy)
G. Steinbeck (Munich, Germany)
D.M. Steinhaus (Kansas City-MO, USA)
C. Steinwender (Linz, Austria)
C. Stellbrink (Bielefeld, Germany)
M. Stewart (Mounds View-MN, USA)
M. Stockburger (Nauen, Germany)
C. Stoepel (Neuss, Germany)
C. Storti (Pavia, Italy)
F. Straube (Munich, Germany)
M. Strieper (Atlanta-GA, USA)
C. Suga (Saitama, Japan)
R. Sutton (Monte Carlo, Monaco)
T. Szili-Torok (Rotterdam, The Netherlands)
M. Taborsky (Olomouc, Czech Republic)
H. Tada (Fukui, Japan)
M. Takagi (Osaka, Japan)
N. Takahashi (Oita, Japan)
S. Takatsuki (Tokyo, Japan)
L. Tavazzi (Cotignola-RA, Italy)
A. Thajudeen (Trivandrum, India)
S. Thanvi (Gujarat, India)
S. Themistoclakis (Mestre-VE, Italy)
B. Thibault (Montreal, Canada)
D. Thomas (Heidelberg, Germany)
G. Tola (Cagliari, Italy)
M. Tomaino (Bolzano, Italy)
L. Tomasi (Verona, Italy)
C. Tondo (Milan, Italy)
M. Toniolo (Udine, Italy)
M. Toscano (Colleferro-RM, Italy)
H.J. Trappe (Herne, Germany)
E. Trip (Berlin, Germany)
M. Tritto (Castellanza-VA, Italy)
R. Tukkie (Haarlem, The Netherlands)
G. Turitto (Brooklyn-NY, USA)
V. Tuzcu (Istanbul, Turkey)
A. Ungar (Florence, Italy)
FACULTY
K. Uno (Tokyo, Japan)
A. Vado (Cuneo, Italy)
E. Vanoli (Milan, Italy)
P.E. Vardas (Heraklion, Greece)
N. Varma (Cleveland-OH, USA)
V.P. Vassilikos (Thessaloniki, Greece)
G. Vergara (Rovereto-TN, Italy)
R. Verlato (Camposampiero-PD, Italy)
A. Verma (Toronto, Canada)
E.G. Vester (Duesseldorf, Germany)
S. Viani (Pisa, Italy)
R. Vijayvergia (Chandigarh, India)
J.F. Viles-Gonzalez (Miami-FL, USA)
G.Q. Villani (Piacenza, Italy)
R. Villuendas (Badalona, Spain)
A. Vincenti (Monza-MI, Italy)
X. Viñolas Prat (Barcelona, Spain)
R. Violini (Rome, Italy)
L. Vitali-Serdoz (Coburg, Germany)
M. Volpe (Rome, Italy)
D. Weishaupt (Zurich, Switzerland)
E. Wissner (Hamburg, Germany)
K. Witte (Leeds, UK)
C. Wolpert (Ludwigsburg, Germany)
S.J. Worley (Lancaster-PA, USA)
J.K. Wranicz (Lodz, Poland)
M. Wright (London, UK)
T. Yamane (Tokyo, Japan)
J. Yang (Beijing, Republic of China)
S.M. Yashin (Saint Petersburg, Russian Federation)
H. Yokoshiki (Sapporo, Japan)
F. Zanon (Rovigo, Italy)
G. Zanotto (Legnago-VR, Italy)
M. Zardini (Parma, Italy)
W. Zareba (Rochester-NY, USA)
P. Zartner (Sankt Augustin, Germany)
R. Zbinden (Zurich, Switzerland)
M. Zecchin (Trieste, Italy)
S. Zhang (Beijing, Republic of China)
M. Ziacchi (Bologna, Italy)
G. Zingarini (San Sisto-PG, Italy)
M. Zoni Berisso (Genoa, Italy)
J. Zou (Nanjing, Republic of China)
H. Zouzou (Algiers, Algeria)
B. Zrenner (Munich, Germany)
L.M. Zuccaro (Rome, Italy)
13
2014
TIMETABLE
2014
Tuesday, December 2
Leptis magna 4 Leptis magna 2
09.00/10.30
Orange 1
Orange 2
COURSE
COURSE
SYMPOSIUM
INTERVENTIONAL
DEVICE IMPLANTATION
NOVEL ORAL
ANTICOAGULANTS
Session I
Session I: State of the art
RELIABILITY AND
CLINICAL IMPACT
OF AUTOMATIC PACING
PROGRAMMING
10.30/11.00 BREAK
11.00/12.30
Symposium
COURSE
COURSE
SYMPOSIUM
Newcomers in
prevention and
treatment of atrial
tachyarrhythmias:
a complete
armamentarium
INTERVENTIONAL
DEVICE IMPLANTATION
NOVEL ORAL
ANTICOAGULANTS
SUDDEN DEATH RISK
STRATIFICATION
BY SURFACE ECG
Session II
Session II: Noacs troubles
and troubleshooting
“STATE OF THE ART”
LECTURES
LECTURES
LUNCHEON PANEL
FREE PAPERS
BUSINESS MEETS
MEDICINE: PROCESS
OPTIMIZATION IN CARDIAC
RHYTHM MANAGEMENT
SYNCOPE
SYMPOSIUM
SYMPOSIUM
LEADS: TECHNOLOGY,
RELIABILITY AND
MONITORING AFTER 60
YEARS OF CARDIAC PACING
NEW TRANSCATHETER
PACING SYSTEM
TECHNOLOGY:
Reducing Dimensions,
Improving Outcome
SYMPOSIUM
SYMPOSIUM
CURRENT APPROACHES
TO REDUCE FLUOROSCOPY
WHILE OPTIMIZING
OUTCOMES IN THE EP LAB
GLOBAL DATA COLLECTION
TO INCREASE PATIENT’S
SAFETY AND QUALITY
OF LIFE
Joint Session with World
Society of Arrhythmias
12.30/14.00
TIMETABLE
Forum
14.00/15.30
HEALTH TECHNOLOGY
ASSESSMENT
EURO-JAPAN ARRHYTHMIA
FORUM (EJAF)
Session I: Sustainability
of Public Health System
Worldwide
Session I: Impact
of financial crisis on
arrhythmia treatment
in Europe
SYMPOSIUM
15.30/17.00
OPTIMIZING APPROACH
AND LEAD POSITION IN
CARDIAC
RESYNCHRONIZATION
THERAPY
EURO-JAPAN ARRHYTHMIA
FORUM (EJAF)
Session II: Pacing / ICD
controversial topics
17.00/17.30 BREAK
17.30/20.00
OPENING CEREMONY
MAGISTRAL LECTURES
16
2014
Tarragona
Spalato
Pola
Cesarea
Interventional EP
curriculum
Alumni meeting
FREE PAPERS
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION:
SURGICAL AND CATHETER
ABLATION
NEW TECHNOLOGY FOR
PACING AND
ELECTROPHYSIOLOGY
The Russian point of view
OPTIMAL IDENTIFICATION
AND MANAGEMENT OF
CRT PATIENTS
Joint Session with ISHNE
Supported by
St. Jude Medical
08.30/10.20
10.30/11.00 BREAK
Interventional EP
curriculum
Alumni meeting
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
RENAL DENERVATION:
A MULTIPURPOSE
TREATMENT
UPDATE ON THE RISK
STRATIFICATION OF SCD AND
VENTRICULAR
TACHYARRHYTHMIAS
FREE PAPERS
FREE PAPERS
FREE PAPERS
ICD OUTCOME
ALGORITHMS AND
FLOWCHARTS TO OPTIMIZE
CRT OUTCOME
ABLATION OF VENTRICULAR
TACHYARRHYTHMIAS
SYMPOSIUM
FORUM
SYMPOSIUM
SYMPOSIUM
MANAGING ICD
INTERVENTIONS
ATRIAL FIBRILLATION
LEADLESS
PACEMAKER
CIED SURVIVAL
AND TROUBLES
IN THE LAST TEN YEARS
Supported by
St. Jude Medical
10.20/12.40
Interventional EP
curriculum
Alumni meeting
Session I: Pathology
and natural history
Supported by
St. Jude Medical
Session II: Imaging to better
understand Atrial Fibrillation
mechanisms
SYMPOSIUM
FORUM
SYMPOSIUM
SYMPOSIUM
NEW AND OLD DRUGS
TO TREAT CARDIAC
ARRHYTHMIAS
ATRIAL FIBRILLATION
EFFICACY AND SAFETY
OF VENTRICULAR
ANTITACHYCARDIA PACING
CHALLENGES IN
CARDIAC PACING
FOR HEART FAILURE
Session III: Trouble
and troubleshooting
17.00/17.30 BREAK
17
TIMETABLE
12.45/13.30
2014
09.00/10.30
Orange 1
Forum
SYMPOSIUM
SYMPOSIUM
HEALTH TECHNOLOGY
ASSESSMENT
NEW PERSPECTIVES
IN THE EP LAB:
ROLE OF THE MOST
ADVANCED
TECHNOLOGIES IN THE
TREATMENT OF
CARDIAC ARRHYTHMIAS
THE SUBCUTANEOUS
DEFIBRILLATOR:
LONG-TERM FOLLOW-UP
Session II: Evaluating
cost-benefits of new
technologies in
electrophysiology
Orange 2
10.30/11.00 BREAK AND POSTER VISIT
11.00/12.30
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
UNEXPLAINED SYNCOPE:
OPTIMAL DIAGNOSTIC
PATHWAY
AND THERAPEUTIC
APPROACH
HOME MONITORING
BRIDGING THE 15th YEAR
OF CLINICAL PRACTICE:
WHAT HAVE WE LEARNED?
CHANGING PARADIGMS
IN TREATMENT OF
BRADYARRHYTHMIAS
Leadless Pacing
and CRTP
LECTURES
LECTURES
LUNCHEON PANEL
MONITORING ISCHEMIA
BY CIED:
THE INSIGHT STUDY
TIMETABLE
12.30/14.00
14.00/15.30
15.30/17.00
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
CRYOABLATION:
SETTING THE NEW
STANDARD
OF Atrial Fibrillation
ABLATION
BRAIN PROTECTION IN
PATIENTS WITH ATRIAL
FIBRILLATION: ONE YEAR
WITH DABIGATRAN
NEW TECHNOLOGIES,
NEW SOLUTIONS
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
IMPLANTABLE DEVICE
AND MRI:
ADOPTION AND CLINICAL
IMPLICATIONS TODAY
DO WE NEED REMOTE
MONITORING ONLY?
REAL SOLUTIONS FOR
ADVANCED PATIENT
MANAGEMENT
CORSO AVANZATO
DI ELETTROFISIOLOGIA
ED ELETTROSTIMOLAZIONE
CARDIACA PER INFERMIERI
E TECNICI DI CARDIOLOGIA
INIZIO ORE 10.00
CORSO AVANZATO
TERMINE ORE 13.00
CORSO AVANZATO
INIZIO ORE 14.30
CORSO AVANZATO
HAEMODYNAMIC
OPTIMIZATION IN CRT: CARDIACA PER INFERMIERI
RESULTS AND RESEARCH E TECNICI DI CARDIOLOGIA
PERSPECTIVES
TERMINE ORE 17.30
17.30/19.00
FREE PAPERS
FREE PAPERS
FREE PAPERS
FREE PAPERS
CLINICAL
ELECTROPHYSIOLOGY
ICD INAPPROPRIATE
SHOCK AND REMOTE
MONITORING
NEWS ON
IMPLANTATION
TECHNIQUES
LEADS INFECTION
AND EXTRACTION
18
2014
Tarragona
Spalato
Pola
Cesarea
EURO-JAPAN
ARRHYTHMIA FORUM (EJAF)
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
STROKE PREVENTION IN
ATRIAL FIBRILLATION
AVOIDING
ANTICOAGULATION
DOUBTS ON ICD
REPLACEMENT
Session III: Controversial in
pacing and electrophysiology
Session IV: Managing
arrhythmia recurrences after
Atrial Fibrillation Ablation
EURO-JAPAN
Session IV: Updating
on Brugada Syndrome
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
MANAGEMENT
OF ELECTRICAL STORM
LEADS INFECTIONS:
DIAGNOSIS AND
TREATMENT
Session V: Atrial
Fibrillation Ablation in unique
disease settings
LUNCHEON PANEL
FREE PAPERS
FREE PAPERS
FREE PAPERS
ATRIAL FIBRILLATION
PREVENTION
AND TREATMENT
ATRIAL FIBRILLATION:
PREDICTION AND TREATMENT
OPTIMIZING RESULTS
OF ATRIAL FIBRILLATION
ABLATION
MULTIPOINT PACING
SYMPOSIUM
FORUM
SYMPOSIUM
SYMPOSIUM
GLOBAL ARRHYTHMIA FORUM
(GAF)
ATRIAL FIBRILLATION
SICK SINUS SYNDROME
TODAY
Session I: Pacemaker
remote control
Session VI: First option
therapeutical strategies for
Atrial Fibrillation
NEWS ON INHERITED
ARRHYTHMOGENIC
CARDIOPATHIES
SYMPOSIUM
FORUM
SYMPOSIUM
SYMPOSIUM
CONTROVERSIAL
INDICATIONS
FOR ICD IMPLANT
ATRIAL FIBRILLATION
OUTCOME IN CRT PATIENTS
ABLATION OF VENTRICULAR
TACHYCARDIA
AND VENTRICULAR
FIBRILLATION
Session VII: Clinical issues
FREE PAPERS
FREE PAPERS
FREE PAPERS
FREE PAPERS
CLINICAL PACING
CATHETER ABLATION
OF ATRIAL FIBRILLATION
SUDDEN DEATH RISK
STRATIFICATION
CARDIAC
RESYNCRONIZATION
THERAPY
19
TIMETABLE
2014
09.00/10.30
Orange 1
Orange 2
CORSO AVANZATO
INIZIO ORE 08.30
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
INSIGHTS INTO
MECHANISMS AND
ADVANCED MAPPING OF
CARDIAC ARRHYTHMIAS:
IMPLICATIONS FOR
CATHETER ABLATION?
THE RECHARGEABLE
PACEMAKER/ICD
Join Session with World
CARDIAC ARRHYTHMIAS
IN FEMALES
11.00/12.30
SYMPOSIUM
SYMPOSIUM
Forum
CARDIAC PACING
AND TRUE
PHYSIOLOGICAL RATE
MODULATION: AN “OLD”
OR A NEW REAL
PERSPECTIVE?
DUTY-CYCLED
PHASED RF:
THE EVOLUTION
OF RF ABLATION
HEALTH TECHNOLOGY
ASSESSMENT
LECTURES
LECTURES
Session III: Ethical and
financial considerations
on leads and devices
Advisory call
TIMETABLE
15.30/17.00
FEATURED SYMPOSIUM
CRYOABLATION OF ATRIAL
FIBRILLATION
12.30/14.00
14.00/15.30
CORSO AVANZATO
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
MRI DEVICES:
FIRST CHOICE OR JUST
AN OPTION?
HEART FAILURE. IMPACT
AND OUTCOME OF
NEW TECHNOLOGIES
PREDICTION AND
MANAGEMENT OF
MAJOR CARDIOVASCULAR
EVENTS IN PATIENTS WITH
DEVICE: HYPE, HOPE OR
REALITY?
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
SLEEP APNEA: DISEASE
FOR HEART SPECIALISTS?
STROKE REDUCTION BY
IMPLANTABLE DEVICES
DIAGNOSTICS: ANGELS
Atrial Fibrillation
PROJECTS
THE SUBCUTANEOUS
DEFIBRILLATOR:
STATE OF THE HEART
CORSO AVANZATO
TERMINE ORE 13.30
CORSO AVANZATO
INIZIO ORE 14.30
CORSO AVANZATO
TERMINE ORE 17.30
17.30/19.00
FREE PAPERS
FREE PAPERS
FREE PAPERS
FREE PAPERS
CRT: SELECTION
OF CANDIDATES
AND PROGRAMMING
OPTIMIZATION
LEADS INSERTION AND
VENOUS OBSTRUCTION
HEART FAILURE
FOLLOW-UP
BY IMPLANTED DEVICES
CRT: NEW LEADS
AND ALGORITHMS
20
2014
Tarragona
Spalato
Pola
Cesarea
EURO-JAPAN
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
RELIABILITY AND
CLINICAL IMPACT
OF ICD DATA STORAGE
AND ALARMS
SUDDEN DEATH:
UNDERSTANDING,
PREVENTING AND TREATING
Session V: Pharmacological
treatment of cardiac
arrhythmias
Session VIII: Rate control
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
Session IX: Living
with permanent
Atrial Fibrillation
MANAGEMENT OF
TACHYCARDIAS
AND ECTOPIC BEATS
FROM THE VENTRICULAR
OUTFLOW TRACT
BRADY AND
TACHYARRHYTHMIAS
IN CCU
LUNCHEON PANEL
FREE PAPERS
LUNCHEON PANEL
FREE PAPERS
UPDATE IN CARDIAC PACING
GENETICS AND MAPPING
OF CARDIAC ARRHYTHMIAS
NEW TECHNOLOGY FOR
HEART FAILURE TREATMENT
BAROREFLEX ACTIVATION
THERAPY
PREDICTORS OF CRT
OUTCOME
GLOBAL ARRHYTHMIA FORUM
(GAF)
FORUM
SYMPOSIUM
SYMPOSIUM
ATRIAL FIBRILLATION
DEBATABLE
INDICATIONS
FOR CARDIAC
RESYNCHRONIZATION
THERAPY
PEDIATRIC
ARRHYTHMIAS
ABLATION TREATMENT
EURO-JAPAN
Session VI: ILR and Remote
Care Solutions: what’s new?
Session II: Syncope update
Session X: Ablation of
paroxysmal and persistent
Atrial Fibrillation: optimizing technique and outcome
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
FREE PAPERS
Sudden Death:
Mechanisms
and timing
LEADS AND DEVICES
RECALL IN THE LAST
DECADE
NEW TECHNOLOGY FOR EPI/
ENDOCARDIAL APPROACH
LEADS EXTRACTION
FREE PAPERS
FREE PAPERS
FREE PAPERS
SYMPOSIUM
DEVICES FAILURE
AND REINTERVENTION
STROKE PREVENTION
IN DEVICE PATIENTS
NEW DEVICES
AND ALGORITHMS
Join Session with
GULF EP LIVE©
DUBAI
21
TIMETABLE
2014
Friday, December 5
09.00/10.30
Orange 1
Orange 2
CORSO AVANZATO
INIZIO ORE 08.30
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
ANTICOAGULATION:
BALANCING THE
HAEMORRHAGIC
AND THE THROMBOTIC
RISKS
SYNCOPE AND
STRUCTURAL
HEART DISEASE
PACEMAKER OPTIMAL
PROGRAMMING
10.30/11.00 BREAK
11.00/12.30
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
HOW TO MAXIMIZE THE
RESPONSE TO CARDIAC
RESYNCHRONIZATION
THERAPY
CIED REUSE
RARE INDICATIONS
FOR PERMANENT VVI
PACING
CORSO AVANZATO
12.15/13.05
13.05/14.05
TIMETABLE
CORSO AVANZATO
14.05/15.05
15.05/15.50
22
2014
Tarragona
Spalato
Pola
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
CIED INFECTIONS
DIFFICULT CRT CASES
Diagnosis and treatment
Progress in Interventional
Cardiology
Left Atrial Appendage
Closure by Implantable
Devices
Cesarea
10.30/11.00 BREAK
SYMPOSIUM
SYMPOSIUM
SYMPOSIUM
THE ROLE OF
ECHOCARDIOGRAPHY
IN ELECTROPHYSIOLOGY
CARDIAC
RESYNCHRONIZATION
THERAPY: IMPROVING
PATIENTS QUALITY
OF LIFE
Cardiology
Debates in Coronary
Interventions
10.30/12.15
SYMPOSIUM
Cardiology
Debates in Coronary
Interventions
LUncheon Panel
Cardiology
SYMPOSIUM
Cardiology
Updates on Structural Heart
Disease
SYMPOSIUM
Cardiology
Flash debate PFO Closure 2014
23
TIMETABLE
Debates in Coronary
Interventions
2014
SCIENTIFIC PROGRAMME
2014
Tuesday, December 2
8:30-10:20 | Tarragona
Interventional EP CURRICULUM
ALUMNI MEETING
Supported by St. Jude Medical
Directors: P. Della Bella (Milan, I)
G. Hindricks (Leipzig, D)
08:30 – 08:40 Welcome and Introduction
The Best of the Technology
08:40 – 09:00
09:00 – 09:20
09:20 – 09:40
Why are Contact Force catheters becoming my catheters of choice?
M. Wright (London, UK)
Mediguide / Velocity: the couple which improves
my AF ablations
P. Sommer (Leipzig, D)
The Precision module enhances my VT ablations
P. Della Bella (Milan, I)
09:40 – 10:00 Flexability: a new generation for AF ablation catheters
F. Sacher (Bordeaux, F)
26
2014
9:00-10:30 | Leptis magna 2
COURSE ON INTERVENTIONAL DEVICE IMPLANTATION
Director: S.J. Worley (Lancaster-PA, USA)
Session I
Chairs: M.G. Bongiorni (Pisa, I)
The Basics of Interventional Device Implantation
T. Steen (Oslo, N)
How to Cross a Subclavian Occlusion for Venous Access
How and when to perform subclavian venoplasty for venous access
E.C. Palma (New York-NY, USA)
How and when to perform femoral extraction
F.A. Bracke (Eindhoven, NL)
Retained wire lead extraction followed by subclavian venoplasty
M. Bernabei (Lancaster-PA, USA)
27
Tuesday, December 2
2014
Tuesday, December 2
9:00-10:30 | Orange 1
COURSE ON NOVEL ORAL ANTICOAGULANTS
Session I
State of the art
Chairs: F. Ammirati (Rome, I)
F. Crea (Rome, I)
Incidence and prevalence of thrombotic and haemorrhagic events with Warfarin
A. Polewczyk (Kielce, PL)
Difficulties in continued anticoagulation by Warfarin (TTR, food/drug limitation, costs)
D. Mocini (Rome, I)
Dabigatran: in RCT and in clinical practice
G. Di Pasquale (Bologna, I)
Rivaroxaban
Apixaban
F. Colivicchi (Rome, I)
Edoxaban
M. Lettino (Milan, I)
28
2014
9:00-10:30 | Orange 2
RELIABILITY AND CLINICAL IMPACT
OF AUTOMATIC PACING PROGRAMMING
Chairs: D.K. Jhamb (New Delhi, IND)
V. Tuzcu (Istanbul, TR)
Rate responsiveness
L.P. Papavasileiou (Athens, GR)
Automatic AV interval regulation
G. Sgarito (Palermo, I)
Auto threshold
R. Gupta (New Delhi, IND)
Antitachycardia atrial pacing
S. Porcellini (Paderno Dugnano-MI, I)
Antitachycardia ventricular pacing
TBA
Automatic pacing programming in children
A.M. Sciegata (Buenos Aires, RA)
29
Tuesday, December 2
2014
Tuesday, December 2
9:00-10:30 | Spalato
Free Papers
ATRIAL FIBRILLATION: SURGICAL AND CATHETER ABLATION
Chairs: S. Takatsuki (Tokyo, JP)
C. Pandozi (Rome, I)
Our experience of combined management of af surgical treatment
R. Latypov, O. Sapelnikov, D. Cherkashin, I. Grishin, A. Toporinsky, A. Partigulova, R. Akchurin
Moscow, RUSSIA
Initial experience of sequential surgical cryomaze followed by rf catheter ablation in patients with atrial fibrillation
M Eisenberger, A Bulava, A Mokracek, J Hanis, V Kurfirst
Ceske Budejovice, CZECH REPUBLIC
Completeness and durability of the ablation lines after cryomaze operation
M Eisenberger, A Bulava, A Mokracek, J Hanis, V Kurfirst
Ceske Budejovice, CZECH REPUBLIC
EFFICACY OF SECOND-GENERATION CRYOBALLON PULMONARY VEIN ISOLATION IN PATIENTS
WITH PAROXYSMAL VERSUS PERSISTENT ATRIAL FIBRILLATION. A SINGLE CENTER EXPERIENCE
A Curnis, F Salghetti, M Cerini, A Lipari, F Vassanelli, M Belotti Cassa, N Ashofair, M Siciliano,
S Bardari, L Inama, F Guidetti, L Bontempi
Brescia, ITALY
THE CHA2DS2-VASC SCORE AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCES AFTER
CRYOBALLON PULMONARY VEIN ISOLATION. A 12 MONTHS SINGLE CENTER EXPERIENCE
F Salghetti, A Curnis, M Cerini, A Lipari, F Vassanelli, M Belotti Cassa, N Ashofair, M Siciliano,
S Bardari, L Inama, F Guidetti, L Bontempi
Brescia, ITALY
SMART ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION WITH AN ANCIENT PERFUME
P Turco, A Antonelli, E Gronda
Milan, ITALY
30
2014
Tuesday, December 2
9:00-10:30 | Pola
NEW TECHNOLOGY FOR PACING AND
ELECTROPHYSIOLOGY
The Russian point of view
Chairs: A. Revishvily (Moscow, RUS)
A. Romanov (Novosibirsk, RUS)
Evolution of pacing and electrophysiology in Russia: key trends and results
A. Revishvily (Moscow, RUS)
Cryo technology in Russia: current experience and prospective
E. Mikhaylov (Saint Petersburg, RUS)
Use of Implantable Cardiac Monitor to improve AF management. What comes next?
A. Romanov (Novosibirsk, RUS)
TEXT
ICD in Russia: moving to shock-free paradigm
N. Neminushiy (Moscow, RUS)
31
2014
Tuesday, December 2
9:00-10:30 | Cesarea
OPTIMAL IDENTIFICATION AND MANAGEMENT
OF CRT PATIENTS
Chairs: D.T. Martin (Burlington-MA, USA)
QRS morphology: how to identify optimal ECG patterns for CRT candidates?
QRS duration >150 ms is it mandatory?
L. Gianfranchi (Ferrara, I)
Optimal management of AF patients with CRT
G. De Martino (Bari, I)
Quality of life in CRT patients
B. Sassone (Bentivoglio-BO, I)
Improvement on CRT outcome by renal denervation
E. Boschetti (Terni, I)
New methods of monitoring patients with devices
J.K. Wranicz (Lodz, PL)
32
2014
10:20-13:30 | Tarragona
Interventional EP CURRICULUM
ALUMNI MEETING
Supported by St. Jude Medical
Directors: P. Della Bella (Milan, I)
The Boxe Ring
10:20 – 11:00 Stroke prevention after AF ablation
- Pro LAAO
- Pro NOACS
11:00 – 11:40 A Contact Force controlled RF ablation strategy is better than a single shot device strategy
- Contact Force controlled RF ablation strategy
K. Rajappan (Oxford, UK)
- Single shot device strategy
B. Schmidt (Frankfurt, D)
The Environment
11:40 – 12:10 12:10 – 12:40
European reimbursement for AF ablation
M. Siebert (Berlin, D)
How a Patient Association can help: the UK example
T.C.A. Lobban (Strutford Upon Avon, UK)
The Best Case Award
12:45 – 13:15 3 AF cases presentation by Alumni as selected by the IEPC Faculty
L. Macle (Montreal, CDN) - M. Scaglione (Asti, I)
13:15 – 13:20 Voting for the best case
C. Scavée (Brussels, B)
13:20
Award ceremony & Wrap-up
13:30
Closing
33
Tuesday, December 2
2014
Tuesday, December 2
11:00-12:30 | Leptis magna 4
NEWCOMERS IN PREVENTION AND TREATMENT
OF ATRIAL TACHYARRHYTHMIAS:
A COMPLETE ARMAMENTARIUM
Chairs: B. Gorenek (Eskisehir, TR)
L. Padeletti (Florence, I)
MVP, atrial preventive and atrial tachycardia pacing, reduce progression to long lasting
AF and permanent AF
G. Inama (Cremona, I)
Role and benefits of MVP compared with standard dual chamber pacing
J. Cosedis Nielsen (Skejby, DK)
Impact of Reactive ATP on clinical outcomes
L. Mont (Barcelona, E)
Impact of MVP and atrial ATP on Health Care Utilization
G. Boriani (Bologna, I)
Remote monitoring of atrial arrhythmic burden allows optimal treatment of patients with
implanted devices
G. Molon (Negrar-VR, I)
The role of pharmacological treatment to increase the efficacy of atrial preventive and
antitachy pacing
R. Tukkie (Haarlem, NL)
34
2014
11:00-12:30 | Leptis magna 2
COURSE ON INTERVENTIONAL DEVICE IMPLANTATION
Director: S.J. Worley (Lancaster-PA, USA)
Session II
Chairs: T. Steen (Oslo, N)
Systematic Use of a 9 Fr. ID Guide Support for LV Lead Placement: it’s not about finding
the CS, but what you can do when you are there
T. Steen (Oslo, N)
How to Perform Coronary Venoplasty for LV Lead Implantation and the potential
complications
K. Ando (Kitakyushu, JP)
Snares for LV Lead Implantation: the most powerful technique for difficult LV lead
insertion that often replaces venoplasty and anchor balloons
How I use interventional techniques for LV lead Implantation
D. O’Donnell (Melbourne, AUS)
Interventional vs. Traditional Approach to Device Implantation
35
Tuesday, December 2
2014
Tuesday, December 2
11:00-12:30 | Orange 1
COURSE ON NOVEL ORAL ANTICOAGULANTS
Session II
Noacs troubles and troubleshooting
Chairs: M. Chudzik (Lodz, PL)
F. Romeo (Rome, I)
How to evaluate the therapeutic efficacy
L. Bianconi (Rome, I)
How to stop haemorrhages
A. Aiello (Rome, I)
How to manage patients with renal insufficiency
G. Andrikopoulos (Athens, GR)
How to manage elderly patients
C. Karmelic Serrano (Santiago, RCH)
How to manage patients with previous cerebral haemorrhages
X. Viñolas Prat (Barcelona, E)
NOACS: are they all the same? When shifting from one to another NOAC?
F. Colivicchi (Rome, I)
36
2014
11:00-12:30 | Orange 2
SUDDEN DEATH RISK STRATIFICATION
BY SURFACE ECG
Chairs: S. Saxena (Chandigarh, IND)
G. Turitto (Brooklyn-NY, USA)
Long-QT: correct measurement and interpretation
A. Brandes (Odense, DK)
Early repolarization patterns
S. Foresti (Milan, I)
QRS fragmentation
R.F.E. Pedretti (Tradate-VA, I)
T wave alternans during exercise
T. Klingenheben (Bonn, D)
Ecg changes in arrhythmogenic displasic cardiomyopathy
A. Campana (Salerno, I)
Ecg variables in Brugada syndrome: how to screen the false positive?
M. Shoda (Tokyo, JP)
37
Tuesday, December 2
2014
Tuesday, December 2
11:00-12:30 | Spalato
FORUM ON ATRIAL FIBRILLATION
Session I
Pathology and natural history
Chairs: C. De Chillou (Nancy, F)
R. De Ponti (Varese, I)
Structural remodelling of left atrium in atrial fibrillation
S. Ficili (Rome, I)
Atriomyopathy due to severe left atrial scarring
C. Storti (Pavia, I)
Correlation between MRI scar and low voltage areas in persistent atrial fibrillation
K. Uno (Tokyo, JP)
Predictors of atrial fibrillation recurrences
F. Bello Morgado (Lisbon, P)
Predictors of poor outcome in patients with atrial fibrillation
A. Buiatti (Munich, D)
Reduced mortality by remote monitoring of atrial fibrillation
S. Bianchi (Rome, I)
38
2014
11:00-12:30 | Pola
RENAL DENERVATION:
A MULTIPURPOSE TREATMENT
Chairs: E. Shlyakhto (St. Petersburg, RUS)
G. Speciale (Rome, I)
The rationale behind Renal Denervation
B. Zrenner (Munich, D)
Technique, trouble and troubleshooting
C. Stefanadis (Athens, GR)
Long term benefits of renal denervation in resistant hypertension
M. Volpe (Rome, I)
Benefits of renal denervation in patients with heart failure
R. Hatala (Bratislava, SK)
Benefits of renal denervation in patients submitted to AF ablation
C. Stellbrink (Bielefeld, D)
Cost-benefit of renal denervation
V. Pasceri (Rome, I)
39
Tuesday, December 2
2014
Tuesday, December 2
11:00-12:30 | Cesarea
UPDATE ON THE RISK STRATIFICATION OF SCD
AND VENTRICULAR TACHYARRHYTHMIAS
Chairs: N. El Sherif (New York-NY, USA)
R. Piotrowicz (Warsaw, PL)
Early repolarization pattern: benign versus malignant
R. Piotrowicz (Warsaw, PL)
Nonsustained VT
C. Carbucicchio (Milan, I)
QRS fragmentation and amplitude
QT variability
G. Piccirillo (Rome, I)
Very low frequency HRV in risk stratification
40
2014
12:30-14:00 | Leptis magna 4
“STATE OF THE ART” LECTURES
Chairs: M. La Meir (Maastricht, NL)
T. Nitta (Tokyo, JP)
Atrial fibrillation surgical treatment
A.S. Revishvili (Moscow, RUS)
Genetic arrhythmias: what’s new
P.J. Schwartz (Milan, I)
41
Tuesday, December 2
2014
Tuesday, December 2
12:30-14:00 | Leptis magna 2
Chairs: E. Crystal (Toronto-ON, CDN)
T. Yamane (Tokyo, JP)
Laser endoscopic ablation
T. Lewalter (Munich, D)
Robotic ablation of cardiac arrhythmias
E. Crystal (Toronto-ON, CDN)
42
2014
12:30-14:00 | Orange 1
Luncheon Panel
BUSINESS MEETS MEDICINE: PROCESS OPTIMIZATION
IN CARDIAC RHYTHM MANAGEMENT
Chairs: H. Bonnemeier (Kiel, D)
L. Santini (Rome, I)
How to do things better?: Designing Innovative Operational Systems for Better Outcomes
and Profits
K. Girotra (INSEAD Business School, France)
Driving efficiency at Karolinska: A NayaMed Center of Excellence
F. Gadler (Karolinska University Hospital, Sweden)
Stripping away the hidden costs: Outcomes of the Hospital Efficiency SuRvey PrOject
M. Biffi (Policlinico S. Orsola - Malpighi, Italy)
43
Tuesday, December 2
2014
Tuesday, December 2
12:30-14:00 | Orange 2
Free Papers
SYNCOPE
Chairs: D.G. Benditt (Minneapolis, MN, USA)
G. Turitto (Brooklyn, NY, USA)
DIAGNOSTIC YIELD OF IMPLANTABLE LOOP RECORDERS IN PATIENTS WITH UNEXPLAINED
SYNCOPE
F. de Jong, D. Grootendorst, B. van Vlies, G. Verdel, M. Janssen, M. Keijzers, R. Tukkie
Haarlem, NETHERLANDS
ROLE OF TILT TABLE TEST TO PREDICT RECURRENCES OF NEURALLY-MEDIATED REFLEX
SYNCOPE IN PATIENTS TREATED USING A PACEMAKER SELECTED BY IMPLANTABLE LOOP
RECORDER
M Tomaino, M Unterhuber, P Sgobino, C Romeo, P Donolato, D Corazzola
Bolzano, ITALY
SAFETY AND TOLERABILITY OF TILT TESTING AND CAROTID SINUS MASSAGE IN THE
OLDEST OLD
G Rivasi, G Toffanello, M Rafanelli, A Ceccofiglio, F Tesi, G Bulli, N Marchionni, A Ungar
Florence, ITALY
APPLICATION OF BOSTON RISK SCORE IN PATIENTS WITH SYNCOPE IN EMERGENCY
G Mora, M Quintero
Bogota, COLOMBIA
RELATIONSHIP BETWEEN ELECTROCARDIOGRAPHIC BASAL PATTERN AND BRADYARRHYTHMIA
DETECTION IN PATIENTS WITH IMPLANTABLE CARDIAC MONITOR
F Martinez-Garcia, M Pombo-Jimenez, L Inigo-Garcia, A Esteban-Luque, E Fernandez-Ochagavia,
F Ruiz-Mateas
Marbella, SPAIN
IMPLANTABLE LOOP RECORDER: A SYNCOPE UNIT EXPERIENCE
M Rafanelli, A Ceccofiglio, S Venzo, F Tesi, G Toffanello, V Chisciotti, G Bulli, N Marchionni, A Ungar
Florence, ITALY
44
2014
Tuesday, December 2
12:30-14:00 | Spalato
Free Papers
ICD OUTCOME
Chairs: A. Michelucci (Florence, I)
R. Choudhury (Sharjah, UAE)
AGE INFLUENCES INTRACARDIAC DEFIBRILLATOR COMPLICATIONS
C. E. P. Brough 1,2, C. McGee 2, A. Rao 2, D.J. Wright 2
1
London, 2 Liverpool, UNITED KINGDOM
WOMEN WITH ICDS: IS THERE A GREAT OUTCOME DIFFERENCE?
S. Magnani, I. Puggia, G. Morea, M. Narciso, A. Nordio, M. Muca, L. Salvatore, L. Vitali-Serdoz,
M. Zecchin, G. Sinagra
Trieste, ITALY
LONGEVITY OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN DAILY CLINICAL PRACTICE:
COMPARATIVE ANALYSIS OF DEVICES FROM SEVERAL MANUFACTURERS
J. De Sousa, N. Cortes-Dias, A. Magalhaes, R. Placido, M. Menezes, A.R. Francisco, T. Guimaraes,
G. Silva, A. Bernardes, L. Carpinteiro
Lisbon, PORTUGAL
PREDICTORS OF PROHIBITIVELY HIGH DEFIBRILLATION THRESHOLD AT THE TIME OF ICD
IMPLANTATION
K. Sedlacek, L. Stefan, J. Kautzner
Prague, CZECH REPUBLIC
RIGHT VENTRICULAR BIPOLAR ELECTROGRAMM AMPLITUDE CHANGING AFTER APPROPRIATE ICD SHOCK IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
G. Gromyko 1, S. Chetverikov 2, A. Kazakov 3, E. Lyan 3, S .Yashin 3
1
Moscow, 2 Khanty Mansiysk, 3 Saint Petersburg, RUSSIA
DRY PERFORATION - FREQUENT MECHANISM OF ICD LEAD DYSFUNCTION
A. Kutarski, A. Tomaszewski, W. Brzozowski, K. Oleszczak
Lublin, POLAND
46
2014
12:30-14:00 | Pola
Free Papers
ALGORITHMS AND FLOWCHARTS TO OPTIMIZE CRT OUTCOME
Chairs: G. Molon (Negrar, VR, I)
A. Arenal-Maiz (Madrid, E)
A NEW ALGORITHM FOR ELECTRICAL DELAY MEASUREMENT IN CARDIAC RESYNCHRONIZATION
THERAPY DEVICES
F. Zanon 3, G. Forleo 2, L. Santini 2, M.T. Lucciola 1, G. Pastore 3, D. Potenza 4, R. Massaro 4, E. Menardi
4
, G. P Ballari 4, E. Bertaglia 6, F. Migliore 6, L. Calò 2, A. Fagagnini 2, G. Morani 7, L. Tomasi 7, A. Curnis
8
, L. Bontempi 8, V. Calabrese 2, F. Marullo 2, M. Giammaria 1
1
Turin, 2 Rome, 3 Rovigo, 4 San Giovanni Rotondo, FG, 5 Cuneo, 6 Padua, 7 Verona, 8 Brescia, ITALY
DETECTION AND EARLY INTERVENTION IN WORSENING HEART FAILURE EPISODES WITH
HOME MONITORING. RESULTS FROM THE HOMEGUIDE REGISTRY
G. Zanotto 1, L. Calò 2, A. Curnis 3, G. Mantovani 4, E. Bertaglia 4, M. Santamaria 6, V. Calvi 7,
F. Chiusso8, A. Gargaro 8, R.P. Ricci 2
1
Legnago, VR, 2 Rome, 3 Brescia, 4 Desio, MB, 5 Padua, 6 Campobasso, 7 Catania, 8 Milan, ITALY
EFFICACY AND SAFETY OF VENTRICULAR ANTITACHYCARDIA PACING THERAPIES IN
HEART FAILURE PATIENTS WEARING A CARDIAC RESYNCHRONIZATION DEVICE WITH
DEFIBRILLATION BACK-UP
R.P. Ricci 1, M. Landolina 2, G. Boriani 3, E. Daleffe 4, A. Proclemer 4, M. Lunati 4, G. Molon 6,
P. Turrini7, A. Rossillo 8, M. Gasparini 9
Rome, 2 Pavia, 3 Bologna, 4 Udine, 5 Milan, 6 Negrar, VR, 7 Camposampiero, PD, 8 Mestre, 9 Rozzano,
MI, ITALY
1
MYOCARDIAL VIABILITY AT THE LEFT VENTRICULAR LEAD LOCATION COULD BE ASSOCIATED WITH
THE OCCURRENCE OF VENTRICULAR TACHYARRHYTHMIAS IN CARDIAC RESYNCHRONIZATION
THERAPY
D. Zizek, M. Cvijic, I. Zupan
Ljubljana, SLOVENIA
SERVICE LIFE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS FOR CARDIAC
RESYNCHRONIZATION THERAPY: AN ANALYSIS OF DETERMINANTS IN CURRENT CLINICAL PRACTICE
G. Morani 1, M. Landolina 2, A. Curnis 3, A. Vado 4, E. Ammendola 4, A. D’Onofrio 4, G. Stabile 4,
M. Crosato6, B. Petracci 2, C. Ceriotti 8, L. Bontempi 3, M. Morosato 1, G. P Ballari 4, M. Gasparini 8
1
Verona, 2 Pavia, 3 Brescia, 4 Cuneo, 5 Naples, 6 Treviso, 8 Rozzano, MI, ITALY
TRANSFORMING THE MORBIDITIES OF ELECTRO-MECHANICAL DYSYNCHRONY. COMPLICATIONS
WITHIN 1-YEAR OF CARDIAC RE-SYNCHRONISATION PROCEDURES
C.E.P. Brough 1,2, C. McGee 2, A. Rao 2, D.J. Wright 2
1
47
Tuesday, December 2
2014
Tuesday, December 2
12:30-14:00 | Cesarea
Free Papers
ABLATION OF VENTRICULAR TACHYARRHYTHMIAS
Chairs: C. De Chillou (Nancy, F)
C. Carbucicchio (Milan, I)
IMPACT OF INTRACARDIAC ECHOCARDIOGRAPHY ON ELECTRICAL STORM ABLATION
F. Turreni, A. Castro, M.L. Loricchio, M. Mercurio, F. Messina, G. Altamura
Rome, ITALY
MECHANISM AND FEATURES OF UPPER SEPTAL LEFT VENTRICULAR TACHYCARDIA: A DISTINCT
TYPE OF VERAPAMIL-SENSITIVE IDIOPATHIC LEFT VENTRICULAR TACHYCARDIA
A. Talib 1, A. Nogami 1, Y. Sekiguchi 1, S. Kurosaki 2, K. Kowase 2, A. Takahashi 3, S. Naito 4, S Uno5,
K Aonuma 1
1
Tsukuba, 2 Yokohama, 3 Yokosuka, 4 Gunma, 5 Sapporo, JAPAN
EVALUATION OF NOT CAPTURED LATE AND FRACTIONATED POTENTIAL DURING ABLATION
REDUCES THE BURDEN OF LESIONS AND RESULTS EFFECTIVE TO AVOID VENTRICULAR
TACHYCARDIA
G. Carreras, S. Donzelli, C. Marini, M. Pirrami, M. Castelli, C. Poltronieri, D. Bovelli, M. Bazzucchi,
E. Boschetti
Terni, ITALY
IMPORTANCE OF EPICARDIAL APPROACH FOR VENTRICULAR TACHYCARDIA ABLATION. A
POSSIBLE PROCEDURE PROTOCOL
G. Barbato, F. Pergolini, V. Carinci, G. Casella, P. Sangiorgio, G. Di Pasquale
Bologna, ITALY
NEAR ZERO X-RAY IN ARRHYTHMIAS ABLATION USING ENSITE NAVX SYSTEM: A MULTICENTER
EXPERIENCE
M. Giaccardi 1, A. Del Rosso 2, V. Guarnaccia 2, L. Chiodi 1, A. Colella 1
1
Florence, 2 Empoli, ITALY
A PROSPECTIVE STUDY ON SAFETY OF CATHETER ABLATION PROCEDURES: CONTACT FORCE
GUIDED ABLATION REDUCES THE RISK OF CARDIAC PERFORATION
F. Akca, P. Janse, D.A.M.J. Theuns, T. Szili-Torok
Rotterdam, NETHERLANDS
48
2014
14:00-15:30 | Leptis magna 4
FORUM ON HEALTH TECHNOLOGY ASSESSMENT
Joint Session with World Society of Arrhythmias
Session I
Impact of financial crisis on arrhythmia
treatment in Europe
Chairs: D.W. Davies (London, UK)
P.E. Vardas (Heraklion, GR)
Sustainability of the Public Health System Cost in Europe
G.F. Gensini (Florence, I)
Evidence based comparison between arrhythmia invasive treatments and other
cardiological and non cardiological invasive procedures
G.L. Botto (Como, I)
Value of HTA in the evaluation of available CIED
C. Wolpert (Ludwigsburg, D)
Centralized purchase by regional or national tender: pros and cons
The new concept of “Total Service” to provide low cost sets for cardiological invasive
procedures
S. Klugmann (Milan, I)
49
Tuesday, December 2
2014
Tuesday, December 2
14:00-15:30 | Leptis magna 2
EURO-JAPAN ARRHYTHMIA FORUM (EJAF)
Session I
Sustainability of Public Health System Worldwide
Chairs: K. Okumura (Hirosaki, JP)
M. Santini (Rome, I)
When and for which patient the “lower price” is acceptable in the CIED purchase?
C. Ermis (Antalya, TK)
Which scientific evidence is requested to evaluate “real added value” of devices new
algorithms?
Should we select different devices and treatments according to the patient ’s age?
K. Matsumoto (Saitama, JP)
Are females with arrhythmias still undertreated also in industrialized countries?
A. Quesada (Madrid, E)
Optimal relationship among Regulators, Scientific Societies, Devices Industries: which
future can we foresee?
K. Soejima (Tokyo, JP)
50
2014
14:00-15:30 | Orange 1
LEADS: TECHNOLOGY, RELIABILITY AND MONITORING
AFTER 60 YEARS OF CARDIAC PACING
Chairs: L. Aguinaga (Buenos Aires, RA)
A. Curnis (Brescia, I)
In what terms the cardiac leads are today different from the past: the role of design,
testing and monitoring: the physician side
S. Iacopino (Bari, I)
In what terms the cardiac leads are today different from the past: the role of design,
testing and monitoring: the industry side
E. Trip (Berlin, D)
The role of remote monitoring: does it help - and in what extent - to address safety of
leads in the follow up?
M. Bertaglia (Mirano-VE, I)
CRT and high voltage lead today: have size and new design an impact on reliability?
C. De Asmundis (Brussels, B)
Left endocardial pacing: a hype or a possible solutions of a subset of patients?
P. De Filippo (Bergamo, I)
Epicardial leads: an old fashion solution?
C.T. Starck (Zurich, CH)
51
Tuesday, December 2
2014
Tuesday, December 2
14:00-15:30 | Orange 2
NEW TRANSCATHETER PACING SYSTEM
Reducing dimensions, Improving outcome
Chairs: P. Neuzil (Prague, CZ)
TBA
14:00 – 14:20 Why do we need leadless pacemakers?
14:20 – 14:45 Design and animal results of the Micra Transcatheter Pacing System
L. Rapallii (Mounds View-MN, USA)
14:45 – 15:15 Early clinical experience with Micra
C. Steinwender (Linz, A)
15:15 – 15:30
Discussion
52
2014
14:00-15:30 | Tarragona
MANAGING ICD INTERVENTIONS
Chairs: F. Anselme (Roven, F)
M. Lunati (Milan, I)
Patient survival and clinical outcome after an ICD therapy
A. Kloppe (Bochum, D)
How to reduce inappropriate ICD interventions
M. Gasparini (Milan, I)
Should we look at inappropriate shocks only? Role of ATP in reducing the appropriate
ones
A. Arenal-Maiz (Madrid, E)
Role of antiarrhythmic drug treatment and ablation in optimal ICD programmed
patients
G. Rovaris (Monza-MI, I)
Economic benefit and cost benefit of optimal ICD programming
A. Proclemer (Udine, I)
Evidence based medicine in ICD therapy: theory or practice?
A. Meijer (Eindhoven, NL)
53
Tuesday, December 2
2014
Tuesday, December 2
14:00-15:30 | Spalato
Session II
Imaging to better understand atrial
fibrillation mechanisms
Chairs: A. Oto (Ankara, TR)
G. Sharma (New Delhi, IND)
Mechanisms underlying persistent and permanent atrial fibrillation
T. Lewalter (Munich, D)
Focal impulse and rotor modulation as AF sources
M. Zardini (Parma, I)
Differences in mapping of paroxysmal, persistent and permanent atrial fibrillation
in humans
A. Ardashev (Moscow, RUS)
Usefulness of pre ablation imaging to optimize patient selection and outcome
A. Bonso (Feltre-BL, I)
Long term atrial structural changes after successful ablation of persistent atrial
fibrillation
M. Silvano (Mestre-VE, I)
Usefulness of implantable loop-recorder to monitor atrial fibrillation onset
E.G. Vester (Duesseldorf, D)
54
2014
14:00-15:30 | Pola
LEADLESS PACEMAKER
Chairs: W. Jung (Villingen-Schwenningen, D)
R.E. Knops (Amsterdam, NL)
Surgical pacemaker implant and replacement related infections
L. Segreti (Pisa, I)
Subclavian vein obstruction in paced patients: incidence and clinical relevance
L.M. Zuccaro (Rome, I)
The concept of the leadless pacemaker: how is it implanted and how it works?
L. Bontempi (Brescia, I)
Preliminary results with the leadless pacemaker in humans
R.E. Knops (Amsterdam, NL)
Dual and triple chamber leadless pacing: the future challenge
Cost-benefit
J. Michaelsen (Lingen, D)
55
Tuesday, December 2
2014
Tuesday, December 2
14:00-15:30 | Cesarea
CIED SURVIVAL AND TROUBLES IN THE LAST TEN YEARS
Chairs: C. Jazra (Beirut, RL)
A. Raviele (Mestre-VE, I)
Pacemaker leads
E. Casali (Modena, I)
Left ventricular leads
P. Mitkowski (Poznan, PL)
ICD leads
Single, double and triple chamber pacemakers
R. Ciudin (Bucharest, RO)
Single, double and triple chamber ICD
H. Benkemoun (Saint Cyprien, F)
Prolonged CIED life by remote control
P. Mazzone (Milan, I)
56
2014
15:30-17:00 | Leptis magna 4
OPTIMIZING APPROACH AND LEAD POSITION IN
CARDIAC RESYNCHRONIZATION THERAPY
Chairs: G.L. Botto (Como, I)
S. Thanvi (Gujarat, IND)
CRT in real world from the Heart Failure Clinician Perspective: do we implant all indicated
patients?
L. Tavazzi (Cotignola-RA, I)
CRT in real world from the EP perspective: we implant all indicated patients!
F. Arribas (Madrid, E)
BLOCK HF: a “Game Changer” for Cardiac Pacing
D. Pecora (Brescia, I)
Towards optimal CRT response: a better Performance
G. Giannola (Cefalù-PA, I)
New lead technology to overcome anatomical barriers
MG. Bongiorni (Pisa, I)
Transeptal approach for non-responders to CRT? The ALSYNC trial
M. Biffi (Bologna, I)
57
Tuesday, December 2
2014
Tuesday, December 2
15:30-17:00 | Leptis magna 2
Session II
Pacing / ICD controversial topics
Chairs: G. Hindricks (Leipzig, D)
T. Nitta (Tokyo, JP)
Usefulness of CIED automatic algorithms: real clinical impact or just a gadget?
T. Ishikawa (Yokohama, JP)
CIED remote control improves patients quality of life and prolongs battery duration
All the abandoned intracardiac leads should be extracted
C. Kennergren (Goteborg, S)
Does silent thromboembolism matter through the ablation procedure for atrial
fibrillation?
T. Yamane (Tokyo, JP)
All the patients with paroxysmal atrial fibrillation submitted to heart surgery should
receive concomitant epicardial pulmonary vein isolation and closure of the left atrial
appendage
K. Imai (Hiroshima, JP)
After two unsuccessful AF catheter ablation, a third one should not be adviced
S. Takatsuki (Tokyo, JP)
58
2014
15:30-17:00 | Orange 1
CURRENT APPROACHES TO REDUCE FLUOROSCOPY
WHILE OPTIMIZING OUTCOMES IN THE EP LAB
Chairs: M. Alvarez (Granada, E)
A. Curnis (Brescia, I)
Ablation fluoroscopy and radiation exposure reduction: safety and cost implications
E. Picano (Pisa, I)
CRT implants guided by 3D navigation and advanced mapping system
M. Del Greco (Rovereto-TN, I)
Minimally invasive approach by 3D mapping system to treat cardiac arrhythmias in
pediatric patients
F. Drago (Rome, I)
SVT ablation using 3D advanced mapping system and no rx exposure: exception of
routine?
M. Piacenti (Pisa, I)
Clinical experience in mapping and catheter ablation using 4D navigation gMPS
technology
M. Martinek (Innsbruck, A)
Impact of gMPS technology in the workflow and outcomes of CRT procedures
B. Thibault (Montreal, CDN) 59
Tuesday, December 2
2014
Tuesday, December 2
15:30-17:00 | Orange 2
GLOBAL DATA COLLECTION TO INCREASE PATIENT’S
SAFETY AND QUALITY OF LIFE
Chairs: K. Matsumoto (Saitama, JP)
Usefulness and lessons from the World and National Registries
A. Proclemer (Udine, I)
Long term efficacy of atrial fibrillation ablation: data from International Registries
R. Cappato (Milan, I)
Reuse of ablation catheters and implantable device: pros and cons
C. Israel (Frankfurt, D)
Device and lead malfunction worldwide: should we have an open access common
website?
International prices of implantable devices and ablation catheters: should they be shown
in a dedicated website?
O. Oseroff (Buenos Aires, RA)
Cost effectiveness of ICD therapies in today economical world beyond guidelines
60
2014
15:30-17:00 | Tarragona
NEW AND OLD DRUGS TO TREAT
CARDIAC ARRHYTHMIAS
Chairs: J.J. Blanc (Brest, F)
F. Ammirati (Rome, I)
Ivabradine in patients with inappropriate sinus tachycardia
J.Y. Le Heuzey (Paris, F)
Drug treatment for catecholaminergic polymorphic ventricular tachycardia recurrences
in ICD patients
N. El Sherif (New York-NY, USA)
Association of Amiodarone and Ranolazine to cardiovert paroxysmal atrial fibrillation
Antiarrhythmic effects of Omega-3 fatter acids: which is the evidence?
A.P. Maggioni (Florence, I)
Should Noacs become the first choice to anticoagulate patients with atrial fibrillation?
61
Tuesday, December 2
2014
Tuesday, December 2
15:30-17:00 | Spalato
Session III
Trouble and troubleshooting
Chairs: M. Kuniss (Bad Nauheim, D)
F. Lamberti (Rome, I)
Silent cerebral thromboembolism post AF ablation
J.F. Viles-Gonzalez (Miami-FL, USA)
The impact of atrial fibrillation termination mode during catheter ablation procedure on
maintenance of sinus rhythm
M. Faustino (Pescara, I)
Electrical isolation of left atrial appendage: pros and cons
S. Grossi (Turin, I)
Usefulness of monitoring esophageal temperature during AF ablation
M. Tritto (Castellanza-VA, I)
Prevalence and management of vascular complications in patients submitted to AF
ablation
G. Bencsik (Szeged, H)
Incidence of stroke and death post AF ablation
G. Stabile (Naples, I)
62
2014
15:30-17:00 | Pola
EFFICACY AND SAFETY OF VENTRICULAR
ANTITACHYCARDIA PACING
Chairs: A. Al Fagih (Riyadh, SA)
J. Clementy (Bordeaux, F)
How to optimize ATP programming
R. Keegan (Bahia Blanca, RA)
Ventricular tachycardia acceleration by ATP: can it be predicted and avoided?
T. Nakai (Tokyo, JP)
Benefits and risks of a combined ATP and antiarrhythmic drug treatment
W.R. Bauer (Wuerzburg, D)
When to switch off ATP therapy?
A. Lupo (Mirano-VE, I)
ATP HTA: Less hospitalizations? Less shocks? Prolonged battery life?
P. Rossi (Rome, I)
63
Tuesday, December 2
2014
Tuesday, December 2
15:30-17:00 | Cesarea
CHALLENGES IN CARDIAC PACING FOR HEART FAILURE
Chairs: Y. Badaineh (Amman, HKJ)
E. Rowland (London, UK)
Usefulness of MRI to assess mechanical dissynchrony
G. Bisignani (Castrovillari-CS, I)
Selection of optimal left ventricular pacing site by quadripolar coronary sinus lead
C. D’Agostino (Bari, I)
CRTP Vs CRTD in heart failure pts
A. Rapacciuolo (Naples, I)
Ventricular arrhythmias in CRT responders: increased or decreased?
J. Koyama (Kumamoto City, JP)
Coronary sinus lead extraction: trouble and troubleshooting
D. Catanzariti (Rovereto-TN, I)
Carotid Baroreceptor Activation Therapy: a new treatment for systolic HF patients
E.G. Gronda (Milan, I)
64
2014
17:30-20:00 | Leptis magna 4
OPENING CEREMONY
17:30
Welcome Address
International Scientific Societies
P.E. Vardas (WSA)
G. Hindricks (EHRA)
N.A.M. Estes (HRS)
R. Cappato (ECAS)
L. Aguinaga (SOLAECE)
Y. Kobayashi (APHRS)
K. Okumura (JHRS)
S. Zhang (CSA)
G.L. Botto (AIAC)
18.30
Awards
19.00 Magistral Lectures:
R.P. Ricci (Rome, I)
20.00
Welcome cocktail
Congress Chairman
M. Santini
65
Tuesday, December 2
2014
Tuesday, December 2
18:30-19:00 | Leptis magna 4
MAGISTRAL LECTURE
PACE journal: 50 years of scientific information in cardiac pacing
and eletrophysiology
Dr. Fisher is Professor of Medicine at Albert Einstein
College of Medicine and served for many years
as Director of the Einstein-Montefiore Arrhythmia
Service, which includes two component services,
namely Clinical Electrophysiology and Pacemakers/
ICDs.
The Arrhythmia Service has close ties withy CT
surgery, imaging, basic EP, and pediatric EP.
He is also the Training Program Director for the
ACGME-accredited fellowship in clinical EP (CCEP).
Education: Yale BA, Wayne State MD, Boston
City Hospital and NY Hospital-Cornell (Int. Med
Residency), Montefiore and Royal Postgraduate
Medical School-Imperial College London UK
(Cardiology and EP).
Interests: Arrhythmia mechanisms and treatment, ablation, VT, VF, SVT, AF, WPW,
pacemakers, ICDs, heart failure resynchronization devices, syncope. R-1006
66
2014
19:00-19:30 | Leptis magna 4
MAGISTRAL LECTURE
Remote management of CIED patients
Renato Pietro Ricci, MD, Cardiologist, Fellow
ANMCO, FESC, Professor of Cardiovascular Diseases
at Catholic University in Rome, Italy, teacher at
ANMCO and ESC Learning Courses. Responsible for
cardiac pacing and outpatient clinic at San Filippo
Neri Hospital in Rome. Past Vice President of the
Italian Society of Pacing and Arrhythmology (AIAC)
(2008-2010). In-coming chairman of the Working
Group on Arrhythmias of ANMCO (2015-2016).
EHRA representative in the HRS Expert Consensus
Statement on Remote Monitoring (2014-2015).
Chairman of the AIAC Working Group on Remote
Monitoring of implanted devices since 2006.
Chairman of the AIAC Task Force for surveillance
of device and lead failures and recall (2004-2010),
member of task forces and policy document committees of the EHRA for ICD shocks and
implantable loop recorders. Chairpersons for the Cardiostim-Europace 2014 and EHRA
Europace 2015 Scientific Program Committee for the topic of device remote monitoring.
Chairman of the Scientific Committee of the AIAC National Congress in 2010. Author of
about 200 peer reviewed manuscripts, editor of 4 books and author of 40 book chapters.
H-index 28. Invited speaker at the major international cardiology congresses, referee of
several international journals.
67
Tuesday, December 2
2014
Session II
Evaluating cost-benefits of new technologies
in electrophysiology
Chairs: J. Morgan (Southampton, UK)
H.J. Trappe (Herne, D)
Various technological models to monitor heart failure by CIED: which one is beneficial
for patients and NHS?
K. Seidl (Ingolstadt, D)
Monitoring ongoing myocardial ischemia by CIED: do we reduce acute coronary
syndromes and prolong patients survival?
C. Kolb (Munich, D)
Remote monitoring of CIED: are there any more doubts to reimburse it?
F. Caravati (Varese, I)
Leadless pacemaker: quantifying social and financial benefits to justify its reimbursement
C. Wolpert (Ludwigsburg, D)
Subcutaneous ICD: which is the real impact on infections and on patients’ quality of life?
B. Sarubbi (Naples, I)
The injectable loop recorder: add value and clinical impact
D.M. Steinhaus (Kansas City-MO, USA)
68
2014
NEW PERSPECTIVES IN THE EP LAB: ROLE OF THE MOST
ADVANCED TECHNOLOGIES IN THE TREATMENT
OF CARDIAC ARRHYTHMIAS
Fluoro Integration in the 3D Mapping system: a new era for the treatment of cardiac
arrhythmias in children
F. Drago (Rome, I)
Circular Ablation Technology: Why, How, When
G.M. Fassini (Monza-MI, I)
How Contact Force and Fluoro integration in the 3D mapping can improve safety and
efficacy in the treatment of VT ablation?
G. Maccabelli (Milan, I)
Why it’s important to get linear lesions and how the new technologies can ensure it?
M. Grimaldi (Aquaviva delle Fonti-BA, I)
Catheter-Tissue Contact Force guided mapping and ablation in AF : how can we increase
the lesion formation?
M. Duytschaever (Gent, B)
VT ablation: how a new 3D Navigation Platform can support the mapping phase and
predict effective lesions?
E. Wissner (Hamburg, D)
69
2014
9:00-10:30 | Orange 1
THE SUBCUTANEOUS DEFIBRILLATOR:
LONG-TERM FOLLOW-UP
Chairs: A. Grace (Cambridge, UK)
M.J. Schalij (Leiden, NL)
Fewer lead related complications with the subcutaneous compared to single or dual
chamber ICD
B. Thibault (Montreal, CDN)
Is the inability to pacing an important limitation in young patients to an ICD?
V. Russo (Taranto, I)
Suitability for subcutaneous defibrillator implantation: data from routine clinical practice
P. Francia (Rome, I)
When to replace an explanted, infected endocardial ICD with the subcutaneous defibrillator?
D. Igidbashian (Gorizia, I)
Indications and long term results in children
TBA
Cost effectiveness of the subcutaneous defibrillator
M.A.E. Schneider (Sindelfingen, D)
70
2014
Session III
Controversial in pacing and electrophysiology
Chairs: K. Aonuma (Tsukuba, JP)
J.C. Daubert (Rennes, F)
Long standing atrial fibrillation should not be considered for PVI catheter ablation
All implanted pacemakers / ICD should be MRI conditional
C. Suga (Saitama, JP)
CRT-D patients should be implanted with a quadripolar system
T. Manaka (Tokyo, JP)
CRT, only for symptomatic patients?
A. Quesada (Madrid, E)
ATP therapies should be always switched on in ICD patients
T. Nakai (Tokyo, JP)
Catheter ablation is also an optimal therapeutic strategy in octogenarians with
tachyarrhythmias
M. Hayashi (Tokyo, JP)
71
2014
9:00-10:30 | Spalato
Session IV
Managing arrhythmia recurrences after Atrial
Fibrillation Ablation
Chairs: S. Levy (Marseille, F)
A.S. Montenero (Sesto S. Giovanni-MI, I)
Ablation of atrial tachycardia after AF ablation
A. Berkowitsch (Bad Nauheim, D)
Antiarrhythmic drugs versus a second ablation to treat AF recurrences
G. Pelargonio (Rome, I)
Significance of post-ablation early recurrences of atrial fibrillation
Efficacy of monitoring post ablation recurrences of atrial fibrillation by an implantable
loop recorder
E. Menardi (Cuneo, I)
Minimally invasive surgical treatment of post ablation AF recurrences
S. Benussi (Milan, I)
Hybrid, catheter and surgical, ablation of recurrent atrial firbrillation
C.R. Cole (Colorado Springs-CO, USA)
72
2014
9:00-10:30 | Pola
STROKE PREVENTION IN ATRIAL FIBRILLATION
AVOIDING ANTICOAGULATION
Chairs: P. Danna (Milan, I)
M. Lawrance Jesuraj (Coimbatore, IND)
Left atrial appendage occluders: indications and evidence
R. Violini (Rome, I)
Epicardial approaches for appendage occlusion
A.S. Revishvili (Moscow, RUS)
Left atrial appendage patency after device or surgical closure
Concomitant left atrial appendage closure during bypass or valvular surgery
R. Moosdorf (Marburg, D)
Stand alone surgical closure of left atrial appendage to avoid anticoagulation
P. Stefano (Florence, I)
Hybrid ablation for atrial fibrillation
A. Bulava (České Budějovice, CZ)
73
2014
9:00-10:30 | Cesarea
DOUBTS ON ICD REPLACEMENT
Chairs: A. Meijer (Eindhoven, NL)
K. Okumura (Hirosaki, JP)
In channelopathies without ICD intervention
A. Sagone (Milan, I)
In athletes with ICD for hypertrophic cardiomyopathies at the end of competitive sport
activity
N. Fragakis (Thessaloniki, GR)
In dilated cardiomyopathies with recovered Ejection Fraction over 40%
D. Gras (Nantes, F)
In end stage heart failure and no indications to heart transplantation
M. Zoni Berisso (Milan, I)
After complete cardiac revascularization in patients treated by ICD for secondary
prevention of sudden death
A. Ardashev (Moscow, RUS)
In ICD patients submitted to VT ablation without recurrences during the follow-up
D.G. Benditt (Minneapolis-MN, USA)
74
2014
11:00-12:30 | Leptis magna 4
UNEXPLAINED SYNCOPE: OPTIMAL DIAGNOSTIC
PATHWAY AND THERAPEUTIC APPROACH
Chairs: F. Ammirati (Rome, I)
J.J. Blanc (Brest, F)
The challenges in managing patients with unexplained neuro-mediated syncope
and normal heart
J.C. Deharo (Marseille, F)
Should ILR be the first diagnostic option?
D. Andresen (Berlin, D)
Are Tilt Test and ILR complementary to increase the diagnostic power?
M. Brignole (Lavagna-GE, I)
Prevalence of brady and tachyarrhythmias detected by ILR in patients with
neuro-mediated syncope
A. Ungar (Florence, I)
Long term follow-up of patients with neuro-mediated syncope treated by permanent
pacing
M. Tomaino (Bolzano, I)
How to manage vasodepressive neuro-mediated syncope?
75
2014
11:00-12:30 | Leptis magna 2
HOME MONITORING
BRIDGING THE 15th YEAR OF CLINICAL PRACTICE: WHAT
HAVE WE LEARNED?
Chairs: A. D’Onofrio (Naples, I)
How important is the organizational model and what can be achieved?
The lessons from HomeGuide Study
Monitoring and remote follow up of Pacemaker and ICD: a given?
P. Mabo (Rennes, F)
The value of AF monitoring and its impact on device therapy: the MATRIX study
G. Maglia (Catanzaro, I)
Monitoring of ventricular arrhythmias in ICD to guide ablation and follow up: the PARTITA
study
Can Heart Failure risk be anticipated to be managed in a timely manner?
K. Witte (Leeds, UK)
Home Monitoring: what’s next? Is it time for a bidirectional interaction?
TBA
76
2014
11:00-12:30 | Orange 1
CHANGING PARADIGMS IN TREATMENT OF
BRADYARRHYTHMIAS
Leadless Pacing and CRTP
Chairs: E. Rowland (London, UK)
Review of pacing history, indications and guidelines
TBA
Leadless Pacing: improving patient care and expanding access
Leadless clinical results overview
J. Sperzel (Bad Nauheim, D)
CRTP for Brady: review of the data and guidelines. Implications for the treatment of
bradyarrhythmias
Better outcome and less complications: quadripolar lead in CRTP
G.B. Forleo (Rome, I)
Improve clinical outcome of the brady patient: Remote Control and advanced algorithm
G. Milasinovic (Belgrade, SRB)
77
2014
11:00-12:30 | Tarragona EURO-JAPAN ARRHYTHMIA FORUM (EJAF)
Session IV
Updating on Brugada Syndrome
Chairs: Y. Nakazato (Tokyo, JP)
Genetics and prevalence
W. Shimizu (Tokyo, JP)
Surface ecg types
K. Okishige (Yokohama, JP)
The role of flecainide test in clinical practice
The role of EP study
P. Adragao (Carnaxide, P)
When and which ICD?
M. Shoda (Tokyo, JP)
Long term follow-up
A. Oto (Ankara, TK)
78
2014
11:00-12:30 | Spalato
Session V
Atrial Fibrillation Ablation in unique disease settings
Chairs: J. Almendral Garrote (Madrid, E)
K. Aonuma (Tsukuba, JP)
Catheter ablation in very long lasting atrial fibrillation
G. Tola (Cagliari, I)
Atrial fibrillation ablation in patients with advanced congestive heart failure
Y. Nakano (Hiroshima, JP)
Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy
Atrial fibrillation ablation in patients with dilated cardiomyopathy
B. Köktürk (Köln, D)
Atrial fibrillation ablation in very elderly patients
C. Amellone (Ciriè-TO, I)
Atrial fibrillation ablation in adult patients with congenital heart disease
A. Dello Russo (Milan, I)
79
2014
11:00-12:30 | Pola
MANAGEMENT OF ELECTRICAL STORM
Chairs: D.G. Benditt (Minneapolis-MN, USA)
B. Ozin (Ankara, TR)
Clinical management of electrical storm
APM Sohrabuzzaman (Dhaka, BD)
Electrophysiological management of electrical storm
M. Ziacchi (Bologna, I)
The VT Unit in the management of electrical storm
C. Lavalle (Rome, I)
Prognostic meaning of ICD shocks and of electrical storm
A. Hersi (Riyadh, SA)
Timing of VT ablation in patients with structural heart disease: earlier is better?
S. Grossi (Turin, I)
Electrical storm in patients without structural heart disease
M. Taborsky (Olomouc, CZ)
80
2014
11:00-12:30 | Cesarea
LEAD INFECTION: DIAGNOSIS AND TREATMENT
Chairs: A. Mishra (Shillong, IND)
C. Pignalberi (Rome, I)
Diagnostic flowchart for lead infection
A. Maciag (Warsaw, PL)
Echocardiographic findings
G. Arena (Massa, I)
Antibiotic therapy: selection and timing
D. Porcelli (Rome, I)
Lead extraction: first or final option?
Y. Al Hebaishi (Riyadh, SA)
When to reimplant a new lead?
A. Kutarski (Lublin, PL)
Complications: do we need the heart surgery stand-by?
C. Kennergren (Goteborg, S)
81
2014
12:30-14:00 | Leptis magna 4
Chairs: O. Berenfeld (Ann Arbor-MI, USA)
Mechanism and mapping of atrial fibrillation
Thoracoscopic ablation of atrial fibrillation
M. La Meir (Maastricht, NL)
82
2014
12:30-14:00 | Leptis magna 2
Chairs: G. Altamura (Rome, I)
S. Levy (Marseille, F)
Continuous monitoring to control post-mi arrhythmic risk
P.E. Bloch-Thomsen (Aalborg, DK)
Altered cardiac electrophysiology in diabetes
D.T. Martin (Burlington-MA, USA)
83
2014
12:30-14:00 | Orange 1
LUNCHEON PANEL
MONITORING ISCHEMIA BY CIED: THE INSIGHT STUDY
Chairs: B. Thibault (Montreal, CDN)
M. Zardini (Parma, I)
Reliability of ST segment continuous monitoring by ICD
V. Nissardi (Cagliari, I)
Clinical impact of continuous ST segment monitoring: the Insight Study
J.K. Wranicz (Lodz, PL)
Continuous monitoring of ST segment: Healt Technology Assessment
84
2014
12:30-14:00 | Tarragona
LUNCHEON PANEL
ATRIAL FIBRILLATION PREVENTION AND TREATMENT
Chairs: M. Gulizia (Catania, I)
Flecainide Acetate: the most used antiarrhythmic drugs to prevent and treat atrial
fibrillation
L. Calò (Rome, I)
Benefits of Flecainide prolonged release
M. Grimaldi (Acquaviva delle Fonti-BA, I)
Potential role of Flecainide prolonged release in the various atrial fibrillation patterns
85
2014
12:30-14:00 | Spalato
Free Papers
ATRIAL FIBRILLATION: PREDICTION AND TREATMENT
Chairs: B. Mariconti (Milan, I)
P WAVE ANALYSIS WITH WAVELETS ATRIAL FIBRILLATION RISK IN HYPERTENSIVE PATIENTS:
A CROSS-SECTIONAL ANALYSIS AND 1 YEAR FOLLOW-UP
G. Dakos 1, D. Konstantinou 2, Y. Chatzizisis 3, I. Chouvarda 1, D. Filos 1, S. Paraskevaidis 1,
L. Mantziari 1, N. Maglaveras 1, H. Karvounis 1, V. Vassilikos 1
1
Thessaloniki, GREECE, 2 London, UNITED KINGDOM, 3 Boston, MA, USA
SERUM GALECTIN-3 LEVELS ARE ELEVATED IN PATIENTS WITH ATRIAL FIBRILLATION AND
NORMAL LEFT VENTRICULAR FUNCTION
K.M. Gurses, M.U. Yalcin, D. Kocyigit, H. Canpinar, B. Evranos, H. Yorgun, M.L. Sahiner, E.B. Kaya,
N. Ozer, L. Tokgozoglu, M.A. Oto, D Guc, K. Aytemir
Ankara, TURKEY
BOTULINUM TOXIN INJECTION IN EPICARDIAL FAT PADS CAN PREVENT RECURRENCES OF
ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: RESULTS OF A RANDOMIZED PILOT STUDY
S. Bayramova 1, A. Strelnikov 1, D. Losik 1, E. Pokushalov 1, B. Kozlov 2, A. Romanov 1, D. Sergeevichev1,
A. Bogachev-Prokophiev 1, S. Zheleznev 1, V. Shipulin 2, D. Risteski 3, A. Karaskov 1, S. Po 4, J.
Steinberg 4
Novosibirsk, 2 Tomsk, RUSSIA, 3 Skopje, REPUBLIC OF MACEDONIA – FYROM, 4 Oklahoma, OK, 5 New
York, NY, USA
1
ENDOCARDIAL BOTULINUM TOXIN INJECTION IN GANGLIONATED PLEXI FOR PREVENTION
RECURRENCES OF ATRIAL FIBRILLATION
A. Strelnikov 1, S. Bayramova 1, D. Losik 1, E. Pokushalov 1, A. Romanov 1, D. Sergeevichev 1, S. Artyomenko
1
, A. Yakubov 1, A. Karaskov 1, D. Risteski 2, S. Po 3, J. Steinberg 4
1
Novosibirsk, RUSSIA, 2 Skopje, REPUBLIC OF MACEDONIA – FYROM, 3 Oklahoma, OK, 4 New York, NY, USA
SUPERIOR EFFICACY OF THE COMBINED USE OF RANOLAZINE AND AMIODARONE COMPARED
WITH AMIODARONE ALONE FOR CONVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
N. Fragakis, K. Koskinas, K. Rossios, E. Pagurelias, D. Tanos, A. Photoglidis, V. Skeberis, V. Vasilikos
Thessaloniki, GREECE
86
2014
12:30-14:00 | Pola
Free Papers
OPTIMIZING RESULTS OF ATRIAL FIBRILLATION ABLATION
Chairs: F. Bianchi (Turin, I)
J.C Deharo (Marseille, F)
UNUSEFULNESS OF IMAGING INTEGRATION IN RADIOFREQUENCY CATHETER ABLATION OF
PAROXYSMAL ATRIAL FIBRILLATION WITH MULTIELECTRODE MAPPING SYSTEMS
B. Majocchi, F. Tundo, G. Fassini, S. Riva, A. Dello Russo, M. Casella, M. Moltrasio, V. Marino, E. Russo,
C. Tondo
Milan, ITALY
CRYOBALLOON ABLATION FOR PERSISTENT ATRIAL FIBRILLATION: ONE YEAR FOLLOW-UP
L. Ottaviano, M. Longobardi, M.C. Negro, E. Broglia, E. Cannas, A.S. Montenero, C. Storti
Pavia, ITALY
OPEN OR CLOSED IRRIGATED CATHETERS IN AF ABLATION PROCEDURE. OUR EXPERIENCE
O. Sapelnikov, P. Mazentsev, R. Latypov, A. Partigulova, D. Cherkashin, I. Grishin, A. Chapurnikh,
R. Akchurin
Moscow, RUSSIA
PULMONARY VEIN DISCONNECTION BY USING PULMONARY VEIN STIMULATION: CONFRONTATION
WITH CONVENTIONAL APPROACH AND SUCCESSFUL ABLATION
M. Rillo, S. Palumbo, R. Punzi, G.B. Semeraro, A. Aloisio, C. Giannattasio, L. My, C. Larosa
Taranto, ITALY
RENAL DENERVATION FOR IMPROVING OUTCOMES OF CATHETER ABLATION IN PATIENTS WITH
ATRIAL FIBRILLATION AND HYPERTENSION: EARLY EXPERIENCE
D. Losik 1, S. Bayramova 1, A. Strelnikov 1, E. Pokushalov 1, A. Romanov 1, D. Katritsis 2, S. Artyomenko1,
V. Baranova 1, D. Risteski 3, A. Karaskov 1, J. Steinberg 4
1
Novosibirsk, RUSSIA, 2 Athens, GREECE, 3 Skopje, REPUBLIC OF MACEDONIA - FYROM, 4 New York, NY, USA
ASPECTS OF ANTIARHYTHMIC TREATMENT OF ATRIAL FIBRILLATION BEFORE AND AFTER
ABLATION
A. Partigulova, O. Sapelnikov, R. Latypov, P. Mezentsev, D. Cherkashin, A. Toporinsky, A. Chapurnikh,
R Akchurin
Moscow, RUSSIA
87
2014
12:30-14:00 | Cesarea
Free Papers
MULTIPOINT PACING
Chairs: P.P. Delnoy (Zwolle, NL)
MULTIPOINT LEFT VENTRICULAR PACING PROVIDES ADDITIONAL ECHOCARDIOGRAPHIC BENEFIT
TO RESPONDERS AND NON-RESPONDERS TO CONVENTIONAL CARDIAC RESYNCHRONIZATION
THERAPY
A. Cuko 1, Z. Calovic 1, L.C. McSpadden 2, C. Jordan 2, K. Ryu 2, E. Romano 3, M. Baldi 1, A. Pappone 1,
M. Saviano 1, L. Giannelli 1, C. Ciaccio 1, C. Catalano 1, A. Petretta 1, M. Moscatiello 1, A. Fundaliotis 4, R.
Vitale 1, B. Ionescu 1, G. Vicedomini 1, V. Santinelli 1, C. Pappone 1
1
Cotignola, RA, ITALY, 2 Sylmar, CA, USA, 3 Milan, 4 Novara, ITALY
IMPROVEMENTS IN HEMODYNAMIC PARAMETERS IN A CRT-D PATIENT USING OPTIMAL MPP
PROGRAMMING
S. Felis, G. Doria, M. Audoly, D. Castelli, G. Arcidiacono, F. Cangemi
Catania, ITALY
A NEW ALGORITHM FOR MULTI POINT PACING IN CARDIAC RESYNCHRONIZATION THERAPY:
FEASIBILITY FROM A MULTICENTER EXPERIENCE
M. Giammaria 3, G. Forleo 2, F. Zanon 1, E. Baracca 1, M .T. Lucciola 3, D. Potenza 4, G. Di Stolfo 4,
E. Menardi 4, G.P. Ballari 4, E. Bertaglia 6, F. Migliore 6, L. Calò 2, E. De Ruvo 2, G. Morani 7, L. Tomasi
7
, A. Curnis 8, L. Bontempi 8, V. Calabrese 2, D. Ricciardi 2, L. Santini 2
1
Rovigo, 2 Rome, 3 Turin, 4 San Giovanni Rotondo, FG, 5 Cuneo, 6 Padua, 7 Verona, 8 Brescia, ITALY
OPTIMIZATION OF MULTI-POINT PACING DEVICES IN CARDIAC RESYNCHRONIZATION THERAPY:
FOCUS ON CLINICAL PRACTICE
D. Potenza 1, G. Forleo 2, L. Santini 2, M. Giammaria 4, G. Di Stolfo 1, G. Pastore 3, M. T. Lucciola 4, A. Vado 4, G.
Rossetti 4, E. Bertaglia 6, F. Migliore 6, L. Calò 2, A. Martino 2, G. Morani 7, L. Tomasi 7, A. Curnis 8, L. Bontempi 8,
G. Di Giovanni 2, D. Ricciardi 2, F. Zanon 3
1
San Giovanni Rotondo, FG, 2 Rome, 3 Rovigo, 4 Turin, 5 Cuneo, 6 Padua, 7 Verona, 8 Brescia, ITALY
MULTI-POINT PACING IN CARDIAC RESYNCHRONIZATION THERAPY: EFFECTS ON QRS
F. Zanon 1, L. Santini 2, M. Giammaria 3, E. Baracca 1, M.T. Lucciola 3, D. Potenza 4, R. Massaro 4,
A. Vado 4, G. Rossetti 4, A. Curnis 6, L. Bontempi 6, E. Bertaglia 7, F. Migliore 7, V. Calabrese 2, D.
Ricciardi 2, C. D’Agostino 8, M. Palella 8, G. Ansalone 2, L. Pauselli 2, G. Forleo 2
1
Rovigo, 2 Rome, 3 Turin, 4 San Giovanni Rotondo, FG, 5 Cuneo, 6 Brescia, 7 Padua, 8 Bari, ITALY
PROGRESSION OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY WITH MULTIPOINT LEFT
VENTRICULAR PACING IN A SINGLE CORONARY SINUS BRANCH FROM 3 MONTHS TO 12 MONTHS
Z. Calovic 1, A. Cuko 1, L.C. McSpadden 2, C. Jordan 2, K. Ryu 2, E. Romano 3, M. Baldi 1, A. Pappone 1,
M. Saviano 1, L. Giannelli 1, C. Catalano 1, C. Ciaccio 1, A. Petretta 1, M. Moscatiello 1, A. Fundaliotis 4, R.
Vitale 1, B. Ionescu 1, G. Vicedomini 1, V. Santinelli 1, C. Pappone 1
1
88
2014
14:00-15:30 | Leptis magna 4
CRYOABLATION: SETTING THE NEW STANDARD
OF AF ABLATION
Chairs: D.W. Davies (London, UK)
M. Kuniss (Bad Nauheim, D)
Best practices with Cryoballoon: state of the art after 100.000 worldwide cases
E. Hoffmann (Munich, D)
Cryoablation in persistent atrial fibrillation
C. Blomstrom Lundqvist (Uppsala, S)
New strategies in Cryoablation of Atrial Fibrillation: from the standard to the tailored
approach
C. Tondo (Milan, I)
Comparing outcomes of radiofrequency ablation and cryoablation for atrial fibrillation
Cryoablation as a first line atrial fibrillation therapy
G.B. Chierchia (Brussels, B)
Next generation cryoballon: which differences, which benefits?
K.R.J. Chun (Frankfurt, D)
89
2014
14:00-15:30 | Leptis magna 2
BRAIN PROTECTION IN PATIENTS WITH ATRIAL
FIBRILLATION: ONE YEAR WITH DABIGATRAN
Chairs: F. Fedele (Rome, I)
The reason for this choice
G. Di Pasquale (Bologna, I)
Use of the drug during cardioversion or ablation
F. Andreotti (Rome, I)
Management of anticoagulation in pacemaker patients
A. Capucci (Ancona, I)
Lessons on pharmaco-economy
90
2014
14:00-15:30 | Orange 1
NEW TECHNOLOGIES, NEW SOLUTIONS
Chairs: P. Adragao (Carnaxide, P)
Flutter ablation: what’s new?
R. Verlato (Camposampiero-PD, I)
New technologies for quadripolar LV pacing
Real world data about S-ICD
MRI safety: is the lead the crucial part of the system?
G. Forleo (Rome, I)
Clinical and device update about LAA occlusion
G. Senatore (Ciriè-TO, I)
New perspectives on left atrial mapping
R. Mantovan (Cesena-FC, I)
91
2014
14:00-15:30 | Tarragona
GLOBAL ARRHYTHMIA FORUM (GAF)
Session I
Pacemaker remote control
Chairs: M. Santini (Rome, I)
S. Zhang (Beijing, Republic of China)
Remote control of pacemaker malfunctions
J. Yang (Beijing, Republic of China)
Remote control of supraventricular tachyarrhythmias
W. Hua (Beijing, Republic of China)
Remote control of ventricular tachyarrhythmias
G. Magliano (Rome, I)
The optimal organization for a Remote Control Center
H. Li (Beijing, Republic of China)
Cost-benefit of pacemaker remote control
M. Roser (Berlin, D)
Remote control in China: state of the art and perspectives
K. Chen (Beijing, Republic of China)
92
2014
14:00-15:30 | Spalato
Session VI
First option therapeutical strategies for Atrial
Fibrillation
Chairs: A. Ardashev (Moscow, RUS)
S. Sharma (Jammu, IND)
No treatment
L.G. Molina (Mexico City, MEX)
Antiarrhythmic drugs: when, which?
F. Del Carpio (La Crosse-WI, USA)
Rate control: drug, AV node ablation?
K.K.N. Namboodiri (Thiruvananthapuram, IND)
Antiplatelets or anticoagulants
N. Takahashi (Oita, JP)
Catheter ablation; when, which energy source?
C. Pratola (Ferrara, I)
Hybrid ablation (catheter and surgical): when, how?
93
2014
14:00-15:30 | Pola
SICK SINUS SYNDROME TODAY
Chairs: T. Ishikawa (Yokohama, JP)
B. Lemke (Luedenscheid, D)
Incidence and prevalence of Sick Sinus Syndrome in the pacemaker, ICD population
A. Ganguly (Durgapur, IND)
Can we increase pharmacologically the sinus rate in Sick Sinus Syndrome
M. Marini (Trento, I)
The permanent pacing therapeutical option: advantages and disadvantages
A. Michelucci (Florence, I)
Catheter ablation to treat atrial tachyarrhythmias in the brady-tachy syndrome
S.M. Yashin (Saint Petersburg, RUS)
Ablate and pace in patient with Sick Sinus Syndrome: pros and cons
F. Quartieri (Reggio Emilia, I)
Pharmacological antiarrhythmic therapy for atrial tachyarrhytmias in Sick Sinus
Syndrome
V.P. Vassilikos (Thessaloniki, GR)
94
2014
14:00-15:30 | Cesarea
NEWS ON INHERITED ARRHYTHMOGENIC
CARDIOPATHIES
Chairs: A.M. Al Musaad (Riyadh, SA)
E.U. Alt (Houston-TX, USA)
The Short QT syndrome: detection and treatment
C. Giustetto (Turin, I)
The Long QT syndrome: when drugs, when implantable devices
S. Castelletti (London, UK)
Cathecholaminergic ventricular tachycardia the role of catheter ablation and ICD
A. Castro (Rome, I)
Arrhythmogenic Right Ventricular Displasia: to whom to implant an ICD
D. Potenza (S. Giovanni Rotondo-FG, I)
Brugada Syndrome: should we implant an ICD in all the Type I patients, regardless of
genetic testing?
T. Manaka (Tokyo, JP)
Hypertrophic Cardiomiopathy: role of drugs and implantable devices to prevent sudden
death
M.F. Márquez Murillo (Mexico City, MEX)
95
2014
15:30-17:00 | Leptis magna 4
IMPLANTABLE DEVICE AND MRI: ADOPTION AND
CLINICAL IMPLICATIONS TODAY
Chairs: J.M. Guerra Romos (Barcelona, E)
European and International legislation on MRI scan in patients with device and the role
of National Health Institutions
G. Calcagnini (Rome, I)
The role of the radiologist and his cooperation with cardiologist to manage MRI patient
flow nowadays
D. Weishaupt (Zurich, CH)
What is the ‘real life’ approach in the clinical practice?
J.M. Guerra Romos (Barcelona, E)
MRI conditional leads: is their reliability better, worse or the same of conventional leads?
G. Senatore (Ciriè-TO, I)
MRI conditional pacemaker and ICD: is it time to offer them to everybody?
G. Maglia (Catanzaro, I)
What are the potential medical – legal problems?
A. D’Urso (Rome, I)
96
2014
15:30-17:00 | Leptis magna 2
DO WE NEED REMOTE MONITORING ONLY?
REAL SOLUTIONS FOR ADVANCED PATIENT
MANAGEMENT
Chairs: M. Khoury (Beirut, RL)
Different benefits of Remote Patient Management based on the pathology and the
implanted device
M. Bertaglia (Mirano-VE, I)
After 10 years of Remote Patient management, is there still room for in-clinic follow-up?
R. Verlato (Camposampiero-PD, I)
Remote Patient Management solutions to implement hub and spoke models
N. Basterra Sola (Pamplona, E)
Actuality and potentiality of handling aggregated data
F. Quartieri (Reggio Emilia, I)
A fully integrated and universal solution to simplify patients follow-up: my experience
with the Mediconnect system
C. Stoepel (Neuss, D)
The real economic value of Remote Patient Management
G. Perego (Milan, I)
97
2014
15:30-17:00 | Orange 1
HAEMODYNAMIC OPTIMIZATION IN CRT: RESULTS
AND RESEARCH PERSPECTIVES
Chairs: M.M. Oliveira (Lisbon, P)
CRT settings optimization: state of the art
Clinical cases of CRT haemodynamic optimization
R. Zbinden (Zurich, CH)
Impact of systematic optimization on CRT costs
Towards new solutions to optimize leads position
P.P. Delnoy (Zwolle, NL)
What’s new from a stethoscope?
P. Ritter (Bordeaux, F)
98
2014
15:30-17:00 | Tarragona
CONTROVERSIAL INDICATIONS FOR ICD IMPLANT
Chairs: N.A.M. Estes III (Boston-MA, USA)
Y. Nakazato (Tokyo, JP)
Early after myocardial infarction
H. Schmidinger (Vienna, A)
Very Elderly patients
H.K. Bali (Chandigarh, IND)
Severe Renal disfunction
S. Sack (Munich, D)
Dual Vs single chamber in primary prevention
F. Borrello (Catanzaro, I)
Appropriate timing of ICD reimplant after infected leads removal
B. Malecka (Krakow, PL)
Subcutaneous ICD
S. Viani (Pisa, I) 99
2014
15:30-17:00 | Spalato
Session VII
Clinical issues
Chairs: M. Disertori (Trento, I)
H. Zouzou (Algiers, DZ)
Increase of cognitive impairment by chronic atrial fibrillation
F. Briand (Besançon, F)
Silent cerebral events after atrial fibrillation ablation
T. Deneke (Bad Neustadt, D)
Long-term improvement in quality of life and reduction in hospitalization by catheter
ablation of atrial fibrillation
M. Santamaria (Campobasso, I)
Retinal microvascular injuries in patients with atrial fibrillation
A. Lubiński (Lodz, PL)
Biomarkers of inflammation as predictors of atrial fibrillation progression to a permanent type
S. Koulouris (Bayreuth, D)
Post ablation increase in biomarkers of myocardial injury: relationship with the energy
source
M. Rebecchi (Rome, I)
100
2014
15:30-17:00 | Pola
OUTCOME IN CRT PATIENTS
Chairs: M. Gulizia (Catania, I)
H. Mansour (Beirut, RL)
Myocardial scar quantification may predict outcome in CRT patients
S. Matsuo (Tokyo, JP)
Gender difference in outcome of CRT patients
C. Marquié (Lille, F)
Results of CRT in the elderly: is it worth?
G. Morani (Verona, I)
Outcome of CRT in patients with atrial fibrillation
O. Aquilina (Msida, M)
When considering not to replace a CRTD device?
S. Aquilani (Rome, I)
When considering to deactivate ICD in CRT-D patients?
A. Vincenti (Monza-MI, I)
101
2014
15:30-17:00 | Cesarea
ABLATION OF VENTRICULAR TACHYCARDIA
AND VENTRICULAR FIBRILLATION
Chairs:C. Lavalle (Rome, I)
T. Szili-Torok (Rotterdam, NL)
How to identify the epicardial origin of ventricular tachycardia
A. Scopinaro (Alessandria, I)
Catheter ablation of epicardial ventricular tachycardia
C. De Chillou (Nancy, F)
Post ablation non inducibility of sustained ventricular tachycardia: can we trust it?
Catheter ablation of idiopathic ventricular tachycardia and ventricular ectopic beats
S. Ikeguchi (Moriyama City, JP)
Catheter ablation for electrical storm in ICP patients
T. Deneke (Bad Neustadt, D)
Haemodynamic support for VT ablation
K. Adalet (Istanbul, TR)
102
2014
17:30-19:00 | Leptis magna 4
Free Papers
CLINICAL ELECTROPHYSIOLOGY
Chairs: A.S. Fak (Istanbul, TR)
L. Gramegna (Trento, I)
ATRIAL FIBRILLATION INCIDENTALLY DETECTED DURING PACEMAKER FOLLOW-UP. EFFECTS
ON ANTITHROMBOTIC TREATMENT
S. Magnani, S. Franco, M. Zecchin, A. Nordio, M. Muca, I. Puggia, G. Morea, M. Narciso, E. Franco,
G. Sinagra
Trieste, ITALY
ATRIAL FIBRILLATION AFTER ORTHOTOPIC HEART TRANSPLANTATION: RISK FACTORS AND
CLINICAL RELEVANCE
S. Ferretto, I. Giuliani, G. Vettor, T. Bottio, G. Feltrin, A. Gambino, G. Toscano, A. Angelini, S. Iliceto,
G. Gerosa, L. Leoni
Padua, ITALY
HIGH PREVALENCE OF BRADY-TACHY SINUS NODE DISEASE AFTER AF ABLATION
E. Pelissero, C. Amellone, G. Trapani, M. Giuggia, B. Giordano, G. Senatore
Ciriè, TO, ITALY
PACE-MAKER DEPENDENCY AT FOLLOW-UP AFTER TAVR PROCEDURES
M. Morosin, L. Vitali Serdoz, M. Zecchin, A. Perkan, K. Salam, E. Fabris, F. Longaro, G. Barbati,
B. Pinamonti, A. Salvi, A. Pappalardo, G. Sinagra
Trieste, ITALY
ATTENUATION OF CLOCK-BMAL1 TRANSCRIPTIONALLY DECREASES THE EXPRESSION OF
BETA1-AR TO ANTICIPATE THE OCCURRENCE OF VENTRICULAR ARRHYTHMIA AFTER CHRONIC
HEART FAILURE
J. Yuan, Z. Qian, Y. Wang, Y. Chen, J. Zou
Nanjing, CHINA
VENTRICULAR TACHYCARDIA IN LEFT DOMINANT ARRHYTHMOGENIC CARDIOMYOPATHY: WHEN
THE ECG LEADS TO THE DIAGNOSIS
F. De Sensi, A. Cresti, G. Miracapillo, S. Severi
Grosseto, ITALY
103
2014
17:30-19:00 | Leptis magna 2
Free Papers
ICD INAPPROPRIATE SHOCK AND REMOTE MONITORING
Chairs: A. Nogami (Tsukuba, JP)
G. Barbato (Bologna, I)
HIGH TACHY DETECTION RATE IN ICD PATIENTS: IMPACT ON INAPPROPRIATE SHOCKS IN
OPTION STUDY
G. Molon 1, G. Mantovani 2, P. Bertocchi 3, E. Aime’ 4, A. Pezzotta 4, C. A. Kolb 6
1
Negrar, VE, 2 Desio, MB, 3 Pavia, 4 S. Donato Milanese, MI, 5 Milan, ITALY, 6 Munich, GERMANY
SENSIBLE REDUCTION OF INAPPROPRIATE SHOCK RATES IN HEART FAILURE PATIENTS
WITH CRT/ICDS USING A NOVEL SUITE OF DETECTION ALGORITHMS
A. Proclemer 1, D. Facchin 1, G. Boriani 2, M. Landolina 3, R.P. Ricci 4, M. Maines 4, L. Tomasi 6,
G.B. Perego 7, G. Allocca 8, M. Gasparini 9, M. Lunati 7
1
Udine, 2 Bologna, 3 Pavia, 4 Rome, 5 Rovereto, 6 Verona, 7 Milan, 8 Conegliano, TV, 9 Rozzano, MI, ITALY
REMOTE MONITORING IMPROVES OUTCOME AFTER ICD IMPLANTATION: THE CLINICAL
EFFICACY OF REMOTE MONITORING IN THE MANAGEMENT OF HEART FAILURE (EFFECT) STUDY
M. Luzi 1, A. De Simone 2, G. Stabile 3, L. Leoni 4, C. Amellone 4, V. La Rocca 2, A. Capucci 1, A. D’Onofrio3,
E. Ammendola 3, F. Accardi 6, S. Valsecchi 6, S. Guardiani 6, G. Buja 4
1
Ancona, 2 Maddaloni, CE, 3 Naples, 4 Padua, 5 Ciriè, TO, 6 Milan, ITALY
HOW BIG IS THE CLINICAL PROBLEM WITH INAPPROPRIATE SHOCKS WHEN DIAGNOSIS AND
TREATMENT ARE FACILITATED BY REMOTE MONITORING?
E. Sandgren 1, C. Rorsman 1, J. Engdahl 2, N. Edvardsson 3
1
Varberg, 2 Halmstad, 3 Gothenburg, SWEDEN
REMOTE MONITORING OF DUAL CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
DETECTS CHANGES IN VENTRICULAR PACING ASSOCIATED WITH AN INCREASED ATRIAL
ARRHYTHMIA BURDEN
J.O. Schwab 1, H. Nägele 2, H. Oswald 3, G. Klein 3, O. Gunkel 4, A. Lang 4, W. R. Bauer 6, P. Korb 7,
T. Hauser 7
1
Bonn, 2 Reinbek, 3 Hannover, 4 Frankfurt/Oder, 5 Erfurt, 6 Würzburg, 7 Berlin, GERMANY
PRELIMINARY RESULTS OF THE HEALTH ECONOMICS EVALUATION REGISTRY FOR REMOTE
FOLLOW-UP (TARIFF)
R.P. Ricci 1, A. Vicentini 2, A. D’Onofrio 3, A. Sagone 4, A. Vincenti 4, L. Padeletti 6, L. Morichelli 1,
A. Fusco 2, W. Bianchi 3, L. Lombardi 4, M. Santini 1
1
Rome, 2 Peschiera del Garda, VR, 3 Naples, 4 Milan, 5 Monza, 6 Florence, ITALY
104
2014
17:30-19:00 | Orange 1
Free Papers
NEWS ON IMPLANTATION TECHNIQUES
Chairs: P.E. Bloch-Thomsen (Aalborg, DK)
E. Occhetta (Novara, I)
BLIND AXILLARY VEIN ACCESS BY SHALLOW NEEDLE TRAJECTORY TECHNIQUES IN
DEFIBRILLATION LEAD IMPLANTATION: A 4-YEAR EXPERIENCE FROM A SINGLE CENTRE IN CHINA
T. Zhang, M.H. Zang, J.L. Mao
Shanghai, CHINA
AXILLARY VEIN TECHNIQUE FOR IMPLANTABLE DEFIBRILLATOR LEADS IMPLANTATION: A
SAFE AND EFFECTIVE ALTERNATIVE APPROACH
F. Migliore, M. Siciliano, S. Ferretto, C. Dalla Valle, M. De Lazzari, S. Iliceto, E. Bertaglia
Padua, ITALY
IMPLANTATION OF CARDIAC ELECTRONIC DEVICES IN YOUNG PATIENTS: REPORT OF A
LONG-TERM SINGLE-CENTER EXPERIENCE WITH SUBAXILLARY APPROACH
M. Morosato, G. Morani, P. Silvestre, L. Tomasi, G. Mugnai, B. Bolzan, C. Vassanelli
Verona, ITALY
ULTRASOUND-GUIDED VENOUS ACCESS FOR PACEMAKERS AND DEFIBRILLATORS.
RANDOMIZED TRIAL
M. Liccardo 1, P. Nocerino 1, A. Russo 2, B. Bonamassa 1, A. Borrino 1, C. Carbone 1, P. Follero 1,
C. Ciardiello 1, L. Prato 3, G. Salzano 3
1
Naples, ITALY, 2 Syracuse, NY, USA, 3 Milan, ITALY
ECG CRITERIA FOR RIGHT VENTRICULAR LEAD POSITIONING. AN ANALYSIS FROM THE
RIGHT PACE STUDY
M. Racheli 1, S. Calcagno 2, F. Dettori 3, V. Carinci 4, D. Porcelli 4, G. Nigro 6, M. Giammaria 7, V. Calvi8,
G. Ciaramitaro 8, D. Pecora 8, G. Maglia 8, G. L Botto 8, M. Malacrida 9, M. Campari 9, E. Savoldelli9,
C. Muto 10
Gavardo, BS, 2 Civitavecchia, RM, 3 Oristano, 4 Bologna, 5 Rome, 6 Naples, 7 Turin, 8 Right Pace Study
Group, 9 Milan, 10 Nola, NA, ITALY
1
THE EFFECT OF SEPTAL VERSUS APICAL RIGHT VENTRICULAR PACING ON LEFT AND RIGHT
VENTRICULAR PERFORMANCE: A CARDIAC MAGNETIC RESONANCE IMAGING STUDY
A. Marzan 1, T. Bischof 1, S.A. Mueggler 1, R. Berli 2, J. Peter 3, R. Maire 4, C. Beynon 1, A. Mueller1,
R. Zbinden 1
1
Zurich, 2 Uznach, 3 Schaffhausen, 4 Maennedorf, SWITZERLAND
105
2014
17:30-19:00 | Orange 2
Free Papers
LEADS INFECTION AND EXTRACTION
Chairs: H. Nakajima (Tokyo, JP)
P.G. Golzio (Turin, I)
CONSERVATIVE TREATMENT OF PACEMAKER POCKET INFECTION: IS IT A VIABLE OPTION?
A. Bisignani 1, G. Bisignani 2, G. San Pasquale 2, S. De Bonis 2
1
Rome, 2 Castrovillari, CS, ITALY
USEFULNESS OF SPECTROPHOTOMETRY IN ASSESSMENT OF SUPERFICIAL DAMAGES ON
SILICONE LEADS EXTRACTED BY MANUAL TRACTION
B. Malecka, A. Zabek, K. Boczar, M. Ziabka
Krakow, POLAND
EXTRACTED LEAD BODY DWELLING TIME. SHOULD IT INFLUECE ON TLE SCENARIO?
A. Kutarski 1, M. Grabowski 2, A. Polewczyk 3, M. Polewczyk 3, M. Czajkowski 1
1
Lublin, 2 Warsaw, 3 Kielce, POLAND
EFFICACY AND SAFETY OF PERMANENT EPICARDIAL LEAD IMPLANTATION BEFORE LEAD
EXTRACTION IN PACEMAKER-DEPENDENT PATIENTS WITH ENDOCARDITIS. A SINGLE SITE
EXPERIENCE
L. Bontempi 1, G.L. Bisleri 1, F. Rosati 1, M. Cerini 1, A. Lipari 1, F. Vassanelli 1, N. Ashofair 1, M. Belotti
Cassa 1, F. Chiusso 2, M. Siciliano 1, S. Bardari 1, L. Inama 1, F. Guidetti 1, F. Salghetti 1, C. Muneretto1,
A. Curnis 1
1
Brescia, 2 Vimodrone, MI, ITALY
EXTRACTION OF PERMANENT PACEMAKER AND IMPLANTABLE DEFIBRILLATOR LEADS: A
SINGLE CENTER EXPERIENCE
L. Inama 1, L. Bontempi 1, A. Lipari 1, M. Cerini 1, F. Chiusso 2, M. Belotti Cassa 1, F. Salghetti 1,
N. Ashofair 1, F. Guidetti 1, M.C. Siciliano 1, F. Vassanelli 1, A. Curnis 1
1
Brescia, 2 Vimodrone, MI, ITALY
106
2014
17:30-19:00 | Tarragona
Free Papers
CLINICAL PACING
Chairs: K. Hirao (Tokyo, JP)
LONG-TERM FOLLOW-UP OF ENDOCARDIAL PACEMAKERS IMPLANTED IN CHILDREN UNDER
AGE 6 YEARS
J. Solís
Mexico DF, MEXICO
INFLUENCE OF GENDER ON LONG-TERM DDD PACING
M. Debski, M. Ulman, A. Zabek, K. Haberka, J. Lelakowski, B. Malecka
Krakow, POLAND
MORTALITY IN PATIENTS WITH CHAGAS CARDIOMYOPATHY USERS IMPLANTABLE CARDIOVERTER
DEFIBRILLATOR FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH
G. Mora, C. Portilla
Bogota, COLOMBIA
MALFUNCTIONING OF CARDIAC DEVICES AFTER RADIOTHERAPY NOT DUE TO IONIZING
RADIATION. EXPERIMENTAL DATA
G. Morea, M. Zecchin, E. Sergi, A. Baratto Rodan, M. Severgnini, A. Nordio, E. Bianco, S. Magnani,
M. Muca, A. Zorzin Fantasia, V. Milan, G. Giannini, G. Sinagra
Trieste, ITALY
PERFORMANCE OF THE ACCENT MRI PACEMAKER SYSTEM IN PATIENTS UNDERGOING HIGHPOWER THORACIC MRI SCANNING
A. Marzan 1, T. Bischof 1, S.A. Mueggler 1, A. Mueller 1, C. Beynon 1, R. Berli 2, J. Peter 3, R. Maire4,
M. Simon 4, R. Zbinden 1
1
Zurich, 2 Uznach, 3 Schaffhausen, 4 Maennedorf, SWITZERLAND, 5 Zaventem, BELGIUM
ACUTE PERFORMANCE AND HANDLING OF NOVEL MR-CONDITIONAL ICD AND CRT-D LEADS.
RESULTS FROM THE REALLY PROMRI PHASE 1 SURVEY
G. Maglia 1, A. Curnis 2, R.P. Ricci 3, M. Brieda 4, P. Bonfanti 4, F. Caravati 4, D. Orsida 6, L. Santini 3,
M. Anaclerio 7, A. Fagagnini 3, V. Caccavo 8
1
Catanzaro, 2 Brescia, 3 Rome, 4 Pordenone, 5 Varese, 6 Gallarate, VA, 7 Bari, 8 Acquaviva delle Fonti,
BA, ITALY
107
2014
17:30-19:00 | Spalato
Free Papers
CATHETER ABLATION OF ATRIAL FIBRILLATION
Chairs: N. Bottoni (Reggio Emilia, I)
B. Köktürk (Köln, D)
AF ABLATION AS “FIRST LINE THERAPY”. FIVE YEARS FOLLOW UP OF A SINGLE CENTRE
C. Pratola, M. Bertini, L. Marcantoni, M. Malagù, F. Casadei, R. Ferrari
Ferrara, ITALY
ELIMINATION OF DORMANT CONDUCTION REVEALED BY ADENOSINE AND CRONIC PULMONARY
VEIN RECONNECTION: LESSON FROM THE REDO PROCEDURES
E. Lyan, A. Morozov, A. Kazakov, A. Merkureva
Saint-Petersburg, RUSSIA
IMPACT OF ESOPHAGEAL TEMPERATURE MONITORING-GUIDED STRATEGY DURING
RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION ON PULMONARY VEIN RECONNECTION
M. Leo, M. Pedersen, K. Rajappan, M. Ginks, Y. Bashir, T. Betts
Oxford, UNITED KINGDOM
PHASED RF EVALUATION OF PULMONARY VEIN ISOLATION WITH NEW GENIUS AND PVAC
GOLD: PRECISION-GOLD STUDY
Y. De Greef 1, L. Dekker 2, L. Boersma 3, S. Murray 4, M. Wieczorek 5, S. Spitzer 6, N. Davidson 7,
S. Furniss 8, M. Hocini 9, J. C. Geller 10, Z. Csanádi 11
Antwerp, Belgium, 2 Eindhoven, 3 Nieuwegein, The Netherlands, 4 Newcastle upon Tyne, United
Kingdom, 5 Bocholt, 6 Dresden, Germany, 7 Manchester, 8 Sussex, United Kingdom, 9 Bordeaux,
France, 10Bad Berka, Germany, 11 Debrecen, Hungary
1
LEFT ATRIAL ANATOMICAL MODEL RECONTRUCTION FOR ATRIAL FIBRILLATION ABLATION:
RELIABILITY OF NEW MAPPING AND CONTACT SYSTEMS
A. Bonso 1, S. Ferrara 1, M. Fantinel 1, G. Scalchi 1, M. Beraldo 1, S. Indiani 2, F. Calore 2
1
Feltre, BL, 2 Agrate Brianza, MB, ITALY
EFFICACY AND SAFETY PROFILE OF RFCA OF SEPTAL ACCESSORY PATHWAYS GUIDED BY
3D MAPPING
A. Avella, P. De Girolamo, F. Laurenzi, A. Pappalardo, M. Uguccioni
Rome, ITALY
108
2014
17:30-19:00 | Pola
Free Papers
SUDDEN DEATH RISK STRATIFICATION
Chairs: V.I. Calvi (Catania, I)
P. Neuzil (Prague, CZ)
RISK OF SUDDEN DEATH FROM NON-CARDIAC AND CARDIAC MEDICATIONS UNDERSTANDING
DRUG-INDUCED BRUGADA AND LONG QT SYNDROMES
M. Santomauro, L. Matarazzo, G. Langella, G. Pirozzi, A. Magliocca, G. Palma, C. Riganti, C. Vosa
Naples, ITALY
EXERCISE-INDUCED CHANGES IN BRUGADA ECG
P. Carvalho, L. Colombatti, A. Previti, G.P. Varalda, R. Pozzi
Orbassano, TO, ITALY
BRUGADA SYNDROME: NEW ALGORITHM FOR ARRHYTHMIC RISK STRATIFICATION
P. Ferrari, F. Giofre, P. De Filippo
Bergamo, ITALY
THE QT INTERVAL AS A RISK FACTOR OF THE SUDDEN CARDIAC DEATH IN PATIENTS WITH
CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
A. Garipova, R.G. Saifutdinov, G.R. Vagapova
Kazan, RUSSIA
INDUCTION OF VENTRICULAR FIBRILLATION DURING ELECTROPHYSIOLOGICAL STUDY.
SPECIFICITY AND PROGNOSTIC VALUE
N. Valera, H. Quiroga Ponce, L. Onetto, L. Tomassini, R. Keegan
Bahia Blanca, ARGENTINA
ARRHYTHMIC RISK STRATIFICATION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
AND NO CONVENTIONAL INDICATIONS FOR IMPLANTABLE CARDIAC DEFIBRILLATOR
F. Pirozzi, D. Stolfo, M. Alonge, M. Gigli, E. Bianco, L. Vitali Serdoz, G. Barbati, M. Zecchin, M. Merlo,
G. Sinagra
Trieste, ITALY
109
2014
17:30-19:00 | Cesarea
Free Papers
CARDIAC RESYNCRONIZATION THERAPY
Chairs: G. Pastore (Rovigo, I)
M. Meine (Utrecht, NL)
DECREASES IN INTERVENTRICULAR ELECTRICAL CONDUCTION DELAY DURING 12-MONTH
OF CRT ARE ASSOCIATED WITH CRT RESPONSE
C. Pappone 1, Z. Calovic 1, A. Cuko 1, L. McSpadden 2, C. Jordan 2, K. Ryu 2, E. Romano 3, M. Baldi1,
A. Pappone 1, M. Saviano 1, L. Gianneli 1, C. Ciaccio 1, A. Petretta 1, M. Moscatiello 1, C. Catalano 4,
A. Fundaliotis 1, R. Vitale 1, B. Ionescu 1, G. Vicedomini 1, V. Santinelli
1
ROLE OF ELECTROCARDIOGRAM IN THE EVALUATION OF LONG TERM PROGNOSIS IN
PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION
F. Casadei, L. Marcantoni, M. Malagu’, C. Pratola, T. Toselli, M Bertini
Ferrara, ITALY
ROLE OF ECHOCARDIOGRAPHIC ASSESSMENT OF RIGHT VENTRICULAR FUNCTION IN
ORDER TO PREDICTS THE RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY
S. Maffè, P. Paffoni, P. Dellavesa, L. Bergamasco, A.M. Paino, L. Baduena, F. Zenone, L.
Cucchi, F. Signorotti, N. Franchetti Pardo, U. Parravicini
Borgomanero, NO, ITALY
PREVALENCE OF TRUE LEFT BUNDLE BRANCH BLOCK IN CURRENT PRACTICE OF
CARDIAC RESYNCHRONIZATION THERAPY IMPLANTATION
F. Migliore 1, A. Baritussio 1, G. Stabile 2, L. Padeletti 3, P. Palmisano 4, A. D’Onofrio 4, A. De
Simone 6, S. I. Caico 7, A. Reggiani 8, M. Malacrida 9, E. Bertaglia 1
Padua, 2 Naples, 3 Florence, 4 Tricase, LE, 5 Naples, 6 Maddaloni, CE, 7 Gallarate, VA, 8 Mantova, 9 Milan,
ITALY
1
LEADS POSITION DOES NOT PREDICT OUTCOME IN PATIENTS WHO UNDERWENT
E. Zubarev, M. Trukshina, V. Lebedeva, D. Lebedev
EFFECT OF POST-IMPLANTATION HEMODYNAMIC RESPONSE TO CARDIAC
RESYNCHRONIZATION THERAPY ON FUNCTIONAL MITRAL REGURGITATION IN
IDIOPATHIC DILATED CARDIOMYOPATHY
D. Stolfo, E. Tonet, G. Barbati, M. Gigli, B. Pinamonti, M. Zecchin, F. Ramani, M .Merlo,
G. Sinagra
Trieste, ITALY
110
2014
INSIGHTS INTO MECHANISMS AND ADVANCED
MAPPING OF CARDIAC ARRHYTHMIAS: IMPLICATIONS
FOR CATHETER ABLATION?
Chairs: J. Almendral Garrote (Madrid, E)
F. Gaita (Turin, I)
Fragmented activity mapping and relationship with underlying atrial substrate
E. De Ruvo (Rome, I)
Electrical coupling discriminates lesion transmurality in humans: from the experimental
model to the clinical facts
C. Tondo (Milan, I)
Which long term data in AF ablation are available on contact force measured by optical
technology?
J.P. Albenque (Toulouse, F)
Long term clinical experience on flex tip ablation catheter design: optimal titration of RF
energy and irrigation flow
T. Gaspar (Leipzig, D)
Non contact and hybrid contact-non contact mapping in VT ablation
M. Oliveira (Lisbon, P)
Importance of late ventricular activation mapping
111
2014
THE RECHARGEABLE PACEMAKER/ICD
Join Session with World Society of Arrhythmias
Chairs: F. De Seta (Rome, I)
Rationale for a rechargeable CIED
G. Corbucci (Milan, I)
External recharge: technology available, pros and cons
C. Schmidt (Minneapolis-MN, USA)
Automatic recharge: technology available, pros and cons
Potential clinical impact
E. Aliot (Vandoeuvre-lès-Nancy, F)
Potential financial impact
F. Naccarella (Bologna, I)
Why is it not yet available?
F. Bellocci (Rome, I)
112
2014
9:00-10:30 | Orange 1
CARDIAC ARRHYTHMIAS IN FEMALES
Chairs: J.C. Geller (Bad Berka, D)
F. Straube (Munich, D)
How to manage brady and tachyarrhythmias in view of pregnancy
V. Romano (Rome, I)
How to treat brady and tachyarrhythmias during pregnancy
M. Gwechenberger (Vienna, A)
Potential problems during pregnancy in pacemaker/ICD patients: their prevention and
treatment
E. Sciaraffia (Uppsala, S)
Arrhythmias in “menopause”: when and how to treat them
S.A. Di Fusco (Rome, I)
Ventricular tachyarrhythmias in patients with post-partum cardiomyopathy: selecting
the most appropriate therapy
M. Lovrić Benčić (Zagreb, HR)
Cardiac Resynchronization therapy: are females undertreated in clinical practice?
L. Vitali-Serdoz (Coburg, D)
113
2014
Session V
Pharmacological treatment of cardiac arrhythmias
Chairs: K. Hirao (Tokyo, JP)
Atrial fibrillation: rate or rhythm control
Y. Kobayashi (Tokyo, JP) Supraventricular tachycardias
J. Kautzner (Prague, CZ)
Sustained ventricular tachycardias
A. Nogami (Tsukuba, JP)
Idiopatic ventricular fibrillation
Electrical storm
H. Tada (Fukui, JP)
Hybrid pharmacological and electrical therapy for ventricular tachyarrhyhtmias
S. Ikeguchi (Moriyama City, JP)
114
2014
9:00-10:30 | Spalato
Session VIII
Rate control
Chairs: J. Borbola (Budapest, H)
H. Baccar (Sfax, TN)
Rate control in atrial fibrillation: how many and which patients should we consider?
A. De Simone (Maddaloni-NA, I)
Which cardiac rate is acceptable on a long term basis? Does age or EF matter?
P. Fumero Lessmann (Caracas, YV)
Clinical follow-up: how to monitor ventricular deterioration?
N. Aspromonte (Rome, I)
Indications and contraindications to a pharmacological rate control
R. Vijayvergia (Chandigarh, IND)
Indications and contraindications to permanent pacing
M. Sgueglia (Rome, I)
Ablate and Pace is superior to pharmacological rate control?
C. Muto (Naples, I)
115
2014
9:00-10:30 | Pola
RELIABILITY AND CLINICAL IMPACT
OF ICD DATA STORAGE AND ALARMS
Chairs: N. Al-Rawahi (Muscat, Oman)
A. Schirdewan (Berlin, D)
Atrial fibrillation burden
A. Borrelli (Rome, I)
Ventricular tachyarrhythmias
P. Scipione (Ancona, I)
Chest fluid accumulation
S. Chandra (New Delhi, IND)
St segment changes
E.C.L. Pisanò (Lecce, I)
Lead damage
P.M.G. Agricola (Crema-CR, I)
Best option in ICD therapy: Dual Chamber Vs Subcutaneous ICD in reducing inappropriate
shocks
J. Sperzel (Bad Nauheim, D)
116
2014
9:00-10:30 | Cesarea
SUDDEN DEATH: UNDERSTANDING,
PREVENTING AND TREATING
Chairs: E.U. Alt (Houston-TX, USA)
G. Steinbeck (Munich, D)
Influence of smoke on appropriate ICD interventions
A. Pandozi (Rome, I)
Are the complications of ICD implant underestimated?
F. Bokhari (Jeddah, SA)
The current role of antiarrhythmic drugs in genetic arrhythmias
G. Zingarini (Perugia, I)
ICD interventions in Brugada syndrome: data from National and International Registries
P. Donateo (Lavagna-GE, I)
The wearable defibrillator: indications and cost-benefit ratio
S. Orazi (Rieti, I)
Clinical outcome after Electrical Storm in ICD patients
G. Neri (Montebelluna-TV, I)
117
2014
11:00-12:30 | Leptis magna 4
CARDIAC PACING AND TRUE PHYSIOLOGICAL RATE
MODULATION: AN “OLD” OR A NEW REAL PERSPECTIVE?
Chairs: J.C. Deharo (Marseille, F)
S. Favale (Bari, I)
Rate modulation adapted to contractility through the Closed Loop Stimulation: what is
the physiological background?
A. Hamaad (Walsall, UK)
Rate Modulation adapted to contractility: is there a role in Sick Sinus Syndrome?
J.M. Guerra Ramos (Barcelona, E)
Rate Modulation adapted to contractility: is there a role in response to Syncope?
E. Occhetta (Novara, I)
Rate Modulation adapted to contractility: is there a role in managing hypertension?
E. Celentano (Bari, I)
Rate Modulation adapted to contractility: is there a role in tracking and responding to
mental stress?
Rate Modulation adapted to contractility combined to algorithms to promote AV
conduction: a synergic combination?
118
2014
11:00-12:30 | Leptis magna 2
DUTY-CYCLED PHASED RF:
THE EVOLUTION OF RF ABLATION
Chairs: D.L. Packer (Rochester-MN, USA)
M.A.E. Schneider (Sindelfingen, D)
Duty-Cycled Phased RF technology principles
C. Geller (Bad Berka, D)
Biophysics of Phased RF Ablation and lesion assessment
A. Verma (Toronto-ON, CDN)
World Wide Experience with 1st and 2nd generation multi-electrode ablation catheters
S. Spitzer (Dresden, D)
Multielectrode-Phased RF Ablation: an update from the clinical trials
L.V. Boersma (Nieuwegein, NL)
Next Generation of Multi-electrode Phased RF catheters: a look into the future
M. Stewart (Monds View-MN, USA)
119
2014
11:00-12:30 | Orange 1
Session III
Ethical and financial considerations on leads
and devices Advisory call
Chairs: R. Cappato (Milan, I)
K. Soejima (Tokyo, JP)
The many system to control the safety of implantable leads and electronic devices by
manufactures
T. Samsel (Minneapolis-MN, USA)
Should we have standard rules for all the CIED manufactures, to start an Advisory action
and consequent operative flow-chart?
Do we need International Registries for CIED malfunctions run by International Scientific
Societies?
Should the “level” of medical reaction to an Advisory Call be decided by a Joint Committee
including medical and industry members?
Should we consider any reimbursement by Industry to the Public Health System for the
unforeseen overwork?
M. Santomauro (Naples, I)
Medical-legal implications of an Advisory requesting a reintervention on the patient:
whose responsibility (manufactures, hospitals, implanting physicians)?
N.A.M. Estes III (Boston-MA, USA)
120
2014
11:00-12:30 | Tarragona
Session VI
ILR and Remote Care Solutions: what’s new?
Chairs: H. Abe (Kitakyushu, JP)
ILR to reduce stroke
ILR to monitor syncopal attacks
H. Abe (Kitakyushu, JP)
ILR and remote monitoring usefulness after catheter or surgical AF ablation
J.C. Daubert (Rennes, F)
Key Remote Care System features to utilize when managing complex patients
M. Takagi (Osaka, JP)
Remote Care Systems: ILR are they all the same?
A. Oto (Ankara, TR)
ILR provided by remote control cost efficacy ratio
121
2014
11:00-12:30 | Spalato
Session IX
Living with permanent Atrial Fibrillation
Chairs: S. Matsuo (Tokyo, JP)
G. Vergara (Rovereto-TN, I)
Quality of life in patients with chronic atrial fibrillation
T. Neumann (Bad Nauheim, D)
How to reach by drugs an acceptable heart rate without prolonged nocturnal asystole
F. Giada (Mestre-VE, I)
Balancing the benefit of a rhythmic ventricular filling with the damage of ventricular
desynchronization in candidates to ablate and Pace therapy
P. Pieragnoli (Florence, I)
When maintaining atrial fibrillation can be the first therapeutical option?
G.Q. Villani (Piacenza, I)
Long-term changes of echocardiographic parameters in patients with chronic atrial
fibrillation
S. Ficili (Rome, I)
Sport practicing with chronic atrial fibrillation: which one, when, for how long
F.M. Moscosa Costa (Lisbon, P)
122
2014
11:00-12:30 | Pola
MANAGEMENT OF TACHYCARDIAS AND ECTOPIC BEATS
FROM THE VENTRICULAR OUTFLOW TRACT
Chairs: A. Berkowitsch (Bad Nauheim, D)
Complex anatomy of the ventricular outflow tract
M. Galeazzi (Rome, I)
Outflow tract ventricular arrhythmias: always a benign condition?
R. Luise (L’Aquila, I)
Outflow tract ventricular arrhythmias: how to distinguish true idiopathic from early stage
ARVD/C?
T. Dickfeld (Baltimore-MD, USA)
Indications to ablation of ectopic beats from the outflow tract: the role of LV enlargement,
symptoms and arrhythmia burden
G. Rodriguez Diez (Mexico City, MEX)
Technique and results of ablation of VT on ectopic beats from the RVOT and the LVOT
Complications management
S. Fichtner (Munich, D)
123
2014
11:00-12:30 | Cesarea
BRADY AND TACHYARRHYTHMIAS IN CCU
Chairs: B. Gorenek (Eskisehir, TK)
P. Serpytis (Vilnius, LT)
How to interprete and treat frequent ventricular ectopic beats in ACS
V. Radeljič (Zagreb, HR)
Sinus arrest, complete AV block in inferior AMI: which outcome? How to treat?
G. Magenta (Milan, I)
Sustained monomorphic ventricular tachycardia in ACS: antiarrhythmic drugs or
revascularization?
A. Kol (Rome, I)
Ventricular fibrillation in ACS: relationship to patient outcome
P. Notarstefano (Arezzo, I)
Paroxysmal atrial fibrillation in ACS: rhythm or rate control?
V. Altamura (Rome, I)
124
2014
12:30-14:00 | Leptis magna 4
Chairs: R. Cappato (Milan, I)
Usefulness of MRI in arrhythmia treatment
Update in intracardiac echocardiography
J. Kautzner (Prague, CZ)
125
2014
12:30-14:00 | Leptis magna 2
Chairs: J. Brachmann (Coburg, D)
W. Shimizu (Tokyo, JP)
Antiarrhythmic gene therapy
D. Thomas (Heidelberg, D)
Syncope: diagnostic and therapeutic flowchart
G. Steinbeck (Munich, D)
126
2014
12:30-14:00 | Orange 1
Free Paper
Cryoablation of atrial fibrillation
Chairs: D. Catanzariti (Rovereto-TN, I)
C. Tondo (Milan, I)
PREDICTORS OF ACUTE SUCCESS IN CRYOBALLON ABLATION OF ATRIAL FIBRILLATION
C. Kowalewski, D. Vukajlovic, F. Heissenhuber, K. Kurzidim
Regensburg, GERMANY
LEFT ATRIAL DIASTOLIC STRAIN AS PREDICTOR OF ATRIAL FIBRILLATION RECURRENCES
AFTER CRYOBALLOON PULMONARY VEIN ISOLATION
G. Ricciardi, A. Giomi, P. Pieragnoli, A. Paoletti Perini, P. Attanà, M. Nesti, G. Mascia, L. Padeletti,
A. Michelucci
Florence, ITALY
THE NEW GENERATION CRYOBALLOON TECHNOLOGY IMPROVES THE THERAPY BOTH FOR
PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION
D. Brala, L. Koch, S. Tessin, M. Roser, O. Goeing, A. Schirdewan
Berlin, GERMANY
ELECTRO-ANATOMICAL MAPPING OF THE LEFT ATRIUM BEFORE AND AFTER CRYOBALLOON
PULMONARY VEIN ISOLATION: COMPARISON BETWEEN TWO DIFFERENT BALLOON
GENERATIONS
P. Pieragnoli 1, G. Ricciardi 1, A. Giomi 1, M. Nesti 1, G. Mascia 1, P. Rodia 2, L. Padeletti 1, A. Michelucci 1
1
Florence, 2 Sesto San Giovanni, MI, ITALY
WORKING WITH FOCAL CRYOABLATION CATHETERS AS FIRST CHOICE IS FEASIBLE AND SAFE
S. Porcellini, G. Tortora, G. Macca, A. Rimini, S. Biasi
Paderno Dugnano, MI, ITALY
ONE SHOT TECHNOLOGIES TO PULMONARY VEIN ISOLATION (1STOP) PROJECT: THE
STANDARD CLINICAL PRACTICE IN ITALY
G. Arena 1, C. Tondo 2, A. Curnis 3, M. Lunati 2, P. De Filippo 4, L. Leoni 4, S. Porcellini 6, D. Catanzariti7,
L. Sciarra 8, L. Padeletti 9
1
Massa, 2 Milan, 3 Brescia, 4 Bergamo, 5 Padua, 6 Paderno Dugnano, MI, 7 Rovereto, TN,
Florence, ITALY
127
8
Rome, 9
2014
12:30-14:00 | Tarragona
LUNCHEON PANEL
UPDATE IN CARDIAC PACING
Chairs: N.A.M. Estes III (Boston-MA, USA)
M. Gulizia (Catania, I)
Benefits of quadripolar coronary sinus lead in CRT: the More CRT trial
News on MRI conditional implantable devices
A. Roguin (Haifa, IL)
New techniques to optimize CRT selection and follow-up
J. Melichercik (Lahr, D)
128
2014
12:30-14:00 | Spalato
Free Papers
GENETICS AND MAPPING OF CARDIAC ARRHYTHMIAS
Chairs: K. Okishige (Yokohama, JP)
M. Faustino (Pescara, I)
THE GENETIC PROFILE OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY IN
SAUDI ARABIA
Z. Al-Hassnan, F. Alhatheq, M. Rababh, W. Almanea, M. Alfayyadh, A. Shafquat, B. Alghamdi
Riyadh, SAUDI ARABIA
PRIMARY DIAGNOSIS OF BRADYARRHYTHMIAS FOR PRE-PACEMAKER ASSESSMENTS USING
NOVEL AUTOMATED DEVICE TECHNOLOGY
F. Ara 1, O. Ahmed 1, I. John 1, C. Crockford 2, R. A. Kaba 1
1
London, 2 Cardiocity Limited, UNITED KINGDOM
ELECTROCARDIOGRAPHIC AND ELECTROPHYSIOLOGICAL PARAMETERS PREDICTORS OF SINUS
NODE DISEASE IN PATIENTS WITH PERSISTENT ATRIAL FLUTTER AND CAVOTRICUSPID ISTHMUS
ABLATION.
R. Jimenez Lopez, R. R. Nolasco, M. Ortiz Muñoz, I. Carrasco, J.C. Solis
Mexico DF, MEXICO
CARDIAC MAGNETIC RESONANCE IMAGING STUDIES IN PATIENTS WITH INAPPROPRIATE SINUS
NODE TACHYCARDIA
J. Borbola 1, T. Simor 2, C.S. Földesi 1, A. Kardos 1
1
Budapest, 2 Pécs, HUNGARY
NONINVASIVE PANORAMIC MAPPING OF HUMAN VENTRICULAR FIBRILLATION
A. Tsyganov 1, V. Kalinin 1, M. Chmelevsky 2, M. Yakovleva 1
1
Moscow, 2 Saint Petersburg, RUSSIA
UTILITY OF CARDIAC MAGNETIC FIELD MAPPING IN A PROSPECTIVE STUDY OF MONOZYGOTIC
AND DIZYGOTIC HEALTHY TWINS TO IDENTIFY CARDIAC DISEASE PREDICTORS
D. Brala, A. Gapelyuk, O. Göing, A. Busjahn, A. Schirdewan
Berlin, GERMANY
129
2014
12:30-14:00 | Pola
LUNCHEON PANEL
NEW TECHNOLOGY FOR HEART FAILURE TREATMENT
BAROREFLEX ACTIVATION THERAPY
Chair: E.G. Gronda (Milan, I)
Activation of the Autonomic Nervous System during Heart Failure
M.T. La Rovere (Montescano-PV, I)
A new implantable device to treat heart failure: implant technique troubles
and troubleshooting
A. Casini (Milan, I)
Medium term benefits of baroreflex activation therapy
E. Vanoli (Milan, I)
130
2014
12:30-14:00 | Cesarea
Free Papers
PREDICTORS OF CRT OUTCOME
Chairs: V. Nissardi (Cagliari, I)
H. Bonnemeier (Kiel, D)
ARTERIAL BAROREFLEX EFFECTIVENESS INDEX IN RISK STRATIFICATION OF CHRONIC HEART
FAILURE PATIENTS CANDIDATES TO CARDIAC RESYNCHRONIZATION THERAPY
J. Serodio, S. Laranjo, C. Tavares, P. Cunha, J. Feliciano, L. Branco, A. Abreu, S. Alves, I. Rocha,
M. Oliveira, R. Ferreira
Lisbon, PORTUGAL
TRANSPULMONARY GRADIENT AND PULMONARY VASCULAR RESISTENCE IN PATIENTS
WITH SEVERE LEFT VENRICULAR DYSFUNCTION
T. Minarik 1, M. Fedorco 2, M. Taborsky 2
1
Ostrava, 2 Olomouc, CZECH REPUBLIC
RELATIONSHIP BETWEEN BETA1-ADRENORECEPTOR ANTIBODIES AND RESPONSE TO
A. Michelucci, M.M. D’Elios, E. Sticchi, P. Pieragnoli, G. Ricciardi, C. Fatini, M. Benagiano, E. Niccolai,
L. Emmi, M. Nesti, A. Giomi, F. Ristalli, L. Padeletti, R. Abbate
Florence, ITALY
A NOVEL MARKER OF TRUE COMPLETE LEFT BUNDLE BRANCH BLOCK INDEPENDENTLY
PREDICTS QRS COMPLEX SHORTENING BY CARDIAC RESYNCHRONIZATION THERAPY
D. Wichterle 1, J. Hanuliakova 2, H. Jansova 1, V. Vancura 1, K. Sedlacek 1, J. Kautzner 1
1
Prague, 2 Liberec, CZECH REPUBLIC
LEFT VENTRICULAR LEAD ELECTRICAL DELAY PREDICTS LONG TERM HEART FAILURE
MORBIDITY AND MORTALITY IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY
T. Roubicek 1, D. Wichterle 2, J. Hanuliakova 1, P. Kucera 1, J. Kupec 1, R. Polasek 1
1
Liberec, 2 Prague, CZECH REPUBLIC
RELATIONSHIP BETWEEN BASELINE ELECTRICAL MEASUREMENTS AND 12-MONTH RESPONSE
TO CARDIAC RESYNCHRONIZATION THERAPY
Z. Calovic 1, A. Cuko 1, L.C. McSpadden 2, C. Jordan 2, K. Ryu 2, E. Romano 3, M. Baldi 1, A. Pappone1,
M. Saviano 1, L. Giannelli 1, C. Catalano 1, C. Ciaccio 1, A. Petretta 1, M. Moscatiello 1, A. Fundaliotis 1,
R. Vitale 4, B. Ionescu 1, G. Vicedomini 1, V. Santinelli 1, C. Pappone 1
1
131
2014
14:00-15:30 | Leptis magna 4
MRI devices: first choice or just an option?
Chairs: F. Duru (Zurich, CH)
A. Roguin (Haifa, IL)
MRI need for cardiac implantable device population
J. Morgan (Southampton, UK)
A close look at technology: not all devices are created equal
T. Sommer (Neuwied, D)
Should MRI conditional devices be the first option: the radiologist’s point of view
A. Guaricci (Foggia, I)
Should MRI conditional devices be the first option: the electrophysiologist’s point of view
Medical legal implications: recommendations for implanters and radiologists
L. Binner (Ulm, D)
Cost benefit of MRI conditional devices
132
2014
14:00-15:30 | Leptis magna 2
HEART FAILURE. IMPACT AND OUTCOME
OF NEW TECHNOLOGIES
TBA
Heart failure: epidemic disease with high economic and social impact
Diastolic HF. Monitoring and treatment strategies
M. Frigerio (Milan, I)
Systolic HF. Monitoring and treatment strategies
G.B. Perego (Milan, I)
Multi Point Pacing: are acute improvements confirmed by chronic outcome?
P.P. Delnoy (Zwolle, NL)
Patient with lower response to CRT: can MPP help?
LV lead positioning guided by 3D mapping
A. Vado (Cuneo, I)
133
2014
14:00-15:30 | Orange 1
PREDICTION AND MANAGEMENT OF MAJOR
CARDIOVASCULAR EVENTS IN PATIENTS WITH DEVICE:
HYPE, HOPE OR REALITY?
Chairs: V. Calvi (Catania, I)
M. Chauvin (Strasbourg, F)
One or multiple parameters to monitor and react to HF worsening risk?
G. Zanotto (Legnago-VR, I)
Continuous hemodynamic monitoring of cardiac function through device: what is the
value?
R. Zbinden (Zurich, CH)
How important is to detect and address AF episodes?
R.A. Kaba (Chertsey, UK)
What is the prognostic value of an implantable diagnostic cardiac monitor?
J.L. Pasquié (Montpellier, F)
The SELENE HF study: initial learning and the long term goals of an integrated approach
to predict major cardiovascular events
L. Calò (Rome, I)
From arrhythmias to patient management: how frequent is necessary to receive objective
diagnostic data through remote monitoring to address patient in a timely manner?
D. Pecora (Brescia, I)
134
2014
14:00-15:30 | Tarragona
GLOBAL ARRHYTHMIA FORUM (GAF)
Session II
Syncope update
Chairs: E. Aliot (Vandoeuvre-lès-Nancy, F)
D. Huang (Chengdu, Republic of China)
Neuromediated syncope
X. Liu (Beijing, Republic of China)
Syncope in structural heart disease
J. Zou (Nanjing, Republic of China)
Syncope in pacemaker patients
Syncope in ICD patients
D. Liao (Shanghai, Republic of China)
Operative diagnostical and therapeutical flow-chart
135
2014
14:00-15:30 | Spalato
Session X
Ablation of paroxysmal and persistent Atrial
Fibrillation: optimizing technique and outcome
Chairs: L. Di Biase (Austin-TX, USA)
F. Straube (Munich, D)
Selection of the optimal approach and energy source
L. Ottaviano (Milan, I)
Real time monitoring of the lesion development
S. Nardi (Castel Volturno-CE, I)
Contact force monitoring: is it mandatory?
S. Themistoclakis (Mestre-VE, I)
A new approach for catheter ablation of atrial tachycardia following atrial fibrillation
ablation
T. Agricola (Pescara, I)
Could renal denervation improve outcome post AF ablation?
E. Pokushalov (Novosibirsk, RUS)
Usefulness of MRI imaging to guide AF ablation
S. Matsuo (Tokyo, JP)
136
2014
14:00-15:30 | Pola
DEBATABLE INDICATIONS FOR CARDIAC
RESYNCHRONIZATION THERAPY
Chairs: S. Alkaabi (Abu Dhabi, UAE)
C. Moro Serrano (Madrid, E)
CRT in patients with RBBB or IVCD
V. Kuznetsov (Tyumen, RUS)
CRT in patients with narrow QRS
A. Kapoor (Lucknow, IND)
CRT in patients with persistent atrial fibrillation
J. Clementy (Bordeaux, F)
Upgrading VVI-DDD to CRT pacing modality
M. Brieda (Pordenone, I)
When to use CRT-P only?
D. Ricciardi (Rome, I)
CRT in elderly patients
E. Casali (Modena, I)
137
2014
14:00-15:30 | Cesarea
PEDIATRIC ARRHYTHMIAS ABLATION TREATMENT
Chairs: C. Akdeniz (Istanbul, TK)
F. Drago (Rome, I)
Ablation in WPW syndrome: when, which energy source?
B. Pezzulich (Turin, I)
Ablation of supraventricular nodal tachycardia
M. Scaglione (Asti, I)
Ablation of focal atrial tachycardia
M.S. Silvetti (Rome, I)
Ablation of outflow tract ventricular arrhythmias
M. Strieper (Atlanta-GA, USA)
Permanent pacing in children: trouble and troubleshooting
K. Dagriri (Riyadh, SA)
ICD implant in children techniques: trouble and troubleshooting
P. Zartner (Sankt Augustin, D)
138
2014
15:30-17:00 | Leptis magna 4
SLEEP APNEA: DISEASE FOR HEART SPECIALISTS?
P. Defaye (Grenoble, F)
Impact of SAS on cardiovascular diseases
N. Combes (Toulouse, F)
Undiagnosed SAS: what is the cost?
SAS screening in pacemaker population
R. Villuendas (Badalona, E)
What’s new in SAS therapy?
A. Braghiroli (Veruno-NO, I)
How to manage SAS diagnosed paced patients?
139
2014
15:30-17:00 | Leptis magna 2
STROKE REDUCTION BY IMPLANTABLE DEVICES
DIAGNOSTICS: ANGELS AF PROJECTS
Chairs: G. Senatore (Ciriè-TO, I)
TBA
Early detection of atrial fibrillation by device remote control: how to implement it?
A. Thajudeen (Trivandrum, IND)
Management of oral anticoagulation therapy guided by device diagnostics remote control
A. Rossillo (Mestre-VE,I)
How to decide oral anticoagulation therapy based on AF burden, AF frequency and stroke
risk factors
Usefulness of implantable loop recorder in monitoring post-ablation AF recurrences
M. Mantica (Milan, I)
Usefulness of implantable loop recorder in cryptogenetic stroke
T. Sanna (Rome, I)
Reveal LINQ system: a new era in cardiac monitoring
M. Moltrasio (Milan, I)
140
2014
15:30-17:00 | Orange 1
THE SUBCUTANEOUS DEFIBRILLATOR:
STATE OF THE HEART
Chairs: R. Choudhury (Sharjah, UAE)
Selection of the appropriate candidate
M. Luzi (Ancona, I)
Acute and long-term efficacy
J. Kobe (Munster, D)
Incidence of the inappropriate interventions
A. Grace (Cambridge, UK)
Advantages and disadvantages on a long-term follow-up: the UK national experience
J.W.E. Jarman (London, UK)
Combination of a previous DDD pacemaker with a new subcutaneous defibrillator
implant for sudden death prevention
L.J.L.M. Jordaens (Rotterdam, NL)
Next generation: what is to be expected?
141
2014
15:30-17:00 | Tarragona
SUDDEN DEATH: MECHANISMS AND TIMING
Chairs: N. Asaad (Doha, Q)
J. Brachmann (Coburg, D)
Sudden death in patients with preserved cardiac function
G. Carreras (Terni, I)
Relationship between sex hormone levels and sudden death risk
W. Jung (Villingen-Schwenningen, D)
Increased risk of sudden death by exercise
A. Biffi (Rome, I)
Circadian and seasonal variations of sudden death
H. Rodriguez Reyes (Aguascalientes, MEX)
Influence of autonomic nervous system on cardiac arrest
R. Hatala (Bratislava, SK)
Sleep apnea and ventricular arrhythmias
A. Curcio (Catanzaro, I)
142
2014
15:30-17:00 | Spalato
LEADS AND DEVICES RECALL IN THE LAST DECADE
Chairs: M.M. Hossain (Dhaka, BD)
C.W. Israel (Frankfurt, D)
Pacemakers and ICD
M. Toniolo (Udine, I)
Leads
M. Landolina (Pavia, I)
What should Companies do more to reduce malfunctions?
P. Neužil (Prague, CZ)
Which would be the optimal management of CIED recall?
F. Laurenzi (Rome, I)
The role of Scientific Societies in managing devices recall
Potential legal problems for implanting physicians, hospital, industries
J. Senges (Heidelberg, D)
143
2014
15:30-17:00 | Pola
NEW TECHNOLOGY FOR EPI/ENDOCARDIAL APPROACH
Chairs: D.L. Packer (Rochester-MN, USA)
Novel epicardial approach needle
Novel active fixation left ventricular leads
F. Gadler (Stockholm, S)
Endocardial approach for autonomic ablation
A. Pappalardo (Rome, I)
Thoracoscopic approach for right and left ventricular lead implantation
E. Ivanitskiy (Krasnoyarsk, RUS)
Intracardiac echocardiography to guide invasive antiarrhythmic procedures
O.V. Sapelnikov (Moscow, RUS)
144
2014
15:30-17:00 | Cesarea
Free Papers
LEADS EXTRACTION
Chairs: C. Kennergren (Goteborg, S)
E. Soldati (Pisa, I)
CARDIAC RHYTHM MANAGEMENT DEVICE EXTRACTION. EXPERIENCE FROM A UNITED
KINGDOM TERTIARY CARDIO-THORACIC CENTRE
C. Brough 1,2, C. McGee 2, A. Rao 2, D.J. Wright 2
1
CLINICAL AND PROCEDURAL IMPACT OF THE EVOLUTION® MECHANICAL DILATOR SHEATH
AS FIRST LINE APPROACH IN COMPLEX TRANSVENOUS LEAD EXTRACTIONS
G. Domenichini, H. Gonna, L. Fiorista, S. Conti, S. Jones, M.M. Gallagher
London, UNITED KINGDOM
1-YEAR PATIENTS’ SURVIVAL AFTER TRANSVENOUS LEADS EXTRACTION
A. Zabek, B. Malecka, K. Boczar, K. Haberka, A. Rydlewska, R. Pfitzner , J. Lelakowski
Krakow, POLAND
TRANSVENOUS EXTRACTION OF A CURLY LOOPED ATRIAL LEAD IN LEFT UNNAMED VEIN
P. Turco, A. Antonelli, E. Gronda
Milan, ITALY
TRANSVENOUS LEAD EXTRACTION IN NANOGENARIANS. SAFETY & EFFECTIVENESS. SINGLE
CENTRE EXPERIENCE AMONG 1684 PROCEDURES
A. Kutarski 1, M. Czajkowski 1, M. Polewczyk 2, A. M. Polewczyk 2, A. Polewczyk 2
1
Lublin, 2 Kielce, POLAND
LEAD DEPENDENT INFECTIVE ENDOCARDITIS WITHOUT VEGETATIONS. DIAGNOSTIC PROBLEM
A. Polewczyk 1, A. Tomaszewski 2, W. Brzozowski 2, M. Janion 1, A. Kutarski 2
1
Kielce, 2 Lublin, POLAND
145
2014
17:30-19:00 | Leptis magna 4
Free Papers
CRT: SELECTION OF CANDIDATES AND PROGRAMMING OPTIMIZATION
Chairs: U. Giordano (Palermo, I)
H. Schmidinger (Vienna, A)
THE P-WAVE DURATION: A POTENTIAL DETERMINANT OF THE OPTIMAL AV INTERVAL IN
PATIENTS UNDERGOING CRT
G. Savarese 1, A. Rapacciuolo 2, A .Pierantozzi 3, T. Giovannini 4, A. Spotti 4, A. Talarico 6, D. Spaziani 7,
G. Bisignani 8, A. Agresta 2, F. Esposito 2, M. Malacrida 9, L. Placentino 9, G. Stabile 2
1
9
Foligno, PG, 2 Naples, 3 Pesaro, PU, 4 Prato, 5 Cremona, 6 Cosenza, 7 Magenta, MI, 8 Castrovillari, CS,
Milan, ITALY
IMPACT OF SONR PARAMETERS DYNAMICS ON RESPONSE TO CARDIAC RESYNCHRONIZATION
THERAPY
D. Zizek, M. Cvijic, A. Djordjevic, P. Milovanovic, I. Zupan
Ljubljana, SLOVENIA
UPGRADE TO CARDIAC RESYNCHRONIZATION THERAPY: PRESENTATION OF PATIENTS AND
CLINICAL DETERMINANTS OF THE INTERVENTION IN THE CURRENT CLINICAL PRACTICE
M. Santamaria1, Q. Parisi1, M. Viscusi2, A. Rapacciuolo3, P. Palmisano4, G. Savarese4, S. Badolati 6,
M. Accogli 4, L. Messano 1, G. L. Botto 7, M. Malacrida 8, F. Maddaluno 8, B. M Bozzo 8, G. Stabile 3
1
Campobasso, 2 Caserta, 3 Naples, 4 Tricase, LE, 5 Foligno, PG, 6 La Spezia, 7 San Fermo della Battaglia,
CO, 8 Milan, ITALY
IS THERE AN UPPER LIMIT OF QRS DURATION IN LEFT BUNDLE BRANCH BLOCK ABOVE WHICH
CARDIAC RESYNCHRONIZATION THERAPY FAILS TO PROVIDE BENEFIT?
M. Beltrami 1, L. Padeletti 1, M. Bertini 3, G. Mascioli 4, S. Bressan 2, G. Fucà 2, F. Pacchioni 2, M. Pedaci2,
F. Michelotti 4, L. Bacchi Reggiani 4, A. Paoletti Perini 1, S. Gambetti 2, B. Sassone 2
1
Florence, 2 Cento, FE, 3 Ferrara, 4 Bergamo, 5 Bologna, ITALY
PROLONGED ELECTRICAL LATENCY DURING LV PACING: EXTENT AND MAGNITUDE IN THE
CRT POPULATION
N. Agostini 1, S. I. Caico 1, V. Bianchi 2, G. Stabile 2, M. Accogli 3, A. Reggiani 4, P. Pepi 4, A. De Simone
4
, L. Padeletti 6, G. Maglia 7, M. Marini 8, D. Orsida 1, P. Palmisano 4, M. Malacrida 9, M. Campari 9,
A. Colombo 9, A. D’Onofrio 2
1
Gallarate, VA, 2 Naples, 3 Tricase, LE, 4 Mantova, 5 Maddaloni, CE, 6 Florence, 7 Catanzaro, 8 Trento, 9
Milan, ITALY
INTER-LEAD DISTANCE AND INTER-VENTRICULAR ELECTRICAL DELAY FOR THE PREDICTION
OF CRT RESPONSE
T. Giovannini 1, M. Marini 2, A. D’Onofrio 3, G. Arena 4, P. Pepi 4, A. Reggiani 4, A. De Simone 6, D. Pecora 7,
S. I. Caico 8, A. Iuliano 3, M. Malacrida 9, A. Zamboni 9, G. Stabile 3
1
Prato, 2 Trento, 3 Naples, 4 Massa, 5 Mantova, 6 Maddaloni, CE, 7 Brescia, 8 Gallarate, VA, 9 Milan, ITALY
146
2014
17:30-19:00 | Leptis magna 2
Free Papers
LEADS INSERTION AND VENOUS OBSTRUCTION
Chairs: M. Stockburger (Nauen, D)
P. Diotallevi (Alessandria, I)
RIGHT VENTRICULAR PACING AND ATRIAL FIBRILLATION
G. Pastore, F. Zanon, E. Baracca, S. Aggio, C. Piccariello, D. Lanza, M. Carraro, L. Conte, L. Roncon
Rovigo, ITALY
RIGHT VENTRICULAR LEAD PLACEMENT IN A PACEMAKER POPULATION: COMPARISON OF
APICAL AND SEPTAL POSITIONS. THE RIGHT PACE STUDY
L. M. Zuccaro 1, V. Calvi 2, R. Calvanese 3, G. Maglia 4, G.L. Botto 4, G. Ciaramitaro 6, D. Pecora 7, A.
Costa 8, A. Lilli 8, A. Reggiani 8, G. Carreras 8, M. Malacrida 9, M. Campari 9, V. Fagiani 9, C. Muto 10
Rome, 2 Catania, 3 Naples, 4 Catanzaro, 5 San Fermo della Battaglia, CO, 6 Palermo, 7 Brescia, 8 Right
Pace Study Group, 9 Milan, 10 Nola, NA, ITALY
1
GENDER-DEPENDENT VEIN OCCLUSION IN THE PRESENCE OF HEART STIMULATING SYSTEM
K. Boczar, A. Zabek, B. Malecka, K. Haberka, J. Bednarek, A. Rydlewska, T. Senderek, M. Hardzina,
J. Lelakowski
Krakow, POLAND
CENTRAL VENOUS OBSTRUCTION IN HEART RHYTHM DEVICES CARRIERS: REPORT FROM A
SINGLE CENTER
S. Di Fusco, R.P. Ricci, A. Santini, F. Colivicchi, M. Santini
Rome, ITALY
TROUBLESHOOTING IN UPGRADING PROCEDURES: PERCUTANEOUS TECHNIQUES TO
OVERCOME VENOUS STENOSIS
M. Morosato, G. Morani, L. Tomasi, B. Bolzan, C. Vassanelli
Verona, ITALY
MYOCARDIAL INJURY IS DETECTABLE DURING PACEMAKER IMPLANTATION
A. Salacata, C. Kazmierzak, B. Rosenberg
Alpena, MI, USA
147
2014
17:30-19:00 | Orange 1
Free Papers
HEART FAILURE FOLLOW-UP BY IMPLANTED DEVICES
Chairs: V. Ducceschi (Vallo Lucania-SA, I)
N. Chadha (Faridabad, IND)
ROLE OF NT-PROBNP IN THE ASSESSMENT OF CLINICAL OUTCOME AND PREDICTION OF
ARRHYTHMIC EVENTS
E. Menardi 1, A. Vado 1, G.P. Ballari 1, G. Rossetti 1, M. Landolina 2, A. Castro 3, R. Massa 4, M. Sassara 4,
A. Kheir 6, S. Orazi 7, C. Vasco 7, F. Achilli 7, C. Klersy 8, M. Malacrida 9, F. Accardi 9, L. M. Biasucci 3
1
Cuneo, 2 Pavia, 3 Rome, 4 Alessandria, 5 Viterbo, 6 Ponte S. Pietro, BG, 7 CAMI GUIDE Study Group, 8
Pavia, 9 Milan, ITALY
LONG-TERM MONITORING OF THE RESPIRATORY RATE IN PATIENTS WITH HEART FAILURE:
THE MULTITUDE-HF STUDY
M. Campoli 1, L. Santini 2, M. Malavasi 1, A. Scaccia 3, L. Carbonardi 4, F. Lamberti 2, G. Carreras 6,
C. Marini 4, S. Orazi 6, D. Della Rocca 2, M. Menichelli 4, M. Sassara 1, M. Lovecchio 7, L. Ariota 7,
S. Valsecchi 7, F. Romeo 2, G. B. Forleo 2
1
Viterbo, 2 Rome, 3 Sora, FR, 4 Frosinone, 5 Terni, 6 Rieti, 7 Milan, ITALY
THE LUNG IMPEDANCE MONITORING IN TREATMENT OF CHRONIC HEART FAILURE (LIMITCHF STUDY): INTERIM RESULTS
G. Domenichini, C. Rahneva, I.G. Diab, O. Dhillon, V. Baker, R.J. Hunter, M.J. Earley, R.J. Schilling
EVALUATION OF THE SAFER MODE IN PATIENTS WITH A DUAL CHAMBER PACEMAKER INDICATION
(ANSWER): LONG-TERM CLINICAL OUTCOME RESULTS OF THE ANSWER TRIAL
M. Stockburger, J. Moreno, S. Boveda, B. Stancak, J.P. Villacastin, A. Lazarus, J. Sipoetz, J. GarciaSeara, M. Rolando, P. Defaye
Nauen, GERMANY
A TRANSTHORACIC IMPEDANCE SENSOR FOR RECOGNITION OF RESPIRATORY SLEEP
DISTURBANCES IN ICD PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION
L. Cicchini, D. Della Rocca, G. Forleo, M. Albanese, A. Romigi, V. Ribatti, L. Guddelmoni, D. Sergi,
L. Santini, N. Mercuri, F. Romeo
Rome, ITALY
POCKET HEMATOMA AFTER CARDIAC ELECTRONIC DEVICE IMPLANTATION IN PATIENTS
RECEIVING ANTIPLATELET AND ANTICOAGULANT TREATMENT: A SINGLE-CENTER EXPERIENCE
G. Demir, G. Guler, E. Guler, F. Kizilirmak, H. Gunes, M. Omaygenc, B. Cakal, F. Olgun, E. Ibisoglu,
U. Savur, I. Barutcu, F. Kilicaslan
Istanbul, TURKEY
148
2014
17:30-19:00 | Orange 2
Free Papers
CRT: NEW LEADS AND ALGORITHMS
Chairs: L.J.LM. Jordaens (Rotterdam, NL)
S. Setti (Genoa, I)
A NEW TRANSVENOUS ACTIVE FIXATION LEFT VENTRICULAR LEAD FOR STABLE TARGETED
PLACEMENT
S. Faerestrand, S. Faerestrand, H. Keilegavlen, T. Hovstad
Bergen, NORWAY
FEMORAL IMPLANTATION AND PULL THROUGH AS AN ADJUNCT TO TRADITIONAL METHODS
IN CARDIAC RESYNCHRONISATION THERAPY
G. Domenichini 1, H. Gonna 1, Z. Zuberi 2, S. Adhya 1, P. Dhillon 3, M.M. Gallagher 1
1
London, 2 Guildford, 3 Chertsey, UNITED KINGDOM
ELECTRICAL PERFORMANCE AND LEAD HANDLING EVALUATION OF A NEW ACTIVE FIXATION
LV LEAD: RESULTS OF AN ITALIAN MULTICENTER EXPERIENCE
M. Biffi 1, M. Landolina 2, G. Giannola 3, M.G. Bongiorni 4, G. Luzzi 4, P. Maglia 6, A. Curnis 7,
M. Gasparini 8, M Lunati 9
1
Bologna, 2 Pavia, 3 Cefalù, PA, 4 Pisa, 5 Bari, 6 Catanzaro, 7 Brescia, 8 Rozzano, MI, 9 Milan, ITALY
18 MONTH EXPERIENCE WITH A NOVEL SENSOR-BASED ELECTROMAGNETIC TRACKING
SYSTEM (MEDIGUIDE™) DURING RESYNCHRONIZATION THERAPY IMPLANT PROCEDURES:
WHERE DOES THE TIME GO?
B. Thibault, M. Dubuc, K. Dyrda, P. Guerra, P. Khairy, B. Mondesert, L. Rivard, D. Roy, M. Talajic, L. Macle
Montreal, CANADA
ALGORITHM FOR OFF-LINE CONFIRMATION OF LV CAPTURE IN CRT DEVICE. THE DREAM
(CRT DEVICE LEFT CAPTURE CONFIRMATION THROUGH AN ELECTROGRAM’S ANALYSIS
MODEL) STUDY
S. Baccillieri 1, D. Ambroso 2, E. Pudia 3, P. Turrini 1, E. Dalla Vecchia 2, R. Verlato 1
1
Camposampiero, PD, 2 Marano Vicentino, VI, 3 Padua, ITALY
149
2014
17:30-19:00 | Tarragona
Free Papers
DEVICES FAILURE AND REINTERVENTION
Chairs: A. Giardina (Cagliari, I)
A. Oto (Ankara, TR)
CARDIAC DEVICE FAILURE AS INDICATION TO REINTERVENTION IN MEDIUM VOLUME CENTRE
G. Boggian, S. Sacca’, R. Vandelli, F. Serafini, A. Lombardi, A. Capecchi, R. Parlangeli, B. Bresciani,
C. Lofiego, A.C. Musuraca, M.D. Scarfoglio, L.G. Pancaldi
Bologna, ITALY
WHAT AND WHEN SHOULD BE IMPLANTED AFTER TAVI-PROCEDURES?
O. Sapelnikov, T. Imaev, D. Cherkashin, A. Komlev, A. Partigulova, A. Kolagaev, R. Latypov, I. Grishin,
K. Gruzdev, P. Lepilin, A. Margolina, M. Lepilin, M. Saidova, R. Akchurin
Moscow, RUSSIA
POCKET HEMATOMA OCCURRENCE AND INTRINSIC BLEEDING RISK IN PATIENTS UNDERGOING
CARDIAC IMPLANTABLE ELECTRONIC DEVICES PROCEDURES WITH UNINTERRUPTED ORAL
ANTICOAGULATION
F. De Sensi 1, L. Addonisio 1, F. Paneni 2, M. Breschi 1, S. Severi 1, G. Miracapillo 1
1
Grosseto, ITALY, 2 Stockholm, SWEDEN
THE EFFECT OF INCREASING DONOR AGE ON PERMANENT PACING AFTER ORTHOTOPIC HEART
TRANSPLANTATION. A THIRTY YEARS EXPERIENCE
F. Akca, T. Szili-Torok, R. Muslem, O. Manintveld, A. Constantinescu, O. Birim, K. Caliskan
RESULTS FROM THE FINE REGISTRY: HANDLING, SAFETY AND ELECTRICAL PERFORMANCES
OF BRADYCARDIA LEADS, IN ACUTE CONDITIONS
H. Benkemoun 1, S. Prevot 2, J.A. Lapuerta 3, X. Dessenne 4, P. Khattar 4, P. Sbragia 2, M. Rolando6,
P. Deutsch 7
1
7
Perpignan, 2 Marseille, FRANCE, 3 Giron, SPAIN, 4 Evry, 5 Lorient, FRANCE, 6 Lausanne, SWITZERLAND,
Saint-Malo, FRANCE
CONSEQUENCES OF HOSPITAL ADMISSION STATUS AND CARDIAC IMPLANTABLE ELECTRONIC
DEVICE RECIPIENT CLINICAL OUTCOMES
C. E. P. Brough 1,2, C. McGee 2, A. Rao 2, D. J. Wright 2
1
150
2014
17:30-19:00 | Spalato
Free Papers
STROKE PREVENTION IN DEVICE PATIENTS
Chairs: L. Pandolfo (Rome, I)
H. Yokoshiki (Sapporo, JP)
STROKE INCIDENCE IN PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES
REMOTELY CONTROLLED. DATA FROM THE HOMEGUIDE REGISTRY
D Vaccari 1, B Villari 2, G Zingarini 3, A Di Girolamo 4, G Piraino 4, E Pisanò 6, E Fanchiotti 7, N Rovai
8
, A Gargaro 8, R P Ricci 9
1
9
Montebelluna, TV, 2 Benevento, 3 Perugia, 4 Trapani, 5 Palermo, 6 Lecce, 7 Marsicovetere, PZ, 8 Milan,
Rome, ITALY
PROGNOSTIC IMPACT OF CHA2DS2-VASC AND RENAL DYSFUNCTION IN NON VALVULAR
ATRIAL FIBRILLATION PATIENTS. WHICH IS THE BEST EQUATION TO STRATIFY THE RISK OF
FUTURE EVENTS?
S Magnani, C Mazzone, C Carriere, G Barbati, A Cherubini, E Grande, G Russo, K Stellato, M
Zecchin, A Di Lenarda
Trieste, ITALY
ORAL ANTICOAGULATION IN PATIENTS WITH DUAL CHAMBER PACEMAKERS AND ATRIAL
FIBRILLATION DETECTED
F Martinez-Garcia, M Pombo-Jimenez, L Iñigo-Garcia, A Esteban-Luque, E Fernandez-Ochagavia,
F Gonzalez-Bonilla, J Torres-Ortiz, F Ruiz-Mateas
Marbella, SPAIN
DOES ANTIPLATELET THERAPY INCREASE THE BLEEDING EVENTS AMONG PATIENTS WITH
NOVEL ORAL ANTICOAGULANT (NOAC) IN REAL WORLD?
Y Okamoto, S Fujii, M Ozaki, M Yoshino, N Oohashi, H Tasaka, K Kadota, K Mitsudo
Kurashiki, JAPAN
ATRIAL FIBRILLATION SCREENING: CARDIOEMBOLIC STROKE PREVENTION IN A SMALL
CALABRIAN COMMUNITY
S De Bonis 1, A Bisignani 2, G Bisignani 1
1
Castrovillari, CS, 2 Rome, ITALY
REDUCTION OF LEFT ATRIUM SPONTANEOUS ECHOCONTRAST AFTER LEFT ATRIAL APPENDAGE
CLOSURE
E Pelissero 1, C Amellone 1, G Trapani 1, M Giuggia 1, B Giordano 1, M Peluso 2, G Senatore 1
1
Ciriè, TO, 2 Milan, ITALY
151
2014
17:30-19:00 | Pola
Free Papers
NEW DEVICES AND ALGORITHMS
Chairs: C. Suga (Saitama, JAPAN)
P. Mazzone (Milan, I)
PERMANENT LEADLESS PACEMAKER: SINGLE CENTRE EXPERIENCE
A. Curnis 1, M. Siciliano 2, M. Cerini 1, A. Lipari 1, F. Vassanelli 1, M. Belotti 1, N. Ashofair 1,
F. Salghetti 1, F. Guidetti 1, L. Bontempi 1
1
Brescia, 2 Padua, ITALY
SAFETY AND EFFICACY OF AN ALTERNATIVE TECHNIQUE FOR S-ICD IMPLANTATION: A
SINGLE-CENTER EXPERIENCE
A. Vado 1, E. Menardi 1, G. P. Ballari 1, M. Malacrida 2, D. Muò 2, S. Chiarenza 2, G. Rossetti 1
1
Cuneo, 2 Milan, ITALY
PERFORMANCE AND SAFETY OF SAINT JUDE MEDICAL ACAP CONFIRM ALGORYTHM
A. Otmani 1, F.E.l. Ghelbazouri 2, X. Dessenne 3, G. Theodore 4, T. Bontemps 4, J.L. Baupre 6,
P. Mansour 7, H. Bader 8, A. Guillemot 9, O. Citerne
1
Paris, 2 Montargis, 3 Evry, 4 Nice, 5 Limoges, 6 Chatellerault, 7 Gueret, 8 Pau, 9 Dinan, 10 Caen, FRANCE
EVALUATION AND MID-TERM PERFORMANCE OF NOVEL RIGHT VENTRICULAR AND ATRIAL
AUTOMATIC CAPTURE CONTROL ALGORITHMS: RESULTS FROM THE ESSENTIAL REGISTRY
M. Biffi 1, M. Bertini 2, D. Saporito 3, G. Belotti 4, F. Quartieri 4, A. Pucci 6, G. Mazzocca 7, D. Giorgi 8,
A. Gargaro 9, D. Grassini 9
Bologna, 2 Ferrara, 3 Rimini, 4 Treviglio, BG, 5 Reggio Emilia, 6 Carrara, MS, 7 Cecina, LI, 8 Monte San
Quirico, LU, 9 Milan, ITALY
1
MULTICENTRE COMPARISON OF SHOCK EFFICACY USING DUAL- VS SINGLE-COIL LEADS
AND ANODAL VS CATHODAL POLARITY IN PATIENTS UNDERGOING ICD IMPLANTATION: THE
MODALITY STUDY
S. Baccillieri 1, G. Gasparini 2, L. Benacchio 1, A. Zorzi 3, E. Marras 4, F. Zerbo 4, L. Tomasi 6, D.
Vaccari 7, G. Pastore 8, C. Bonanno 9, A. Olivieri 1, D. Corrado 3, R. Verlato 1
1
8
Camposampiero, PD, 2 Mestre, 3 Padua, 4 Conegliano, TV, 5 Mirano, VE, 6 Verona, 7 Montebelluna, TV,
Rovigo, 9 Vicenza, ITALY
MORBIDITY BEYOND THE PRIMARY CARDIAC RHYTHM MANAGEMENT DEVICE IMPLANT.
ARE PATIENTS ADEQUATELY INFORMED?
1
152
2014
17:30-19:00 | Cesarea
Joint session with GULF EP LIVE© DUBAI
Chairs: R. Choudhury (Sharjah, UAE)
M. Magdi (Sharjah, UAE)
Pacemakers and ICD’s lessons from the trials in Heart Failure patients
N. Asaad (Doha, Q)
Follow up of patients with CRT: drug and device optimization
C. Jazra (Beirut, RL)
Strength and weakness of implementing AF ablation in the region
M. Khoury (Beirut, RL)
VT ablation in the extreme cases, is it really an option?
Y. Al Hebaishi (Riyadh, SA)
Left Atrial Appendage closure
A. Abdel-Aziz (Cairo, ET)
Is right ventricular pacing really decremental?
A. Al Fagih (Riyadh, SA)
153
2014
Friday, December 5
ANTICOAGULATION: BALANCING THE HAEMORRHAGIC
AND THE THROMBOTIC RISKS
Chairs: A.S. Fak (Istanbul, TR)
R. Sapra (Faridabad, IND)
In paroxysmal, persistent and permanent atrial fibrillation
M. Patete Ayala (Caracas, YV)
In dilated cardiomyopathy
E.N. Simantirakis (Heraklion, GR)
In patients with ventricular aneurism
G. Al-Mohani (Rome, I)
In very elderly patients
M. Bocchiardo (Pietra Ligure-SV, I)
In patients with previous cerebral haemorrhage
J.O. Schwab (Bonn, D)
In patients already under post ptca double antithrombotic treatment
154
2014
SYNCOPE AND STRUCTURAL HEART DISEASE
Chairs: H. Abdeddayem (Tunis, TN)
L. Aguinaga (Tucuman, RA)
In hypertrophic cardiomyopathy
T. Pezawas (Vienna, A)
In ischemic cardiomyopathy
G. Russo (Como, I)
In dilated idiopatic cardiomyopathy
R. Rordorf (Pavia, I)
New role of External Loop Recorder in Arrhythmia and Syncope assessment
E.T. Locati (Milan, I)
In pacemaker patients
A. Shafquat (Riyadh, SA)
In ICD patients
H. Yokoshiki (Sapporo, JP)
155
Friday, December 5
2014
Friday, December 5
9:00-10:30 | Orange 1
PACEMAKER OPTIMAL PROGRAMMING
Chairs: S. Paraskevaidis (Thessaloniki, GR)
K. Seidl (Ingolstadt, D)
RV pacing minimization in all pacemaker patients?
H. Bonnemeier (Kiel, D)
In congestive heart failure patients
Q. Parisi (Campobasso, I)
In permanent atrial fibrillation
S. Faerestrand (Bergen, N)
In hypertrophic cardiomyopathy
F. Guarracini (Milan, I)
In athletes
L. Tomasi (Verona, I)
156
2014
CIED INFECTIONS
Chairs: N. Kadri (Amman, HKJ)
A. Kutarski (Lublin, PL)
Diagnostic flow chart to identify infected leads
G. Luzzi (Bari, I)
Lead extraction as first therapy: to whom?
H. Nakajima (Tokyo, JP)
When reimplant a new pacing system in pacemaker dependent patients?
M. Rillo (Taranto, I)
Post-extraction usefulness of the wearable defibrillator waiting for the new implant
optimal timing
M. Stockburger (Nauen, D)
When considering a down grading of the system implanting a subcutaneous
defibrillator?
B. Thibault (Montreal, CDN)
157
Friday, December 5
2014
Friday, December 5
9:00-10:30 | Spalato
DIFFICULT CRT CASES
Diagnosis and treatment
Chairs: A. Gopi (Calicut, IND)
C. Pignalberi (Rome, I)
Difficult implantation
M. Biffi (Bologna, I)
Device programming optimization
P.C. Mandal (Kolkatta, IND)
Managing non responders
B. Elencwajg (Buenos Aires, RA)
Left ventricular lead troubles
G. Mascioli (Bergamo, I)
Recurrent atrial fibrillation in CRT remotely control
G. Campisi (Ragusa, I)
Surgical lead implant: when, which position?
M. Czajkowski (Lublin, PL)
158
2014
9:00-10:30 | Pola
PROGRESS IN INTERVENTIONAL CARDIOLOGY
Left Atrial Appendage Closure by Implantable Devices
Chairs: M. Magdi (Sharjah, UAE)
G. Speciale (Rome, I)
Selection of the appropriate candidate
P. Danna (Milan, I)
Are all the available implantable devices similarly effective?
S. Berti (Massa, I)
Concomitant atrial fibrillation catheter ablation and left atrial appendage closure
L.V. Boersma (Nieuwegein, NL)
Periprocedural complications: how to avoid them
M.J. Schalij (Leiden, NL)
Long-term follow-up
C. Tondo (Milan, I)
Cost-benefit on a long-term basis
C. Pristipino (Rome, I)
159
Friday, December 5
2014
Friday, December 5
10:30-12:15 | Pola
Progress In Interventional Cardiology
Chairman: G. Speciale (Rome, I)
Debates in Coronary Interventions
Pretreatment with P2Y12 inhibitors in acute coronary syndromes
10:30 – 10:45 Time to switch to new drugs
10:45 – 11:00 Clopidogrel still has an important role
11:00 – 11:20 Discussion
Thromboaspiration in STEMI
11:20 – 11:35 A standard treatment for everybody
11:35 – 11:55 A treatment to be reserved to selected patients
160
2014
11:00-12:30 | Leptis magna 4
HOW TO MAXIMIZE THE RESPONSE TO CARDIAC
RESYNCHRONIZATION THERAPY
Chairs: S. Favale (Bari, I)
M. Senni (Bergamo, I)
CRT indications: state of the art
U. Khanolkar (Goa, IND)
Who and when? The importance of patient selection for improving CRT responsiveness
M. Landolina (Pavia, I)
Optimizing left ventricular pacing: from Echo to the novel AdaptiveCRT algorhythm
M. Meine (Utrecht, NL)
Efficacy of device based algorithms: results from AdaptivCRT Trial
B. Lemke (Luedenscheid, D)
How do we translate the Partners HF results into clinical practice?
Optimal HF patients management through remote monitoring and diagnosis
L. Calo’ (Rome, I)
What’s next in CRT? Clinical, economical and cost-benefit aspects
F. Leyva (Birmingham, UK)
161
Friday, December 5
2014
Friday, December 5
11:00-12:30 | Leptis magna 2
CIED REUSE
Chairs: R. Ciudin (Bucharest, RO)
M. Toscano (Colleferro-RM, I)
How many implanted devices could be considered for reuse?
D. Spaziani (Magenta-MI, I)
Potential candidates to an implant with a reused electronic device
G. Sharma (New Delhi, IND)
Safety of sterilization processes and biocompatibility
F. Censi (Rome, I)
Should all the extracted devices be controlled by its manufacturer before to be reimplanted
in another patient?
C.W. Israel (Frankfurt, D)
Should the patient be informed and accept the implant of a reused devices? Etical and
legal problems
I. Can (Ankara, TR)
Cost-benefit of PMK/ICD reuse
E. Soldati (Pisa, I)
162
2014
11:00-12:30 | Orange 1
RARE INDICATIONS FOR PERMANENT VVI PACING
Chairs: A. Abdel-Aziz (Cairo, ET)
In Sick Sinus Syndrome
S.K. Dwivedi (Lucknow, IND)
In paroxysmal AV block
R. Nayak (Thodupuzha, IND)
In anatomic venous abnormalities
F. Melandri (Sassuolo-MO, I)
In post-extraction of infected pacing systems
P. Palmisano (Tricase-LE, I)
In sleep apnea with prolonged asystolic pauses
B. Abi-Saleh (Beirut, RL)
In pediatric patients
T. Karagoz (Ankara, TR)
163
Friday, December 5
2014
Friday, December 5
11:00-12:30 | Tarragona
THE ROLE OF ECHOCARDIOGRAPHY IN
ELECTROPHYSIOLOGY
Chairs: S. Ficili (Rome, I)
Evaluation of intra-interventricular dissinchrony and guide for CRT optimal programming
M. Russo (Rome, I)
Evaluating of atrial and ventricular function pre and post cardioversion for atrial fibrillation
A. Auriti (Rome, I)
Reduction of mitral valve insufficiency by optimal programming of AV and VV intervals
A. Rónaszéki (Nice, F)
Identification and quantification of PFO in patients with TIA
C. Cianfrocca (Rome, I)
Identification of infected vegetations on cardiac valves or intracardiac pacing leads
N. Cabanelas (Coimbra, P)
Intracardiac echocardiography: a multipurpose technique
D. Lin (Philadelphia-PA, USA)
164
2014
11:00-12:30 | Spalato
CARDIAC RESYNCHRONIZATION THERAPY: IMPROVING
PATIENTS QUALITY OF LIFE
Chairs: A.S. Al-Khadra (Riyadh, SA)
G. Ansalone (Rome, I)
How to predict ATP effectiveness in CRTD patients
D. Bänsch (Rostock, D)
Right versus biventricular ATP: which is more effective?
J.O. Schwab (Bonn, D)
Preventing loss of capture by optimal selection and positioning of the LV lead
F. Zanon (Rovigo, I)
Benefits of device remote control in CRTD patients
F. Solimene (Mercogliano-AV, I)
Infections in CRTD implants: prevalence and management
H. Sabbour (Abu Dhabi, UAE)
Cost-efficacy of CRTD on a long term basis
M. Zecchin (Trieste, I)
165
Friday, December 5
2014
Friday, December 5
12:15-13:05 | Pola
Bioabsorbable scaffolds or Bioresorbable polymer DES for complex lesions
12:15 – 12:30 The future is now
12:30 – 12:45 Wait a minute
12:45 -13:05 Discussion
166
2014
13:05-14:05 | Pola
LUncheon Panel
Timing of revascularization in AMI patients with multivessel disease
13:05 – 13:25 Aggressive strategy
13:25 – 13:45 Elective strategy
167
Friday, December 5
2014
Friday, December 5
14:05-15:05 | Pola
Updates on Structural Heart Disease
14:05 – 14:20 Second generation TAVI devices: will they make a difference?
14:20 – 14:35 TAVI for patients with low gradient and low flow
14:35 – 14:50 Interventional treatment of mitral regurgitation
168
2014
15:05-15:50 | Pola
Flash debate PFO Closure 2014
15:05 – 15:20 Still an important indication
15:20 – 15:35 Medical therapy is the first choice
15:35 – 15:50
Discussion
169
Friday, December 5
2014
POSTER SESSION
2014
POSTER SESSION Wednesday, December 3
1
2
ASSESSMENT OF THE ASSOCIATION BETWEEN BLOOD FATTY ACID LEVELS AND
CARDIAC AUTONOMIC FUNCTIONS IN OBESE CHILDREN AND ADOLESCENTS
M. Gulgun, M.K. Fidanci, A. Genc, A. Tas, A. Kilic
Ankara, TURKEY
PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN ARMY POPULATION AFTER
ONE YEAR TRAINING
M. Febrianora 1, D. Novera 2, D. Herlambang 1, C. Achmad 3
1
Garut, 2 Jakarta, 3 Bandung, INDONESIA
3CONDUCTION DISORDERS AFTER ORTHOTOPIC HEART TRANSPLANTATION:
INCIDENCE, RISK FACTORS AND OUTCOME
S. Ferretto, E. Tafciu, T. Bottio, G. Feltrin, A Gambino, G. Toscano, A. Angelini, S. Iliceto,
G. Gerosa, L. Leoni
Padua, ITALY
Zagreb, CROATIA
Brno, CZECH REPUBLIC
Savigliano, CN, ITALY
Sassuolo, MO, ITALY
4EFFECT OF N-3PUFA ADMINISTRATION ON INCIDENCE OF AF IN PATIENTS WITH
SICK SINUS SYNDROME
M. Lovric Bencic, D. Fabijanovic, T. Simoncek, M. Mihajlovic
5CONGENITAL ANOMALIES OF THE INFERIOR VENA CAVA COMPLICATING
ELECTROPHYSIOLOGY STUDIES
J. Jez, F. Lehar, Z. Starek, J. Wolf, T. Kulik, A. Zbankova, M. Lukasova
6EARLY REPOLARIZATION AND VENTRICULAR FIBRILLATION IN PATIENT WITH
THYROID STORM
L. Valeri, A. Coppolino, G. Bricco, A. Dellavalle, A. Bassignana, L. Correndo, M. De Benedictis,
S. Dogliani, A. Magliarditi, D. Pancaldo, D. Tedeschi, B. Doronzo
7EARLY REPOLARIZATION: A BENIGN EVIDENCE…BUT NOT ALWAYS
F. Melandri, G. Lolli, M. Scapinelli, P. Bellesi, S. Merighi, A. Guerra
8
A STRANGE CASE OF INTERMITTENT PREEXCITATION WITH MARKED
REPOLARIZATION ALTERATIONS EXCLUSIVELY DURING PHYSICAL ACTIVITY
D. Malaspina 1, R. De Ponti 2, M. Pala 1, G. Guenzati 1, A. Mafrici 1
1
Milan, 2 Varese, ITALY
172
9LYME DISEASE PRESENTING WITH COMPLETE INFRA-HISIAN ATRIO-VENTRICULAR
BLOCK
A. Pinsino 1, L. Mastrine 2, G. Turitto 2
1
Santarem, PORTUGAL
1
1
Milan, ITALY, 2 Brooklyn, NY, USA
10DIABETES MELLITUS AND ATRIOVENTRICULAR BLOCK: A NEW ASSOCIATION?
D. Severino, B. Santos, C. Costa, L. Marta, V. Martins, M.L. Pitta, M. Leal
11IMMUNOHISTOCHEMISTRY OF ENDOCARDIAL BIOPSY SAMPLES FOR PLAKOGLOBIN
IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
N. Murakoshi 1, S. Kawano 1, D. Xu 1, Y. Sekiguchi 1, M. Igarashi 1, H. Yamasaki 1, T. Kuroki1,
T. Machino 1, Y. Seo 1, A Haussaini 1, I. Yamaguchi 2, H. Tada 3, A. Nogami 1, K. Aonuma 1
Tsukuba, 2 Mito, 3 Fukui, JAPAN
12COMMON VARIANTS AT SCN5A, SCN10A, AND HEY2 ARE ASSOCIATED WITH
CARDIAC CONDUCTION DISTURBANCE IN PATIENTS WITH BRUGADA SYNDROME
D. Xu 1, N. Murakoshi 1, A. Nogami 1, Y. Naruse 3, S. Kowase 3, N. Makita 2, K. Aonuma 1
Tsukuba, 2 Nagasaki, 3 Yokohama, JAPAN
13CLINICAL AND PROGNOSTIC SIGNIFICANCE OF IDIOPATHIC INTRAVENTRICULAR
CONDUCTION DISTURBANCES IN YOUNG SUBJECTS
L. Ucci 1, G. Allocca 1, N. Sitta 1, L. Sciarra 2, F. Sperandii 2, A. Cati 1, M. Centa 1, L. Coro’ 1,
L. Calo’ 2, P. Delise 1
14
1
Conegliano, TV, 2 Rome, ITALY
ANTI-TACHICARDIA PACING IN ELDERLY PATIENTS. MODERN CONCEPT OF HYBRID
THERAPY
I. Skigin, I. Pyaterichenko, K. Shorokhov, T. Elizarova, E. Voitkovskaya, A. Abramov
15
T WAVE OVERSENSING IN CARDIAC RHYTHM DEVICES: THE EFFECT OF HYPERKALEMIA
Verona, ITALY
B. Bolzan, M. Morosato, L. Tomasi, R. Tomei, G. Morani, C. Vassanelli
16CLINICAL IMPACT OF AN AUTOMATED LEAD SURVEILLANCE SYSTEM
J. Sperzel, J. Leick, D. Pajitnev, S. Wolter, T. Neumann, M. Kuniss
Bad Nauheim, GERMANY
17HOW LONG IS A LEARNING CURVE ON LEAD EXTRACTION. PERSONAL EXPERIENCE
1
173
2014
2014
18CHRONIC PERFORMANCE OF A LEADLESS CARDIAC PACEMAKER: SINGLE CENTER
18-MONTH FOLLOW-UP RESULTS
F. Tjong, J. R. De Groot, A. A. M Wilde, R. E. Knops
Amsterdam, NETHERLANDS
1
Salt Lake City, UT, USA
Sassuolo, MO, ITALY
Penza, RUSSIA
19INCREASING DEVICE LONGEVITY BY USING NEW ALGORITHMS AND OPTIMIZING
DEVICE SETTINGS
M. Ziacchi 1, D. Saporito 2, M. Zardini 3, F. Quartieri 4, G. Morgagni 4, E. De Maria 6,
M. Bertini 7, M. Luzi 8, G. Boriani 1, M. Biffi 1
Bologna, 2 Rimini, 3 Parma, 4 Reggio Emilia, 5 Macerata, 6 Carpi, 7 Ferrara, 8 Ancona, ITALY
20CONTINUOUS MOBILE MONITORING LOWERS EMERGENCY ROOM AND CLINIC
VISITS POST-ATRIAL FIBRILLATION ABLATION
L. Kanamu, S. Hamele, J. Rabkin, C. Pacchia, H. Margetts, N. Marrouche
21REMOTE MONITORING IN SASSUOLO AREA. THE ROLE OF THE TECNICAL
CARDIOLOGY
F. Melandri, G. Lolli, M. Scapinelli, P. Bellesi, S. Merighi, A. Guerra
22
FEATURES OF CONNECTION TO THE SYSTEM OF REMOTE MONITORING OF
IMPLANTABLE CARDIOVERTERS-DEFIBRILLATORS IN RUSSIA
R. Marchenko, S. Durmanov, O. Popilkova, N. Makarova, A. Kozlov, V. Bazilev
23REMOTE MONITORING OF PERMANENT PACEMAKERS IS ASSOCIATED WITH
REDUCED MORTALITY
B. Davies, I.B. Harries, L. Schultz, B. Chandrasekaran, W.A. Mccrea, P.W. Foley
Swindon, UNITED KINGDOM
1
Berlin, GERMANY, 2 Madrid, SPAIN, 3 Toulouse, FRANCE, 4 Kosice, SLOVAK REPUBLIC, 5 Neuilly,
FRANCE, 6 Vienna, AUSTRIA, 7 Santiago de Compostela, SPAIN, 8 Saluggia, VC, ITALY, 9 Grenoble,
FRANCE
24BENEFITS OF IECG APPLICATION IN THE ASSESSMENT OF PACING EFFECTIVENESS
F. Zanon 1, E. Baracca 1, P. China 2, A. Corrado 2, G. Pastore 1, G. Gasparini 2, A. Barbetta 3,
F. Di Gregorio 3
Rovigo, 2 Mestre Venezia, 3 Rubano, PD, ITALY
25CLINICAL BENEFIT OF THE SAFER MODE IN A MIXED DUAL CHAMBER POPULATION:
RESULTS FROM THE ANSWER STUDY
M. Stockburger 1, J. Moreno 2, S. Boveda 3, B. Stancak 4, J.P. Villacastin 2,
A. Lazarus 4, J. Sipoetz 6, J. Garcia-Seara 7, M. Rolando 8, P. Defaye 9
1
174
26MAGNETIC RESONANCE IMAGING-INDUCED RADIOFREQUENCY HEATING OF
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEADS
Q. Wang, S. Feng, C. Wen, J. Chen
Houston, TX, USA
27RESULTS FROM THE IKONE STUDY: CLINICAL EVALUATION OF THE KORA AND
BEFLEX LEAD MAGNETIC RESONANCE CONDITIONAL PACING SYSTEM
A. Savoure, A. Bouharaoua, M. Burban, F. Maneval, A. Lazarus
1
Gijon, SPAIN
Hamilton, Canada, 2 Ancona, Italy, 3 Ottawa, Canada, 4 Kassel, 5 Frankfurt, Germany, 6 Barcelona,
Spain, 7 Prague, Czech Republic, 8 Québec, Canada, 9 Leiden, the Netherlands, 10 Stockholm,
Sweden, 11 Rennes, France, 12 Tel Hashomer, Israel, 13 New York, NY, USA, 14 Liverpool, UK
Rouen, 2 Marseille, 3 Nantes, 4 Clamart, 5 Saint-Cloud, FRANCE
28LONG-TERM PERFORMANCE OF A MRI-CONDITIONAL VENTRICULAR LEAD: BEFLEX
MRI RF46D
J. Lapuerta Irigoyen, P. Vigil Escalera
29Incidence and Predictors of Wound Hematoma Following Defibrillator
Implantation: Results from the Shockless Implant Evaluation (SIMPLE)
Trial
S. Masiero 1,2, S.J. Connolly 1, D. Birnie 3, J. Neuzner 4, S.H. Hohnloser 5, X. Vinolas 6,
J. Kautzner 7, G. O’Hara 8, L. VanErven 9, F. Gadler 10, J. Wang 1, P. Mabo 11, M. Glikson 12,
V. Kutyifa 13, D. J. Wright 14 and J.S. Healey, MSc1 On behalf of the SIMPLE Investigators
1
30WE SHOULD DO VENOUS CONTRAST EXAMINATION BEFORE DEVICE IMPLANTATION
TO AVOID TECHNICAL COMPLICATIONS
T. Sakai 1, T. Muramatsu 1, R. Tsukahara 1, M. Noro 2, K. Sugi 2
1
Chandigarh, INDIA
Yokohama, 2 Tokyo, JAPAN
31MARKERS OF COAGULATION ACTIVATION IN PATIENTS WITH IMPLANTABLE
DEVICES
M. Sepsi, G. Chlupova, T. Novakova, P. Scheer
32
33
PERCUTANEOUS INTERVENTION OF POST-PERMANENT PACEMAKER IMPLANTATION
SUBCLAVIAN VEIN STENOSIS
R Vijayvergiya
AN INCIDENCE AND PREDICTORS OF VENTRICULAR LEAD DISLODGEMENT IN EARLY
POSTOPERATIVE PERIOD (A SINGLE CENTER EXPERIENCE)
S. Zadorozhnaya, V. Agapov, V. Samitin, D. Terehov
Regional Cardiosurgical Center, Saratov, RUSSIA
34DECLINE OF DEFIBRILLATION TESTING USE IN CLINICAL PRACTICE: AN 8-YEAR
175
2014
2014
NATION-WIDE ASSESSMENT
E. Occhetta 1, M. G. Bongiorni 2, A. Proclemer 3, S. Favale 4, M. Gasparini 4, S. Valsecchi 6,
C. Rojatti 6, M. Brignole 7
1
1
Tokyo, JAPAN
38
FAILURE OF ICD THERAPY FOR VENTRICULAR FIBRILLATION DUE TO A LACK OF SENSING
AMPLITUDE DURING VENTRICULAR FIBRILLATION (THROUGH 2 CASES)
Novara, 2 Pisa, 3 Udine, 4 Bari, 5 Rozzano, MI, 6 Milan, 7 Lavagna, GE, ITALY
35DIAGNOSTIC ACCURACY OF THE FIRST POSTPACING INTERVAL STABILITY IN
ARRHYTHMIC EPISODES DETECTED BY ICDS
J. Martinez Sanchez 1, A. Garcia Alberola 1, P. Peñafiel Verdu 1, J. Martinez Ferrer 2,
J. Alzueta 3, X. Viñolas 4, A. Rodríguez 4, N. Basterra 6
Murcia, 2 Alava, 3 Malaga, 4 Barcelona, 5 Santa Cruz de Tenerife, 6 Pamplona, SPAIN
36DEACTIVATION OF DEFIBRILLATORS. CONSIDERATIONS AT THE END OF LIFE IN OUR
EXPERIENCE
N. Matsushita, Y. Momose, K. Hoshida, S. Higuchi, Y. Miwa, I. Togashi, A. Ueda, T. Sato,
K. Soejima, H. Yoshino
37ELDERLY PATIENTS AND PREVENTION OF SUDDEN CARDIAC DEATH WITH
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: A SINGLE CENTRE REPORT
K. Polymeropoulos, A. Vosnakidis, P. Ioannidis, G. Maligos, P. Giannakopoulou, J. Zarifis
1
39RESPIRATE PROJECT 2: THE HF PATIENT’S CO-MANAGEMENT BETWEEN HF
SPECIALIST AND GENERAL PRACTITIONER
P. Rocca, P. Neri, L. Viscardi, A. Locatelli, B. Casiraghi, M. Tespili, V. Giudici
Seriate, BG, ITALY
Goettingen, GERMANY
40INVESTIGATION ON ROUTINE FOLLOW-UP (FU) IN CONGESTIVE HEART
FAILURE PATIENTS WITH REMOTELY MONITORED IMPLANTED CARDIOVERTER
DEFIBRILLATORS (ICD) SYSTEMS. INCONTACT STUDY
C. Hansen
41OUR EXPERIENCE WITH NEUROSTIMULATION IN THE TREATMENT OF CHRONIC
HEART FAILURE (SPINAL VS VAGAL STIMULATION)
M. Mudroch 1, J. Naar 1, H. Psotová 1, J. Petru 1, M. Ståhlberg 2, J. Sorf 1, J. Meschede 3,
J. Neuzil1
1
Prague, CZECH REPUBLIC, 2 Stockholm, SWEDEN, 3 Diagem, BELGIUM
176
42TRICUSPID REGURGITATION FOLLOWING PACEMAKER IMPLANTATION. AN
UNDERESTIMATED PROBLEM
A. Rydlewska, A. Zabek, K. Boczar, J. Lelakowski, B. Malecka
Krakow, POLAND
Zagreb, CROATIA
43SUCCESSFULL AV NODE ABLATION AND CARDIAC RESYNCHRONISATION IN PATIENT
AFTER SENNING PROCEDURE WITH PERSISTENT ATRIAL FLUTTER AND SEVERE
TRICUSPID REGURGITATION (A CASE REPORT)
M. Lovric Bencic, I. Aladrovic, J. Bulum, J. Separovic Hazevacki, D. Anic, B. Ferek Petric,
A. Ernst, B. Glavas Konja
44BRUGADA PHENOCOPY IN THE CONTEST OF PERICARDIAL TAMPONADE
A. Coppolino, G. Bricco, L. Valeri, D. Tedeschi, D. Pancaldo, L. Correndo, M. De Benedictis,
A. Magliarditi, S. Dogliani, A. Bassignana, B. Doronzo
Savigliano, CN, ITALY
Herne, GERMANY
46
ACUTE EXACERBATION OF HEART FAILURE ATTRIBUTED TO COMPLETE
ATRIOVENTRICULAR BLOCK IN A PATIENT WITH LEFT UNIVENTRICULAR PACING BY
N. Nishiyama, S. Takatsuki, S. Kashimura, Y. Katsumata, T. Nishiyama, T. Kimura, Y. Aizawa,
K. Fukumoto, Y. Hagiwara, K. Fukuda
45THE BURDEN OF SCAR RATHER THAN THE AETIOLOGY OF CARDIOMYOPATHY
INDICATES THE RISK FOR ICD-THERAPY IN PATIENTS WITH CRT-D
M. Grett, H. J. Trappe
Tokyo, JAPAN
Rome, ITALY
47THE FIDE PROJECT (FITNESS IN IMPLANTABLE DEVICES)
B. Di Giacinto, M.R. Squeo, M. Santini, M.L. Sette, A. Parisi, A. Spataro, A. Biffi
48COURSE OF PATIENTS WITH SARCOIDOSIS WHO RECEIVED PACEMAKER
IMPLANTATION: EFFICACY OF CORTICOSTEROIDS
I. Abe, Y. Ebata, S. Saito, H. Kondo, T. Shinohara, Y. Teshima, K. Yufu, M. Nakagawa,
N. Takahashi
49
Oita, JAPAN
ARE THERE ANY SPECIFIC FACTORS AFFECTING VEGETATIONS DEVELOPMENT IN
PATIENTS WITH IMPLANTABLE PACING SYSTEMS?
A. Polewczyk 1 A. Tomaszewski 2, W. Brzozowski 2, M. Janion 1, A. Kutarski 2
1
Kielce, 2 Lublin, POLAND
177
2014
2014
50
PREVALENCE OF ECG ABNORMALITIES IN A LARGE SCHOOL POPULATION
M. Mignano, L. Santini, G. Cassoni, M. Santini
Rome, ITALY
178
2014
POSTER SESSION
2014
POSTER SESSION Thursday, December 4
1THE TREND IN ATRIAL FIBRILLATION TREATMENT IN THE JAPANESE POPULATION
1
1
Herne, GERMANY
1
Florence, ITALY
Olomouc, CZECH REPUBLIC
2BEPRIDIL IS EXTREMELY EFFECTIVE TO PAROXYSMAL ATRIAL FIBRILLATION
3SURVIVAL UNTIL HOSPITAL DISCHARGE AFTER SUCCESSFUL DEFIBRILLATION IN
RELATION TO THE NUMBER OF SHOCKS DELIVERED IN VICTIMS FROM OHCA WITH AN
INITIAL SHOCKABLE RHYTHM
M. Christ, K. I. von Auenmueller, J. Liebeton, J. P. Noelke, M. Grett, I. M. Breker, M. Brand,
H.J. Trappe
4EMERGENT CATHETER ABLATION IN PATIENTS WITH POOR OVERALL MEDICAL
CONDITION IS HIGHLY EFFECTIVE
5COMPLEX DIAGNOSIS OF TRANSIENT LOSS OF CONSCIOUSNESS IN OLDER
PATIENTS: A CASE REPORT
F. Tesi, M. Rafanelli, A. Ceccofiglio, G. Toffanello, G. Bulli, S. Venzo, G. Rivasi, D. Romagnolo,
N. Marchionni, A. Ungar
6INSERTABLE CARDIAC MONITOR. MULTIDISCIPLINARY DECISION MAKING
I. Skigin, A. Zorin, I. Pyaterichenko, K. Shorokhov, T. Elizarova, E. Voitkovskaya, A. Abramov,
M. Steblyankina
7LONG-TERM MONITORING OF HEART RHYTHM SUBCUTANEOUS MONITOR: FIRST
EXPERIENCE IN YOUNG PATIENTS WITH CRYPTOGENIC ISCHEMIC STROKE
M. Fedorco, D. Sanak, M. Taborsky, P. Kanovsky, M. Hutyra, M. Kral, T. Skala, T. Veverka
8CORONARY SINUS REENTRANT TACHYCARDIA AFTER ATRIAL FIBRILLATION
ABLATION: FROM BAD TO WORSE
P. Turco, A. Antonelli, E. Gronda
Milan, ITALY
182
2014
10
PULMONARY VEIN ISOLATION WITH THE SECOND-GENERATION CRYOBALLOON
CATHETER ARCTIC FRONT ADVANCE
J. Petru 1, V. Reddy 2, L. Sediva 1, J. Skoda 1, M. Chovanec 1, S. Dukkipati 2, P. Neuzil 1
1
Prague, CZECH REPUBLIC, 2 New York, NY, USA
FEASIBILITY AND SAFETY OF CATHETER ABLATION OF ATRIAL FIBRILLATION WITH
ZERO FLUOROSCOPY: EVIDENCE FROM MORE THAN HUNDRED CASES
E. Lyan, A. Kazakov, S. Yashin
11CRYOBALLOON ABLATION OF A “STUMP” PULMONARY VEIN
B. Evranos, M. Gürses, S. Asil, D. Koçyigit, V. Hekimsoy, H. Yorgun, L. Sahiner, B. Kaya,
N. Ozer, G. Kabakci, L. Tokgözoglu, K. Aytemir
Ankara, TURKEY
12SINGLE CENTER EXPERIENCE WITH SIMULTANEOUS IMAGING OF THE LEFT ATRIUM
AND ESOPHAGUS USING THREE-DIMENSIONAL ROTATIONAL ATRIOGRAPHY
A. Zbankova, T. Kulik, Z. Starek, J. Jez, F. Lehar, J. Wolf, M. Lukasova
13THREE DIMENSIONAL ROTATIONAL ATRIOGRAPHY AND VENTRICULOGRAPHY
SUPPORTING THE TREATMENT OF COMPLEX CARDIAC ARRHYTHMIAS. SINGLE
CENTER EXPERIENCE: 500 PATIENTS
T. Kulik, A. Zbankova, Z. Starek, F. Lehar, J. Jez, J. Wolf, M. Lukasova
14
15
ABLATION OF A RIGHT FREE WALL ACCESSORY PATHWAY AND DISAPPEARANCE OF
RIGHT VENTRICULAR OUTFLOW TRACT PREMATURE VENTRICULAR CONTRACTIONS.
WHAT IS THE COMMON LINK?
T. Szili-Torok, F. Akca
PULMONARY VEIN ISOLATION FOR PAROXYSMAL ATRIAL FIBRILATION WITH
CIRCULAR MULTIPOLAR IRRIGATED NMARQ CATHETER
L. Sediva, M. Janotka, J. Petru, J. Skoda, M. Chovanec, P. Neuzil
16COMPARISON OF CLINICAL OUTCOME AND SAFETY OF CATHETER ABLATION FOR
ATRIAL FIBRILLATION GUIDED BY CT SCAN OR THREE-DIMENSIONAL ROTATIONAL
ANGIOGRAM OF LEFT ATRIUM
F. Lehar 1, Z. Starek 1, J. Jez 1, M. Novak 1, T. Kulik 1, A. Zbankova 1, R. Jancar 2
1
Brno, 2 Ostrava, CZECH REPUBLIC
183
9
2014
17EVALUATION OF THE FIRST SOFTWARE TOOL FEATURING 3D VISUALIZATION
OF CRYO BALLOON ABLATION CATHETERS IN ATRIAL FIBRILLATION ABLATION
PROCEDURES
C. Kowalewski, D. Vukajlovic, F. Heissenhuber, K. Kurzidim
18
19
20
21
22
Regensburg, GERMANY
ABLATION OF ATRIAL FIBRILLATION AND ESOPHAGEAL INJURY: THE ROLE OF
BIPOLAR AND UNIPOLAR ENERGY USING A NOVEL MULTIPOLAR IRRIGATED
ABLATION CATHETER (NMARQ)
A. Di Monaco, F. Quadrini, G. Katsouras, G. Cecere, T. Langialonga, M. Grimaldi
Acquaviva delle Fonti, BA, ITALY
ATRIAL FLUTTER ABLATION THROUGH SUPERIOR VENA CAVA IN A PATIENT WITH
CONGENITAL ABSENCE OF INFERIOR VENA CAVA
Y. Shirai, T. Nishimura, K. Sugiyama, S. Tao, T. Sasaki, M. Kawabata, T. Sasano, M. Goya,
K. Hirao
Tokyo, JAPAN
FIRST CLINICAL EXPERIENCE USING A NEW FLUOROSCOPY-INTEGRATED CATHETER
TRACKING SYSTEM (MEDIGUIDE) FOR ABLATION OF VENTRICULAR TACHYCARDIA
M. Derndorfer, E. Sigmund, G. Kollias, S. Winter, H.J. Nesser, H. Pürerfellner, M. Martinek
Linz, AUSTRIA
A NURSE-LED PRE ADMISSION CLINIC. A NEW STANDARD FOR PATIENTS
SCHEDULED FOR ABLATION OF ATRIAL FIBRILLATION
Z. Pidova, M. Eisenberger, A. Bulava, J. Svejdova, A. Hudackova
Budweis, CZECH REPUBLIC
PERIMITRAL ATRIAL FLUTTER. EXTRAPOLATION OF ARRHYTHMIA SIMULATION
DATA TO ABLATION CLINICAL RESULTS
E. Zhelyakov, A. Ardashev, M. Mazurov, I. Kaluzhny, V. Finko
Moscow, RUSSIA
23REGULAR ATRIAL TACHYCARDIAS OCCURRING AFTER SURGICAL TREATMENT
OF ATRIAL FIBRILLATION: ELECTROPHYSIOLOGICAL ANALYSIS AND ABLATION
STRATEGIES
R. Krausova, D. Wichterle, P. Peichl, J. Kautzner, J. Pirk
Moscow, RUSSIA
24CLINICAL IMPLICATION OF UNIPOLAR RECORDING FOR THE SLOW PATHWAY
MAPPING IN PATIENT WITH TYPICAL AV NODE RE-ENTRY TACHYCARDIA AND
PROLONGED PR INTERVAL
E. Zhelyakov, A. Ardashev
184
2014
1
Regional Cardiosurgical Center, Saratov, RUSSIA
26BENEFICIAL EFFECT OF CARDIAC RESYNCHRONIZATION THERAPY IN BETA
THALASSEMIA PATIENT
H. Zouzou 1, J.C. Deharo 2, D. Nibouche 1
Algiers, ALGERIA, 2 Marseiile, FRANCE
27THE ROLE OF HOLTER MONITORING DURING FOLLOW-UP IN PATIENTS WITH
S. Zadorozhnaya, V. Agapov, V. Samitin, D. Terehov
28
ACUTE PERFORMANCE OF A SHORT SPACED NEW QUADRIPOLAR LEFT
VENTRICULAR LEAD
M. Ziacchi 1, D. Saporito 2, M. Zardini 3, F. Quartieri 4, G. Morgagni 4, E. De Maria 6,
M. Bertini 7, M. Luzi 8, G. Boriani 1, M. Biffi 1
1
8
29
Bologna, 2 Rimini, 3 Parma, 4 Reggio Emilia, 5 Macerata, 6 Carpi, MO, 7 Ferrara,
Ancona, ITALY
POST IMPLANT PAYOR COST ANALYSIS OF PATIENTS WITH QUADRIPOLAR VS
BIPOLAR CRT-D: A COMPARATIVE EFFECTIVENESS ANALYSIS MODELED FOR THE
US HEALTHCARE SYSTEM
D. Della Rocca 1, G. B Forleo 1, G. Panattoni 1, E. Romano 1, R. Bharmi 2, N. Dalal 2, L. Duro1,
V. Ribatti 1, F. Onorato 1, D. Sergi 1, L. Papavasileiou 1, L. Santini 1, F. Romeo 1
1
1
Rome, ITALY, 2 Sylmar, CA, USA
30NEW QUADRIPOLAR LEFT VENTRICULAR LEAD DESIGN ELIMINATES PHRENIC
NERVE STIMULATION
J. Castro Dorticós 1, J. Balaguer 1, S. Moreno 1, B. Tarancón 1, E. Novo 1, A. Salas 2,
G. Sanchez 2, M. Iglesias 2
Guadalajara, 2 Madrid, SPAIN
31REDUCED PHRENIC NERVE STIMULATION AND MORTALITY WITH QUADRIPOLAR LEFT
VENTRICULAR LEADS FOR CARDIAC RESYNCHRONIZATION THERAPY COMPARED WITH
CONVENTIONAL BIPOLAR LEADS
J. Behar, J. Bostock, A. Li, H .Chin, M. Sohal, T. Jackson, S. Claridge, E. Sammut,
C.A. Rinaldi
185
25COMPLEX ELECTROPHYSIOLOGY INTERVENTION IN A PATIENT WITH AN INFERIOR
VENA CAVA FILTER: CASE REPORT
Z. Starek, J. Jez, F. Lehar, J. Wolf
2014
32INCIDENCE OF UNRESOLVABLE PNS DURING THE PERI-OPERATIVE PERIOD RELATED
TO THE QUARTET™ LV LEAD
R. Corbisiero1, M. Cao2, S. Beau3, S. Allison4, D. Schleinkofer 5, T.G. Farazi 6, S Zhang 7,
N. Harbert 8, D Martin 9
Browns Mills, NJ, 2 Rosemead, CA, 3 Little Rock, AR, 4 Birmingham, AL, 5 Fort Wayne, IN, 6 Sunnyvale,
CA, 7 Sylmar, CA, 8 Plano, TX, 9 Burlington, VT, USA
1
33COMPARISON OF ALL CAUSE RE-HOSPITALIZATION RATES AT 30, 90 AND 180
DAYS POST HEART FAILURE HOSPITALIZATION FOR QUADRIPOLAR AND BIPOLAR
V. Ribatti 1, G.B. Forleo 1, A. Pollastrelli 1, R. Bharmi 2, N. Dalal 2, G. Panattoni 1, V. Schirripa
1
, G. Magliano 1, D. Sergi 1, L. Papavasileiou 1, D. Della Rocca 1, L. Santini 1, F. Romeo 1
34
1
Rome, ITALY, 2 Sylmar, CA, USA
QUADRIPOLAR LEFT VENTRICULAR LEAD IMPROVES HEMODYNAMIC RESPONSE IN
PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY
B. Urbanek, M. Chudzik, J.K. Wranicz
Lodz, POLAND
35SONR® A NEW ALGORITHM FOR CARDIAC RESYNCHRONIZATION THERAPY. CASE
REPORT
R. Luise, G. De Berardinis, G. Palermo, T. Civitarese, S. Cicogna
36
37
L’Aquila, ITALY
ASSESSMENT OF INFLUENCE OF LEVOSIMENDAN ON THE PROCESS OF HEART
REVERSE REMODELING IN PATIENTS WITH DILATED CARDIOMYOPATHY AND
IMPLANTED CRT
R. Marchenko, S. Durmanov, N. Makarova, A. Kozlov, V. Bazilev
Penza, RUSSIA
ASSISTANCE OF A TRAINING DOCTOR FROM ANOTHER HOSPITAL DURING LEAD
EXTRACTION. UNDERESTIMATED RISK FACTOR OF TLE COMPLICATIONS?
1
38THE EFFECT OF DIABETES ON HEART FAILURE OUTCOME IN A LARGE QUADRIPOLAR
CRT-D REGISTRY
D. Martin1, M. Cao2, S. Beau3, S. Allison4, D. Schleinkofer5, T.G. Farazi 6, S. Zhang 7,
N. Harbert 8, R. Corbisiero 9
Burlington, VT, 2 Rosemead, CA, 3 Little Rock, AR, 4 Birmingham, AL, 5 Fort Wayne, IN, 6 Sunnyvale,
CA, 7 Sylmar, CA, 8 Plano, TX, USA, 9 Browns Mills, NJ, USA
1
186
39NON INVASIVE HEMODYNAMIC ANALYSIS IN CRT PATIENTS WEARING
QUADRIPOLAR LEFT VENTRICULAR LEADS
L. Santini, F. Condemi, J. Legramante, M. Gugliotta, V. Doldo, L.M. Santucci, P. Crobeddu,
D. Sergi, G. Magliano, G.B. Forleo, F. Romeo
Rome, ITALY
1
40SUPPRESSION OF PREMATURE VENTRICULAR CONTRACTION WITH MULTIPOINT LV
PACING IN CARDIAC RESYNCHRONIZATION THERAPY RECIPIENTS
A. Cuko 1, Z. Calovic 1, L.C. McSpadden 2, F. Qu 2, K. Ryu 2, M. Baldi 1, A. Pappone 1, M. Saviano 1,
L. Giannelli 1, C. Ciaccio 1, A. Petretta 1, C. Catalano 1, M. Moscatiello 1, R. Vitale 1, B. Ionescu 1,
G. Vicedomini 1, V. Santinelli 1, C. Pappone 1
41
Cotignola, RA, ITALY, 2 Sylmar, CA, USA
PREVALENCE FOR ADDITIONAL TREATMENT WITH THE MITRACLIP® DEVICE
IN PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY AND PERSISTENT
SEVERE FUNCTIONAL MITRAL REGURGITATION
J. Roeing Genannt Noelke, M. Grett, I.M. Breker, T. Butz, M. Christ, S. Tzikas,
R. Wennemann, H.J. Trappe
Herne, GERMANY
1
42IMPROVING CARDIAC IMPLANTABLE ELECTRONIC DEVICE IMPLANTATION
STANDARDS THROUGH STANDARDISED COMPLICATION REPORTING. INTRODUCING
MORTALITY CENSORING
43SINGLE CENTER EXPERIENCE WITH SUBCUTANEOUS IMPLANTABLE
CARDIOVERTER-DEFIBRILLATOR (S-ICD)
L. Hodacova, J. Petru, L. Sediva, K. Holdova, P. Neuzil
44SAFETY OF MAGNETIC RESONANCE IMAGING IN PATIENTS WITH IMPLANTABLE
SUBCUTANEOUS CARDIOVERTER-DEFIBRILLATOR (S-ICD)
K. Holdova, L. Hodacova, J. Petru, J. Keller, M. Janotka, J. Brada, J. Vymazal, J. Weichet,
P. Neuzil
45THE SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR: PERSONAL EXPERIENCE IN A
LARGE VOLUME ICD LEAD EXTRACTION CENTRE
S. Viani, E. Soldati, G. Zucchelli, A. Di Cori, L. Segreti, L. Paperini, A. Boem, D. Levorato,
G. Branchitta, D. Andreini, M.G. Bongiorni
Pisa, ITALY
187
2014
2014
46EVALUATION OF A YOUNG POPULATION CANDIDATE FOR S-ICD. IS INABILITY TO
PACING AN IMPORTANT LIMITATION?
P. Galvão, D. Cavaco, P. Adragão, F. Morgado, P. Carmo, F. Costa, S. Carvalho, K. Reis
Santos, M. Abecasis, M. Mendes
Lisbon, PORTUGAL
Naples, ITALY
Algiers, ALGERIA
Naples, 2 Padua, 3 Palermo, 4 Milazzo, ME, 5 Brescia, 6 Venice, 7 Piacenza, 8 Milan, 9 Rome,
ITALY
47HYPERTROPHIC CARDIOMYOPATHY: SUBCUTANEOUS ICD SYSTEM IS BETTER THAN
TRANSVENOUS ICD. A CASE REPORT
E. Ammendola, G. Del Giorno, L. Santangelo, D. Masarone, G. Limogelli, G. Pacileo,
l.M.G. Russo, R. Calabrò
48
“ASYMPTOMATIC” RIGHT VENTRICLE PERFORATION BY IMPLANTABLE
CARDIOVERTER-DEFIBRILLATOR LEAD IN A CHILD
D. Lebedev, E. Grehov, D. Chuev, V. Lebedeva, E. Zubarev, E. Vasichkina, M. Samohvalova
49THE EFFECTIVENESS OF ANTI TACHYCARDIA PACING IN SELECTED PATIENTS WITH
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
H. Zouzou, D. Nibouche
50IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND PREVENTION OF SUDDEN
CARDIAC DEATH: A SINGLE CENTRE REPORT
K. Polymeropoulos, A. Vosnakidis, P. Ioannidis, G. Maligos, J. Zarifis
51TRENDS OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE DATA DURING TIME
FRAMES PRECEDING DEATH. RESULTS FROM THE HOMEGUIDE REGISTRY
A. D’Onofrio 1, G. Buja 2, P. Vaccaro 3, L. Vasquez 4, D. Pecora 4, A. Vaglio 6, L. Rossi 7,
L. Giovene 8, F. Chiusso 8, R. P. Ricci 9
1
188
2014
SCIENTIFIC AND GENERAL
INFORMATION
2014
SCIENTIFIC INFORMATION
Faculty
Guidelines for Chairs:
* find yourself in the Meeting Room at least 10 minutes before the beginning of the Session
* respect the timing assigned to the Session and to each presentation
* all presentations, discussions and questions must be in English.
Guidelines for Speakers:
* follow the instructions indicated at the paragraph “Audiovisual Instructions”
* find yourself in the Room assigned for presentation at least 10 minutes before the
beginning of the Session
* respect the timing allowed for your presentation
* all presentations, discussions and questions must be in English
Audiovisual Instructions
A Slide Centre is located in the Congress Venue at Floor -2 .
ONLY PC DATA PROJECTION IS AVAILABLE DURING THE CONGRESS
Each room is provided with a laptop. Therefore the use of one’s laptop is not allowed.
Should speakers have their personal laptop or USB key, they are kindly requested to go
to the Slide Centre to have their presentation copied.
The presentation will be then forwarded through a LAN network from the Slide Centre
directly to the computer in the presentation room.
We kindly recommend speakers to contact the Slide Centre the day before presentation.
If this is not possible, please visit the Slide Centre as below:
* 45 minutes before for Power Point presentation on USB key
* 1 hour before for Power Point presentations on Personal Computer
Free Papers
Free Paper Sessions are held from Tuesday, December 2 to Thursday, December 4, 2014.
Guidelines for Speakers:
* find yourself in the Room assigned for presentation at least 10 minutes before the
beginning of the Session to meet the Chairs
* you will have 10 minutes at disposal for the speech and 5 for discussion
* respect the timing allowed for your presentation
* please note that the presenting author must be registered to the Symposium to give
his/her presentation
192
Instructions for Power Point presentations:
* Standard fonts should be used (included in Windows XP SP3/Vista and Office 2007)
On the contrary, if other fonts are used, please bring them to the Slide Centre, at least
6 hours before the presentation, informing the technicians who will be present there.
* To make the download of the presentation at the Slide Centre, USB device is advisable.
However, the presentation can be downloaded from a personal computer by visiting
the slide centre at least 3 hours before the presentation.
Posters
All delegates are invited to visit the posters which are displayed in the Corridor at Floor -1
Guidelines for poster display
* your poster has been given a number and shall be fixed on the poster board marked
with the same number
* poster size must be cm. 75 (width) x cm. 150 (height) and the format must be VERTICAL
Posters session December 3: must be hanged on December 3 from 08:00 to 09:00 and
removed on December 3 from 18:00 to 19:00.
Posters session December 4: must be hanged on December 4 from 08:00 to 09:00 and
removed on December 4 from 18:00 to 19:00.
All posters that have not been collected on December 3 and 4 will be thrown away and
the Organizing Secretariat is not responsible for them
* you are kindly asked to stand by your Poster from 10.30 to 11.00 and from 17:00 to
17:30 on December 3 and 4 according to the day of your poster for possible questions
by Congress delegates. Otherwise, please hang a note to inform when you will be
available
* pins and tape will be at your disposal at the Congress Venue, in case you need them
* please note that the presenting author must be registered to the Congress to give his/
her presentation
193
2014
2014
Luncheon Panels
The participation in the Luncheon Panels is reserved only to duly registered delegates
on a first come first served basis, according to room capacity. You will find the coupons
of the Luncheon Panels inside your badge. The coupons are distinguished by different
colors according to the day and will be collected at the entrance of the room before the
beginning of the session.
TUESDAY, DECEMBER 2 · 12.30/14.00
BUSINESS MEETS MEDICINE: PROCESS OPTIMIZATION IN CARDIAC RHYTHM
MANAGEMENT (PG. 43 - Orange 1)
WEDNESDAY, DECEMBER 3 · 12:30/14:00
MONITORING ISCHEMIA BY CIED: THE INSIGHT STUDY (PG. 84 - Orange 1)
ATRIAL FIBRILLATION PREVENTION AND TREATMENT(PG. 85 - Tarragona)
THURSDAY, DECEMBER 6 · 12:30/14:00
UPDATE IN CARDIAC PACING (PG. 128 - Tarragona)
NEW TECHNOLOGY FOR HEART FAILURE TREATMENT BARORFLEX ACTIVATION THERAPY
(PG. 130 - Pola)
194
2014
Congress venue
Ergife Palace Hotel
Via Aurelia, 619
00165 Rome – Italy
Phone +39 06 66 441
www.ergifepalacehotel.com
Language
The official language of the Congress is English. Simultaneous translation will not be
provided.
Opening Ceremony and Welcome Reception
The official Opening Ceremony of the Congress takes place on Tuesday, December 2 in
Leptis Magna 4 at 17:30 hrs.
Prof. Massimo Santini, Chairman of the Congress, and the Representatives of most of the
National and International Societies, welcome the Participants.
Magistral Lectures, given by Prof. J.D. Fisher (New York-NY, USA) and Dott. R.P. Ricci
(Rome, I) will follow.
After the Opening Ceremony, all participants are invited to attend the Welcome Reception
which takes place in the restaurant of Ergife Palace Hotel at ground floor.
Access to the Opening Ceremony and Welcome Cocktail is included in the registration fee.
Registration
Registration Desk Opening hours
• December 2 7:30 - 17:30 hrs.
• December 3-4 8:00 - 19:00 hrs.
• December 5 8:00 - 13:30 hrs
Delegate registration fee
On-site registration fee
€ 1108,00 (22% VAT included)*
*Should Italian VAT increase, registration fees will be revised accordingly.
- Payment is possible only by credit card
- Daily registration is not prouded
The registration fee entitles delegates to the following:
> entry to all Scientific Sessions including Luncheon Panels and Exhibition Area
> admission to the Opening Ceremony and Welcome Reception
> scientific material
> abstract book available on the official Congress website
195
GENERAL INFORMATION
The Meeting will take place in Rome, at the Ergife Palace Hotel. It combines a comfortable
accommodation solution with a large and efficient Congress Centre.
2014
Exhibitor registration fee
On-site registration fee
€ 444,00 (22% VAT included)*
GENERAL INFORMATION
*Should Italian VAT increase, registration fees will be revised accordingly.
- Payment is possibile only by credit card
- Daily registration is not provided
The registration fee entitles exhibitors to the following:
• entry to exhibition area and does not include any scientific material
Badges
Admission to the Sessions is restricted to registered participants wearing their name
badge.
Lost badges are replaced against the payment of a handling fee of € 50,00 (VAT 22%
included) and upon proof of original registration.
Accompanying persons are not entitled to attend the congress.
Delegate: violet
Faculty: red
Presenting: blue
Exhibitors: yellow
Press: green
Attendance Certificates
Certificate of attendance is issued on request to all registered participants at the end of
the Congress.
Exhibition
A technical, pharmaceutical and publication exhibition takes place in the Congress
Venue throughout the scientific works.
Exhibition opening hours
• December 2-3-4 8:30 - 17:30 hrs.
• December 5
8.30 - 14:00 hrs.
Exhibition desk opening hours
• December 2-3-4
7:30 - 17:00 hrs.
7:30 - 14:00 hrs.
• December 5 Cloakroom
A cloakroom is at participants’ disposal at their own charge at floor 0 in the Congress
Venue. Delegates are requested not to leave their personal belongings after the closingtime.
196
2014
Bar & Restaruant
Insurance
The congress organizers cannot accept liability for personal injuries sustained or for loss
of or damage to property belonging to congress participants, either during or as a result
of the congress. Please check the validity of your own insurance.
NO-SMOKING
Smoking in the Congress area is not allowed. MOBILE PHONES
Delegates are kindly requested to set their mobile phones on silent
mode in the Rooms where scientific sessions are being held.
Travel and Accommodation Desk
The Travel and Accommodation Desk is at participants’ disposal in the Congress Venue
for the following services:
• flight and train reservations and information
• hotel booking
• transfer services
• car rental
• guided tours of Rome
• pre-post congress tours
• tourist information
Travel and Accomodation Desk opening hours:
• December 2 7:30 - 17:30 hrs.
• December 3-4 8:00 - 19:00 hrs.
8:00 - 13:30 hrs.
• December 5 Hotel Accommodation
Official Housing Bureau of the Conference at your disposal in the meeting Venue
for all the duration of the Congress:
AIM Group International – AIM Congress – Milan Office
Via G. Ripamonti, 129 – 20141 Milan, Italy
Phone: +39 02 566011 – Fax: +39 02 56609043
E-mail: [email protected]
197
GENERAL INFORMATION
A bar and a restaurant are located at floor 0 is at participants’ disposal at their own
charge
2014
GENERAL INFORMATION
Public transportation
• Subway
The 2-line system has an X shape, with both lines meeting at the Central Railway Station
Termini.
Line A links Anagnina, in the south, with Battistini.
Line B goes from Laurentina to Rebibbia.
The metro operates from 5:30 until 23:30 hrs. (0:30 hrs. on Saturdays) every 3-4
minutes during rush hours, every 5-6 minutes during the day and every 8-10 minutes
early morning and late evening.
• Taxi
Licensed taxis are white, have an identification number, and are equipped with a taxi-meter.
A taxi can be called at the following telephone numbers: 063570, 064994, 065551.
• Buses
There are two companies providing bus service in Rome: ATAC and COTRAL.
Lines and timetables may be consulted on the websites:
http://www.atac.roma.it
http://www.cotralspa.it
Currency
According to the Monetary Union, the official currency is the Euro.
Bank and exchange
Banks are open from Monday to Friday, from 8:30 to 13:30 hrs. and some of them again
in the afternoon from 14:45 to 15:45 hrs. (afternoon opening may vary depending on the
bank). Banks are closed on Saturday and Sunday.
Weather
December weather in Rome is generally cold. Rain is also possible.
The temperature doesn’t rise over 10°.
Electricity
Voltage in Italy is mostly 220 volts - 50 Hz. Foreign appliances could require an adapter.
Tipping
Service is usually included in the bill in bars and restaurants, but tips are welcome.
Useful links
• www.romaturismo.it
• www.metroroma.it
• www.adr.it
• www.rome.info
• www.liveinrome.com
198
GENERAL INFORMATION
2014
199
CONGRESS VENUE AND EXHIBITION FLOORPOLAN
2014
Congress Venue and Exhibition Floorplan
Booth n.
AIAC - Italian Association of Arrhythmology and Cardiac Pacing............................ 10
ARRHYTHMIA ALLIANCE.......................................................................................... 8
ATRIAL FIBRILLATION............................................................................................ 28
BIOTRONIK ITALIA................................................................................................... 2
BOEHRINGER INGELHEIM...................................................................................... 15
BOSTON SCIENTIFIC.........................................................................................6+6B
BRUNO FARMACEUTICI......................................................................................... 20
CARDIAC RHYTHM NEWS...................................................................................... 29
CARDIAC SCIENCE................................................................................................ 24
CARDIOSTIM 2016................................................................................................ 25
COOK MEDICAL - William Cook Europe................................................................. 16
CVRX.................................................................................................................... 12
ECAS European Cardiac Arrhythmia Society............................................................ 9
EUMACO Helth Care System................................................................................. 21
FIAB...................................................................................................................... 19
IL CUORE DI ROMA ONLUS.................................................................................... 23
JHRS...................................................................................................................... 7
MEDICO.................................................................................................................. 3
MEDITERRANEAN CARDIOLOGY MEETING............................................................. 26
MEDTRONIC ITALIA................................................................................................. 5
MERIT MEDICAL.................................................................................................... 30
MICROLIFE - Colpharma......................................................................................... 4
NUUBO ................................................................................................................ 11
SANIMPRESA ....................................................................................................... 13
SORIN GROUP ITALIA............................................................................................ 18
ST. JUDE MEDICAL.................................................................................................. 1
VENICE ARRHYTMIAS .......................................................................................... 27
VIOLATECH........................................................................................................... 14
WISEPRESS ......................................................................................................... 22
WSA – WORLD SOCIETY OF ARRHYTHMIAS........................................................... 17
200
MAPPA
201
CONGRESS VENUE AND EXIBITION FLOORPLAN
2014
2014
EXHIBITION GUIDE
2014
AIAC - Italian Association of Arrhythmology and Cardiac Pacing
BOOTH n. 10
EXHIBITION GUIDE
Via Biagio Petrocelli 226
00173 Rome, Italy
Phone: +39 06 42020412
Fax: +39 06 42020037
Website: www.aiac.it
Contact Persons: Dott. Giovanni Luca Botto (President),
Dott. Emanuele Bertaglia (National Secretary).
AIAC (Italian Association of Arrhythmology and Cardiac Pacing) is an organization of physicians,
scientists and allied professionals throughout the Italian country dedicated to the study and
management of cardiac arrhythmias. The mission of the Association is to improve the care of
patients by promoting research, education and training for arrhythmias management, providing
leadership toward optimal healthcare policies and standards. The Association counts more and
less 1000 members and a board of twelve trustees is elected by the members at the biennial
meeting of the Association. The Executive Committee is represented by the President, one
VicePresident, a Treasurer and a Secretary. Since 2006 the new president is nominated in
advance (elected president).
The present Board members are: Botto (President), Boriani (Elected-President), D’Onofrio
(Vicepresident), Bertaglia (Secretary), Pisanò (Treasurer), Calvi (Coordinator of Regional Presidents),
Golzio, Maglia, Nissardi, Santini, Padeletti (past president) and Lunati (Editorial Director).
AIAC has several Committees, Task Forces and Registries, which have the task to design the
scientific and education strategy of the Society (see the website for more details).
AIAC has website (www.aiac.it) which can be visited without any charge.
Furthermore, AIAC has an intense research activity, organizing multicentric trials on various topics
in the field of cardiac pacing and arrhythmias.
AIAC is a member of the Italian Federation of Cardiology and represents the Italian Arrhythmology
in the Italian Government Institutions and in the European Society of Cardiology.
204
2014
ARRHYTHMIA ALLIANCE
BOOTH n. 8
Arrhythmia Alliance is a coalition of charities, professional medical organisations and industry
groups that works to promote the timely diagnosis and effective management of arrhythmias. By raising awareness and campaigning for the improved detection and care of heart rhythm
disorders, Arrhythmia Alliance aims to extend and improve the lives of the millions around the
world that these conditions effect.
ATRIAL FIBRILLATION
BOOTH n. 28
Corso Matteotti 200
51016 Montecatini Terme, Italy
Phone: +39 0572911864
Fax: +39 0572904259
Website: www.bk1.it/events
Contact Person: Chiaralberta Valentini
The XI edition International Meeting on Atrial Fibrillation and Hearth Failure will
take place on February, 19-20 2015. This confirms a great interest, due to the
presence of an international faculty with the highest level of experience.
This edition will deal with the following main topics:
• The genome of the AF patient
• Atrial fibrosis as the only pathologic substratum
• Rate control easy in-hospital but in real life?
• New hopes in rhythm control pharmacology
• Dronedarone, Ranolazine, Vernakalant: new fighters to come
• CRT and AF: odd couple or possible coexistence?
• New and easy ablation techniques enlarge the horizon
• How to make the ablation procedure really safe
• How to reproduce the positive results of the ablation procedures
205
EXHIBITION GUIDE
PO Box 3697, Stratford Upon Avon
Worwickshire, cv 37 89L, United Kingdom
Phone: +44 1789450787
Fax: +44 1789450682
Website: www.aa-international.org
Contact Person: Becky Hughes
2014
BIOTRONIK ITALIA
BOOTH n. 2
EXHIBITION GUIDE
Via delle Industrie 11
20090 Vimodrone, Italy
Phone: +39.02.274394.200
Fax: +39 0227 4394313
Website: www.biotronik.com
Contact Person: Vita Mangogna
One of the world’s leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK
is headquartered in Berlin, Germany, and represented in over 100 countries by a global workforce
of more than 5600 employees. Several million patients have received BIOTRONIK implants
designed to save lives and improve quality of life. Our mission is to develop and manufacture
products of the highest quality that save patients’ lives and improve their quality of life.
BIOTRONIK strives to incorporate our vision of “excellence for life” in everything we do.
BOEHRINGER INGELHEIM
BOOTH n. 15
Via Lorenzini 8
20139 Milan, Italy
Phone: +39 025355.1
Fax: +39 02 5355222
Website: www.boehringer-ingelheim.com
Contact Person: Marta Scoccianti
Boehringer Ingelheim’s corporate culture is characterised by its guiding principles (Leitbild) and
its vision
Value through Innovation
Our Leitbild defines our corporate values and guides our business, innovation, technology and
organisation and thus our corporate culture.
Our Value through Innovation vision has guided and will continue to guide our company. It is the
driver and strength of our corporate principles and values.
206
2014
BOSTON SCIENTIFIC S.P.A.
BOOTH n. 6+6B
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices with
approximately 23,000 employees and 12 manufacturing facilities worldwide. For more than 30
years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad
and deep portfolio of innovative products, technologies and services across a wide range of
medical specialties. The Company’s products help physicians and other medical professionals
improve their patients’ quality of life by providing alternatives to surgery.
For more information, please visit www.bostonscientific-international.com
BRUNO FARMACEUTICI
BOOTH n. 20
Via Delle Ande, 15
00144 Rome, Italy
Phone: +39 06 6050601
Fax: +39 06 60506050
Website: www.brunofarmaceutici.org
Contact Person: Rosanna Pennasilico
Bruno Farmaceutici SpA is a fast-growing Italian pharmaceutical company focused on researching,
developing and offering the market advanced therapeutic solutions and improved formulations.
Since a long time Bruno is the Italian market leader in the solid oral corticosteroid segment and
in the Metformin market for Type-2 diabetes.
In the recent years Bruno has evolved into a more complete and mature company, developing
advanced and improved formulations of Alendronate, Flecainide and Ciprofloxacin for otologic
use. Also a new breakthrough technology in the Ophtalmic market for the dry-eye syndrome
has been developed and launched internationally in the last two years. Still based in Italy with
a strong focus on the internal market, Bruno ha salso started expanding abroad with the final
purpose of making available its products in several markets throughout Europe.
207
EXHIBITION GUIDE
Viale Forlanini 23
20134 Milan, Italy
Phone: +39 02 269831
Fax: +39 02 26993230
Website: www.bostonscientific-international.com
Contact Person: Grazia Bellarte
2014
CARDIAC RHYTHM NEWS
BOOTH n. 29
44 Burlington Road
London SW6 4NX, United Kingdom
Phone: +44 2077368788
Fax: +44 2077368283
Website: cardiacrhythmnews.com
Contact Person: Noora Lobo
EXHIBITION GUIDE
Cardiac Rhythm News is the one-stop source for news, views, comment and controversy. It is
an editorially independent newspaper that reflects the voice of the cardiac rhythm management
specialist.
CARDIAC SCIENCE
BOOTH n. 24
Via Francesco Corselli 11
29122 Piacenza, Italy
Phone: +39 0523 1901052
Fax: +39 0523 1885099
E-Mail: [email protected]
Website: www.cardiacscience.it
Contact Person: Stefano Santini
Cardiac Science: At the Heart of Saving Lives™
Cardiac Science designs, manufactures and markets Powerheart® automated external
defibrillators (AEDs) and related services that facilitate successful deployments. Our growing
list of AED placements include today’s Fortune 500® businesses, physician offices, schools,
restaurants, malls, airports, sports fields and other public places to combat sudden cardiac arrest
(SCA), the leading cause of the death in the United States.
Cardiac Science extends lives by providing the public and healthcare professionals with lifesaving devices. We are committed to eliminating needless delays between sudden cardiac arrest
(SCA) and life-saving defibrillation by ensuring automated external defibrillators (AED)s are
accessible and simple to use. Our innovative, patented Powerheart AEDs provide assistance to
SCA victims in all walks of life.
Protecting Communities Through Public Access Defibrillator (PAD) Programs
Our life-saving defibrillators are needed everywhere the public can access them to save lives.
For practical purposes, that means at home or wherever two or more meet: at work, school, in
restaurants, malls, airports, libraries, and other public places.
A Subsidiary of Opto Cardiac Care Limited.
Cardiac Science is a global medical device company and a subsidiary of Opto Cardiac Care Ltd.
Our global capabilities include direct and indirect sales personnel and distribution in more than
100 countries and an extensive worldwide service network.
Headquartered in Waukesha, Wisconsin, just west of Milwaukee, the company also has a
manufacturing facility in Deerfield, Wisconsin, as well as operations in California, Denmark,
France, Italy and the United Kingdom.
208
2014
CARDIOSTIM 2016
BOOTH n. 25
World Congress on Cardiac Electrophysiology
The next edition will be held on June 8-11, 2016 in Nice, France. It is a congress dedicated to
Electrophysiology and device therapies, which was created by Jacques Mugica, MD in 1978. In
2014, there were over 5650 participants from all over the world, 700 speakers and chairmen,
and more than 200 scientific sessions. The Congress is unique as programs are organized by
Europeans, in close relationship with North Americans, South Americans and Asians, and offers a
platform for the industry to present its latest technological advances.
The language of the congress is English.
COOK MEDICAL - WILLIAM COOK EUROPE
BOOTH n. 16
Sandet 6
4632 Bjaeverskov, Denmark
Website: www.cookmedical.com
Contact Person: Nunzia Radogna
Cook Medical - Pioneering Lead Extraction devices and techniques for 25 years.
The Advanced Platform devices give you the Cook Mechanical Advantage throughout the most
challenging Lead Extraction™ procedures. These devices give you a secure traction source,
advanced vessel access, dilate tissue along the entire length of the lead and stabilize binding
sites.
209
EXHIBITION GUIDE
52-54 quai de Dion-Bouton
CS80001 Puteaux Cedex, France
Phone: +33 1 47 56 24 56
Fax: +33 1 47 56 24 55
Email: [email protected]
Website: www. cardiostim.com
Contact Person: Jocelyne Toulouse, PA to Dr Philippe Ritter, Chairman
2014
CVRX
BOOTH n. 12
EXHIBITION GUIDE
C/O Gesis Srl, Centro Direzionale Colleoni,
Palazzo Astrolabio, Via Cardano 2
20864 Agrate Brianza, Italy
Phone: +33613865709
E-Mail: [email protected]; [email protected]
Website: www.cvrx.com
Contact Person: Jean-Philippe Zana
CVRx® developed a proprietary implantable technology for the treatment of high blood pressure
and heart failure. Barostim neo uses CVRx-patented technology that is designed to trigger the
body’s own natural blood flow regulation system to treat these conditions. Barostim neo can be
adjusted to meet each patient’s individual therapy needs.
ECAS EUROPEAN CARDIAC ARRHYTHMIA SOCIETY
BOOTH n. 9
2 Place Delibes
13008 Marseille, France
Phone: +33(0)953 677 241
Website: www.ecas-heartrhythm.org
Contact Person: Samuel Levy
ECAS is a non-profit Society registered in August 2004 and located in Marseille, France’. Objective:
of the Society: to promote excellence in the care of patients with cardiac rhythm disorders and
promote education of the general public.
Various categories of membership: MDs, Scientists, fellows, technicians, nurses (See website).
TEL: +33 4 89 14 45 33
Cell: +33 6 26 07 55 74
e-mail: [email protected]
ECAS Goals
The missions of ECAS are to promote excellence in the care of patients with cardiac arrhythmias
by: fostering continuing medical education And training; by the design, performance, coordination
and interpretation of multicenter basic and clinical research aimed at improving therapies
providing leadership toward optimal healthcare policies and standards; supporting applied
and clinical research; improving communication with the medical community and health care
authorities; organization of symposia, meetings and workshops Education of the General Public
related to cardiac arrhythmias.
210
2014
EUMACO Health Care System
BOOTH n. 21
EUMACO is the leading company in telemedicine in Italy. We offer solutions for Telecardiology and
telemonitoring with the purpose of monitoring the patient through the recording and transmission
of medical parameters. EUMACO’s organization permits to offer both products and turnkey
projects developed on the specific technological and logistic needs of each single customer.
We operate in the Italian market since 2006 and our customers are public and private hospitals,
public administrations, pharmaceutical companies, private cardiologists, gp, and so on.
Eumaco’s engineer staff offers technical support services for our devices, create softwares for
the management of the devices when required, and constantly look for new technologies to
provide the best possible solutions to our customers.
FIAB SPA
BOOTH n. 19
Via Costoli 4
50039 Vicchio (Fi), Italy
Phone: +39 055.8497999
Fax: +39 055.8497979
Website: www.fiab.it
Contact Person: Roberta Bonini
FIAB is an Italian manufacturer of temporary cardiac pacing devices as diagnostic and pacing
lead, trans-esophageal cardiac pacing leads and stimulators, external pacemaker, Esotest device
for the esophageal temperature monitoring, PSA and accessories for cardiac stimulation.
211
EXHIBITION GUIDE
Viale Regione Veneto, 19
35127 Padua, Italy
Phone: +39 049.7800837
Fax: +39 049.7806979
Website: www.eumaco.it
Contact Person: Ilena Stecconi
2014
IL CUORE DI ROMA ONLUS
BOOTH n. 23
EXHIBITION GUIDE
Cardiovascular Department,
S.FilippoNeri Hospital
Via G. Martinotti 20
00135 Rome, Italy
Phone: +39 06 3306 3191
Fax: +39 06 3306 2489
Website: www.ilcuorediroma.org
ContactPerson: Giulia Carganico
“Il Cuore di Roma ” is a non-profit organization for Social Utility (Onlus). It pursues only charitable
initiatives in social and health care areas for cardiovascular diseases. It works in the field of
prevention, therapy, rehabilitation and information for patients, also encouraging initiatives for
social recoveries of heart patients. A quarterly magazine “Il Cuore di Roma” dealing with the main
cardiological news is also available.
JHRS
BOOTH n. 7
Kiyo Tokyo Building 6F, 2-5 Kanda
Ogawamachi
101-0052 Tokyo, Japan
Phone: 81-3-5283-5591
Website: jhrs.or.jp
Contact Person:
In 2015, the Japanese Heart Rhythm Society will be merged with the Japanese Society of
Electrocardiology and a new body bearing the name Japanese Heart Rhythm Society will be
established. It is believed that the merger between the JHRS and JSE will promote further
development in the field of arrhythmia via a multidisciplinary approach spanning pathology,
diagnosis and treatment. In addition, the merger is also expected to promote a closer relationship
between basic and clinical electrocardiology.
As to the next congress, the 30th annual meeting of the JHRS will be held jointly with the JSE in
Kyoto from July 29 to August 1, 2015. To reflect our hope of helping to shape a brighter tomorrow,
we propose the meeting be held under the theme Prologue to a Glorious Future. The JHRS and
JSE welcome and encourage the submission of abstracts from abroad and the participation of
international guests.
212
2014
MEDICO SPA
BOOTH n. 3
40 years for the heart with the heart - this is our long story of commitment to the advancement
of cardiac pacing, run by people motivated by life.
Medico’s principal interest is Cardiac Rhythm Management (pacing and cardiac resynchronization
systems). All along its 40 years of activity MEDICO SPA has been investigating and developing
new cardiac stimulation solutions to ensure top technology pacing devices to physicians and
patients. The corporate philosophy is founded on the principles of Quality, Safety and Innovation
with the ambition to supply physicians with suitable tools for optimizing the pacing therapy in
each single patient and to ensure a better quality life. Come to visit us in our booth, we will show
our innovations in detail.
MEDITERRANEAN CARDIOLOGY MEETING
BOOTH n. 26
c/o Adria Congrex srl – Organizing Secretariat
Via Sassonia, 30 47921 Rimini
Phone: +39 0541 305822 +39 0541.305820
Fax: +39 0541 305842
Website: www.mcmweb.it
Contact Person: Lucia Bini
In April 2015 Catania (Italy) will host the 7th edition of the Mediterranean Cardiology Meeting
(MCM). Over thousand and five hundred participants attended our last meeting with a strong
international attendance which confirmed the highest interest aroused by this biannual meeting.
An outstanding Faculty, selected between the leading experts on these fields, will provide the
highest quality teaching, highlighting the current state and limitation of scientific knowledge
and presenting a detailed analysis of the most recent developments in the treatment of:
Atrial Fibrillation, Sudden Cardiac Death, Heart Failure, Acute Coronary Syndromes, Global
Cardiovascular Prevention, Syncope, Genetics and Cardiac Monitoring technologies. The main
target of the meeting is to give the latest update on Clinical & Interventional Cardiology and it is
addressed to cardiologists, internists, first aid clinicians, physicians of general medicine, fellows,
nurses and technicians with high interest in the whole management of cardiac pathologies.
213
EXHIBITION GUIDE
Via Pitagora 15
35030 Rubano, Italy
Phone: +39 0498976755
Website: www.medicoweb.com
Contact Person: Gabriella Nigro
2014
MEDTRONIC ITALIA SPA
BOOTH n. 5
EXHIBITION GUIDE
Via Varesina 162
20156 Milan, Italy
Phone: 02.24137.1
Fax: 02.241381
Website: www.medtronic.it
Contact Person: Maria Rosa Santeramo
Medtronic is the world’s largest medical technology company, offering an unprecedented breadth
and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and
extending life. Last year, more than 10 million people benefited from our medical therapies, which
treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions.
With a global reach that extends to more than 140 countries, we have a deep understanding
of many universal healthcare challenges. We’re using our experience, extensive partnerships,
and the passion of 49,000+ employees to help transform healthcare worldwide by improving
outcomes, expanding access, and enhancing value.
MERIT MEDICAL
BOOTH n. 30
Amerikalaan 42
6199 Ae Maasctricht-Airport, Netherlands
Phone: +31 43 3588222
Fax: +31 43 3555221
Website: www.merit.com
Contact Person: Luisa Prearo
Merit Medical offers diverse, integrated portfolio of products that support radial procedures from
preparation to close. What’s more, you can pick and choose which of our products you want in a
custom procedure pack to optimise your clinical, procedural and economical efficiency. Our new
radial products include the PreludeEASE™ Hydrophilic Sheath Introducer, designed to deliver
smooth transitions, and the HeartSpan® Steerable Sheath Introducer that delivers responsive
control and a softer, flexible tip. The steerable sheath works in unison with our HeartSpan®
Transseptal Needle. We will also be showcasing our Worley™ Advanced LV Lead Delivery System,
proven to decrease failed LV lead implants, improve LV lead location, and shorten procedure times.
Merit Medical is an international company with leading-edge manufacturing and distribution
facilities supported by dedicated sales representatives, customer service professionals, and
clinical experts who are globally ready to support you.
214
2014
MICROLIFE - COLPHARMA
BOOTH n. 4
Microlife is one of the world leaders in the development and manufacturing of medical
diagnostic equipment for home monitoring and institutional use. Blood pressure monitors,
digital thermometers, asthma monitors are Microlife’s core business. Our vision is to empower
consumers through our products and services to be able to manage and promote their own
health.
We strive for high quality, reliability and accuracy. Our medical devices are clinically validated
and guarantee the highest level of safety. Microlife’s technology provides you with accurate and
reliable solutions for consumer and professional target.
In 2006, Microlife patented the technology Microlife AFIB ( Atrial Fibrillation ) for the detection
of Atrial fibrillation, a major risk factor for stroke ischemic stroke , with an oscillometric blood
pressure monitor . In 2013 NICE - UK, AFIB validation.
NUUBO
BOOTH n. 11
Calle Toronga, 21 Local 1
28043 Madrid, Spain
Phone: +39 913604431
Fax: +39 913605649
Website: www.nuubo.com
Contact Person: Lidia Jara
Nuubo envisions wireless health and remote monitoring of physiological parameters as a simple,
transparent and non-intrusive experience that should be available to anyone, anywhere.
Nuubo is a wearable wireless medical device company, with headquarters based in Madrid
(Spain) and R&D labs and manufacturing facilities in Valencia (Spain). The company designs,
manufactures and sells a proprietary portfolio of innovative wearable wireless medical
technologies for cardiac prevention, diagnosis and rehabilitation.
215
EXHIBITION GUIDE
Ivia Aquileia 37
20092 Cinisello Balsamo, Italy
Phone: +39 340 2660439
Website: www.microlife.it
Contact Person: Valter Belloni
2014
SANIMPRESA
BOOTH n. 13
EXHIBITION GUIDE
Via Enrico Tazzoli,6
00195 Rome, Italy
Phone: +39 06.37.51.17.14
Fax: +39 06.37.500.617
Website: www.sanimpresa.it
Contact Person: Lorenzo Ciavoni
With its 80,000 associated workers and more, Sanimpresa is the point of reference for
companies and working categories. Sanimpresa’s numbers speak for themselves. The non-profit
organization, established by sectoral collective bargaining, increased its catchment area, being
the only one organization for every branch of the tertiary sector.
Since November 2006, moreover, Sanimpresa has approved the possibilities of admission for
every working category that provided integrative health care in their collective bargaining.
Sanimpresa provides high level health services in the best clinics, health centers and laboratories
in Rome, in Lazio, in Italy.
Sanimpresa’s health policy costs 252 euro per year: less than a coffee a day.
Sanimpresa – Cassa di assistenza sanitaria integrativa di Roma e del Lazio – Via Enrico Tazzoli
n°6 – 00195 Roma. Tel. 06/37511714 – fax 06/37500617 – email: [email protected] – www.
sanimpresa.it
SORIN GROUP ITALIA SRL
BOOTH n. 18
Via Benigno Crespi 17
20159 Milan, Italy
Phone: +39 02 69465368
Fax: +39 02 69465343
Website: www.sorin.com
Contact Person: Patrizia Garavaglia
Sorin Group is a global medical device company and a leader in the treatment of cardiovascular
diseases. The Company develops, manufactures and markets medical technologies for cardiac
surgery and for the treatment of cardiac rhythm disorders.
With over 3,500 employees worldwide, the company focuses on three major therapeutic areas:
Cardiopulmonary bypass, Cardiac rhythm management (CRM) and Heart valve repair and
replacement.
216
2014
ST. JUDE MEDICAL
BOOTH n. 1
Turning What If Into Why Not™
What if a company could invent breakthrough technologies that transform the treatment of some
of the world’s most expensive epidemic diseases? At St. Jude Medical we are turning what if
into why not by partnering with physicians, hospitals and insurers to save and improve millions
of lives worldwide, while reducing health care costs for all. St. Jude Medical is committed to
meeting or exceeding the high quality and safety expectations of our patients, customers and
regulators. Quality is the shared belief that unites all 16,000 of our employees; it is built into
everything we do and is the guiding principle behind every product we create. Headquartered in
St. Paul, Minn., USA, St. Jude Medical is a global medical technology leader focused on six key
treatment areas: Heart Failure, Arrhythmias, Vascular Disease, Structural Heart, Chronic Pain,
Neurological Diseases.
VENICE ARRHYTHMIAS
BOOTH n. 27
c/o Adria Congrex srl
Via Sassonia, 30 47921 Rimini
Phone: +39 0541.305820
Fax: +39 0541 305842
E-Mail: [email protected] ; [email protected]
Website: www.venicearrhythmias.org
Contact Person: Rita Reggiani
Venice Arrhythmias 2015 will be held in Venice, Italy on October 16-18, 2015, under the auspices
of the most important International Scientific Societies.
The Scientific program will be focused on the following central topics: Atrial Fibrillation Ablation,
Syncope, Heart Failure and Cardiac Resynchronization Therapy, Pacemakers and ICDs, Sport and
Arrhythmology, Surgical Approach to Cardiac Arrhythmias.
It also provides special Corner Sessions prepared in co-operation with Scientific Societies and
representatives of different geographic areas, including emerging countries. A unique feature of the 14th International Workshop will be a special program dedicated to the
relationship between Food and Arrhythmias.
217
EXHIBITION GUIDE
Centro Direzionale Colleoni
Palazzo Andromeda, 20/3
20864 Agrate Brianza (MB), Italy
Phone: +39 039 607471
Fax: +39 039 6074744
Website: www.sjm.com
Contact Person: Luciano Resnati
2014
VIOLATECH
BOOTH n. 14
Via Armando Armuzzi, 6
00122 Rome, Italy
Phone: +39 06.5922087
Fax: +39 0659290468
Website: www.violatech.it
Contact Person: Daniela Coluzzi
EXHIBITION GUIDE
Violatech operates in the field of high specialized supplies offering the most advanced equipment
and life-saving devices for the Interventional Cardiology, Vascular Surgery, Interventional
Radiology, Electrostimulation and Cardiac Surgery.
WISEPRESS LTD
BOOTH n. 22
25 High Path
Merton Abbey, London, United Kingdom
Phone: +44 2087151812
Fax: +44 2087151722
Website: www.wisepress.com
Contact Person: James Davie
Wisepress.com, Europe’s leading conference bookseller, has a range of books and journals
relevant to the themes of the meeting. In addition to attending 200 conferences per year,
Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow
us on Twitter for the latest news @WisepressBooks.
218
2014
WSA – World Society Of Arrhythmias
BOOTH n. 17
In confederation with national and international scientific societies, the WSA promotes worldwide
education in the fields of cardiac pacing and electrophysiology and supplies an international
platform for scientific exchange. Every four years the WSA hosts the World Congress on
Cardiac Pacing and Electrophysiology. The XV WSA – World Congress on Cardiac Pacing and
Electrophysiology will be held from “September 17 to 20, 2015 in Beijing” and will be organized
by the next Secretary General Prof. Zhang Shu.
219
EXHIBITION GUIDE
Cardiovascular Department, S.FilippoNeri Hospital
Via G. Martinotti 20
00135 Rome, Italy
Phone: +39 06 3306 3191
Fax: +39 06 3306 2489
Web Site: www.wsa-icpes.org
Contact Persons: Prof. Massimo Santini
Ms. Giulia Carganico (Secretary)
INDEX OF CHAIRMEN AND AUTHORS
2014
220
2014
221
2014
222
2014
Scientific Secretariat
Cardiovascular Department – S. Filippo Neri Hospital
Via G. Martinotti, 20 – 00135 Rome, Italy
Ph. +39 06 33063191 – Fax +39 06 33062489
AIM Group International
Via Flaminia, 1068 – 00189 Rome, Italy
Ph. +39 06 330531 – Fax +39 06 33053229
223
SECRETARIATS
Organizing Secretariat

FINAL PROGRAMME Chairman: Massimo SANTINI Co-Chairmen: Renato P. RICCI, Claudio PANdozI www.pacing2014.com

Transcription

Similar documents

Carta topografica di Roma. From the collection of the

Fibrillazione atriale persistente e Fibrillazione atriale asintomatica

The Westin Excelsior Rome for meeting and events

atrial fibrillation - BK1

University of Rome La Sapienza

2014

airfare booking secrets get the best rates to

Eating in Rome - SuperBreak Blog

ENG - PETRAPAPAE Casavacanza in Roma